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Abstract
REACH: a mixed-methods study to investigate the
measurement, prediction and improvement of retention and
engagement in outpatient HIV care
Alison Howarth,1 Vanessa Apea,2 Susan Michie,3 Steve Morris,4
Memory Sachikonye,5 Catherine Mercer,1 Amanda Evans,6
Valerie Delpech,7 Caroline Sabin1 and Fiona Burns1,6*
1Research Department of Infection and Population Health, University College London,
London, UK
2The Ambrose King Centre, Barts Health NHS Trust, London, UK
3Centre for Behaviour Change, University College London, London, UK
4Department of Applied Health Research, University College London, London, UK
5UK Community Advisory Board (UK-CAB), London, UK
6Royal Free London NHS Foundation Trust, London, UK
7Public Health England, London, UK
*Corresponding author f.burns@ucl.ac.uk
Background: Antiretroviral therapy (ART) benefits individuals living with human immunodeficiency virus
(HIV) through reduced morbidity and mortality, and brings public health gains through a reduction in HIV
transmission. People living with human immunodeficiency virus (PLWH) need to know their HIV status and
engage in HIV care in order for these individual and public health benefits to be realised.
Objective: To explore, describe and understand HIV outpatient attendance in PLWH, in order to develop
cost-effective interventions to optimise engagement in care.
Design: A mixed-methods study incorporating secondary analysis of data from the UK Collaborative HIV
Cohort (UK CHIC) study and primary data collection.
Methods: Phase 1 – an engagement-in-care (EIC) algorithm was developed to categorise patients as in care
or out of care for each month of follow-up. The algorithm was used in group-based trajectory analysis to
examine patterns of attendance over time and of the association between the proportion of months in
care before ART initiation and post-ART mortality and laboratory test costs. Phase 2 – a cross-sectional survey
was conducted among patients attending seven London HIV clinics. Regular attenders (all appointments
attended in past year), irregular attenders (one or more appointments missed in past year) and non-attenders
(recent absence of ≥ 1 year) were recruited. A ‘retention risk tool’ was developed to identify those at risk of
disengaging from care. Individual in-depth interviews and focus groups were conducted with PLWH. Phase 3 –
key informant interviews were conducted with HIV service providers. Interventions were developed from the
findings of phases 2 and 3.
Results: Plots from group-based trajectory analysis indicated that four trajectories best fitted the data.
Higher EIC is associated with reduced mortality but the association between EIC before starting ART, and
post-ART mortality [relative hazard (RH) per 10% increase in EIC 0.29, 95% confidence interval (CI) 0.18 to
0.47] was attenuated after adjustment for fixed covariates and post-ART cluster of differentiation 4 counts
and viral loads (RH 0.74, 95% CI 0.42 to 1.30). Small differences were found in pre-ART EIC and the costs
of post-ART lab tests. The final model for the retention risk tool included age at diagnosis, having children,
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recreational drug use, drug/alcohol dependency, insufficient money for basic needs and use of public
transport to get to the clinic. Quantitative and qualitative data showed that a range of psychological,
social and economic issues were associated with disengagement from care. The negative impact of stigma
on attendance was highlighted. Interventions were proposed that support a holistic approach to care
including peer support, address stigma by holding clinics in alternative locations and involve training staff
to encourage attendance.
Conclusions: The study shows the adverse health impacts of disengaging from HIV care and demonstrates
the importance of the wider health and social context in managing HIV effectively. Although phase 1
analysis was based on UK data, phases 2 and 3 were limited to London. The interventions proposed are
supported by the data but their cost-effectiveness requires testing. Future research is needed to evaluate
the interventions, to validate our retention risk tool across populations and settings, and to fully analyse
the economic costs of disengaging from HIV care.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
The UK CHIC study is funded by the Medical Research Council UK (grant numbers G0000199, G0600337,
G0900274 and M004236).
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Glossary
Adolescents and Adults Living with Perinatal HIV A prospective cohort study of two groups of young
people: perinatally human immunodeficiency virus-infected individuals and human immunodeficiency
virus-negative controls.
Agenda for Change The NHS grading and pay system for all staff, except apprentices, doctors, dentists
and some senior managers.
Antiretroviral therapy Treatment for people with human immunodeficiency virus; the standard
treatment is a combination of three or more drugs that suppress human immunodeficiency virus
replication.
Area under the receiver operating characteristic curve A graphical plot illustrating the performance
of a binary classifier system as its discrimination threshold is varied.
Cluster of differentiation 4 Cluster of differentiation 4 cells are white blood cells which play an
important role in the immune system; the cluster of differentiation 4 count indicates how strong the
immune system is.
COM-B model ‘Behaviour system’ proposing that behaviour (B) occurs as an interaction between three
necessary conditions of capability (C), opportunity (O) and motivation (M).
Computer-assisted self-interview A research technique in which the respondent uses a computer to
answer the questions.
Duke-UNC Functional Social Support Questionnaire An eight-item survey instrument to measure the
strength of an individual’s social support network.
HIV and AIDS Reporting System A data set of information on patients diagnosed with human
immunodeficiency virus and attending human immunodeficiency virus outpatient care in England, Wales
and Northern Ireland.
Household Food Insecurity Access Scale A nine-item survey instrument that is used to distinguish
food-insecure from food-secure households across different cultural contexts.
Indefinite leave to remain The right to stay in the UK without any time restrictions.
Irregular attender A person living with human immunodeficiency virus who has missed one or more of
their human immunodeficiency virus outpatient clinic appointments within the past year and not rebooked
within 4 weeks.
Men who have sex with men Any male who engages in sexual activity with members of the same sex,
irrespective of sexual identity.
Non-attender A person living with human immunodeficiency virus who has experienced a period of
non-attendance for a year or more at any human immunodeficiency virus outpatient service that ended
within the past year.
Non-nucleoside reverse transcriptase inhibitor Antiretroviral therapy that is used to treat the human
immunodeficiency virus.
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xv
Patient Health Questionnaire A four-item survey instrument used for brief and accurate measurement
of depression and anxiety.
People who inject drugs People who inject drugs, often in the context of substance dependence and/or
recreational drug use.
Protease inhibitor A class of antiretroviral therapy that is widely used to treat the human
immunodeficiency virus/acquired immunodeficiency syndrome.
Psychological Well-Being Scales A survey instrument that measures the multiple facets of psychological
well-being.
Regular attender A human immunodeficiency virus patient who has attended all human
immunodeficiency virus clinical appointments in the past year.
UK Collaborative HIV Cohort A database of routinely collected clinical information on human
immunodeficiency virus-positive adults who have attended one of the collaborating centres for care since
in 1996.
Value added tax An indirect tax on the domestic consumption of goods and services.
Viraemia The presence of detectable virus in the blood.
Viral load The amount of human immunodeficiency virus in the blood expressed in copies/ml.
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List of abbreviations
–2LL minus twice the log-likelihood
AALPHI Adolescents and Adults Living with
Perinatal HIV
AfC Agenda for Change
AIDS acquired immunodeficiency
syndrome
aOR adjusted odds ratio
ART antiretroviral therapy
ASTRA Antiretrovirals, Sexual Transmission
Risk and Attitudes
AUROC area under the receiver operating
characteristic
BIC Bayesian information criterion
BMQ Belief about Medicines
Questionnaire
CASI computer-assisted self-interview
CD4 cluster of differentiation 4
CI confidence interval
COM-B ‘capability’, ‘opportunity’,
‘motivation’ and ‘behaviour’
DUFSS Duke-UNC Functional Social
Support Questionnaire
EIC engagement in care
FG focus group
GP general practitioner
GUM genitourinary medicine
HARS HIV and AIDS Reporting System
HIV human immunodeficiency virus
IA irregular attender
IQR interquartile range
LTFU lost to follow-up
MARS Medication Adherence Report Scale
MDT multidisciplinary team
MSM men who have sex with men
NA non-attender
NNRTI non-nucleoside reverse transcriptase
inhibitor
NRA not regular attender
PHQ4 Patient Health Questionnaire
PI protease inhibitor
PLWH people living with human
immunodeficiency virus
PWB Psychological Well-Being Scales
RA regular attender
REACH Retention and Engagement Across
Care services for HIV positive
patients in the UK
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SD standard deviation
UK-CAB UK Community Advisory Board
UK CHIC UK Collaborative HIV Cohort
DOI: 10.3310/hsdr05130 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Howarth et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xvii

Plain English summary
Medication for human immunodeficiency virus (HIV) is highly effective but lifelong. People living withHIV need to take their medication regularly and have their health monitored at a specialist HIV clinic.
This is vital for their health, and reduces the possible transmission of HIV and cost of missed appointments
to the NHS.
We looked at patient data collected over 12 years from HIV clinics across the UK to examine the
consequences of not keeping up appointments at the HIV clinic. This showed that people who attend
the clinic on a regular basis have a healthier immune system and are likely to live longer.
We conducted a survey among 983 people living with HIV in London, organised interviews and focus
groups, and interviewed health-care professionals. Patients were generally satisfied with their HIV care.
People who were younger, had been diagnosed for longer, had children or had drug issues tended to have
greater difficulties with attendance. We developed a formula that clinics can use to identify people who
may find it difficult to keep up their appointments in the future, so that clinic staff can intervene to
help them.
The stigma associated with HIV has a strong negative impact on attendance and our study suggests a need
to manage the complex psychological, social and economic issues which stop people attending their
appointments at the clinic. Our findings support holistic, multidisciplinary approaches to care, including
peer support from other people living with HIV. Clinics held in alternative locations may help those who
are afraid to be seen at the HIV clinic.
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Scientific summary
Background
The number of people living with human immunodeficiency virus (PLWH) in the UK is estimated to be
107,800 and continues to rise. Although those who are diagnosed promptly and treated successfully with
antiretroviral therapy (ART) now have a similar life expectancy to that of the general population, PLWH
who engage poorly with human immunodeficiency virus (HIV) care have poorer health outcomes and are
at risk of increased mortality. ART also reduces the HIV viral load, thereby reducing the risk of onwards
transmission of HIV. Maintaining PLWH in care may furthermore reduce the costs of emergency department
visits and hospitalisations, as well as the cost of missed outpatient attendances, which can be as high as
25% in London.
In order to achieve these individual, public health and financial benefits, PLWH must be aware of their HIV
status and have sustained engagement in care (EIC). Studies have found that PLWH in the UK are more likely
to disengage if they are female, younger, of black ethnicity and not on ART. They are also likely to have
complex social needs, poorer mental health and be affected by HIV stigma. However, engaging PLWH in
care remains a major challenge and the evidence on the factors that need to be addressed is limited. There
have, furthermore, been no trials to evaluate interventions to improve engagement in HIV care in the UK.
The ultimate aim of the Retention and Engagement Across Care services for HIV positive patients in the UK
(REACH) study is to ensure the effective use of resources to improve engagement in HIV care and optimise
health and economic outcomes.
Objectives
The REACH study set out to explore HIV outpatient attendance in PLWH, in order to develop cost-effective
interventions to optimise EIC. Its objectives were to:
l examine HIV outpatient attendance patterns among PLWH
l identify predictive factors of disengagement
l investigate the potential health and financial costs of disengaging from care
l develop a retention risk assessment tool
l understand the situational, environmental, behavioural and social factors influencing outpatient attendance
l develop intervention models to improve EIC, to be tested in future studies.
Methods
We conducted a mixed-methods study in three phases, involving secondary analysis of routine clinical
data and primary data collection. Phase 1 was an analysis of data from the UK Collaborative HIV Cohort
(UK CHIC) study. We developed an algorithm to identify whether patients were in care or out of care for
each month of follow-up, incorporating a time-updated measure of patients’ treatment and health status.
The EIC algorithm was used in group-based trajectory analysis to identify individuals following similar
progressions of attendance over time. The algorithm enabled examination of the association between
background factors and the proportion of months that patients were engaged in HIV care; and the
association between EIC and mortality. We examined EIC before starting ART and its association with
mortality and the cost of laboratory tests after ART initiation.
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Phase 2 was a quantitative and qualitative examination of patient experience. The quantitative component
comprised a cross-sectional survey among patients recruited from seven London HIV clinics (from May
2014 to August 2015). We recruited regularly attending patients who had attended all intended HIV
clinical appointments in the past year, irregularly attending patients who had missed one or more intended
HIV clinical appointments in the past year, and non-attending patients who had experienced a period of
non-attendance for 1 year or more that ended within the past year. Patients self-completed an anonymised
questionnaire containing 80 questions, which took about 20–30 minutes. Questionnaire responses were
linked to clinical data by clinic staff. Questions were based on variables from the COM-B (‘capability’,
‘opportunity’, ‘motivation’ and ‘behaviour’) model, which proposes that behaviour occurs as an interaction
between three necessary conditions of capability, opportunity and motivation.
Survey data were analysed to develop a ‘retention risk tool’ that may help clinicians identify newly diagnosed
patients at risk of disengaging from care. Variables were considered for inclusion in the model if they were
potentially predictive of future disengagement at the time of diagnosis. Multivariable backwards-stepwise
binary logistic regression was used to select the best set of variables predicting poor attendance. Standard
methods for assessing model effectiveness were applied. Survey data were also analysed to examine the
factors associated with membership of the three attendance groups.
The qualitative component of phase 2 involved exploratory, face-to-face, semistructured interviews with
a purposively selected sample of men and women recruited via the HIV clinics where survey recruitment
took place (from June 2014 to February 2015). Participants were recruited to ensure maximum diversity
in attendance pattern and key characteristics. Interviews took 60–90 minutes and were based on a topic
guide developed from the COM-B model, as described above. Participants were given a £20 high street
voucher for taking part. We also conducted two focus groups (FGs) with PLWH who had all experienced
a prolonged period of non-attendance. The groups were made up of (1) gay men and (2) black African
men and women (January 2015). Participants were recruited via community contacts and were paid £30
for participation. The data from the patient interviews and the FGs were combined and a thematic analysis
was conducted using framework.
Phase 3 was a key informant study to examine how to optimise engagement in HIV care from the service
provider perspective. The sampling frame was defined according to key constituencies in the field of
HIV service provision: clinical services, public health, academia, community support, health promotion
and policy. Interviews were based on a topic guide and took about 30 minutes. A thematic analysis
was conducted.
Data from phases 2 and 3 informed the development of interventions to improve engagement in HIV care,
for which preliminary analyses of the costs were undertaken.
Results
Phase 1: patterns and associations with engagement in HIV care
Phase 1 involved use of the EIC algorithm in a group-based trajectory analysis to examine patterns of
attendance for patients who were diagnosed during three 3-year periods from 2000 to 2002 (n = 6110),
from 2003 to 2005 (n = 6747) and from 2006 to 2008 (n = 5615). We compared the interpretability and
statistical fit of the models for each of the three diagnosis periods, for one to five trajectories. The best
model for all three diagnosis groups included four trajectories. As this analysis resulted in three different
models (one for each of the 3-year diagnosis periods) and the interpretation of the trajectories was not
clear, we used the proportion of time in care as a more straightforward and flexible measure of
engagement for further analyses.
Our exploration of associations with the EIC measure included 44,432 patients, contributing 3,021,224 months
of follow-up. Univariable analysis indicated that EIC was higher in later calendar years and for those who were
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men, aged > 45 years, of white ethnicity, who acquired HIV through sex between men, had higher nadir and
current cluster of differentiation 4 (CD4) counts and had been recently first seen at the clinic. In multivariable
analysis, after controlling for the other factors, there was no strong association between gender and EIC, those
currently on ART had higher levels of engagement, only those of ‘other’ ethnicities appeared to have poorer
EIC and, after adjustment for the nadir CD4 count, current CD4 count did not provide any independent
association with EIC.
We examined the association between the EIC measure and health outcomes. After adjusting for fixed
covariates and ART status, higher EIC was associated with improved mortality and a combined measure of
acquired immunodeficiency syndrome/mortality at least 1 year into the future. Further analysis indicated
that those with lower EIC had poorer CD4 counts both at the time of EIC assessment and over the
subsequent 12 months. We found an association between EIC before starting ART and mortality after
starting ART that was attenuated after adjustment for fixed covariates and post-ART CD4 counts and viral
loads. Overall, the analyses indicated that higher levels of engagement in HIV care is strongly associated
with reduced mortality at all stages of infection. Our analysis of the economic costs of disengaging from
care showed only small differences in EIC before starting ART and costs of lab tests after ART initiation.
Phase 2: analysis of survey data
Patients taking part in our survey during phase 2 (n = 983) comprised 550 regular attenders (RAs),
269 irregular attenders (IAs) and 164 non-attenders (NAs). Survey data were used to develop a retention
risk tool to identify newly diagnosed patients at risk of disengaging from care. We used binary logistic
regression to examine 17 variables that were potentially predictive of future disengagement from care and
significantly associated (p < 0.05) with poor attendance. The final model included age at diagnosis, having
children, recreational drug use, drug/alcohol dependency, not enough money for basic needs and use of
public transport to get to the clinic.
We conducted multivariable analyses of factors relating to irregular and non-attendance, adjusting for the
clinic that the respondent was attending, age, gender and education. Our analysis indicated that irregular
attendance (missed appointments) was associated with being female, younger, diagnosed with HIV for longer,
having children, symptoms of neurocognitive impairment, poorer recent health, diagnosis of depression,
complex needs according to the HIV and AIDS Reporting System (HARS) category 3 criteria, HIV-related
hospitalisation, drug/alcohol dependency issues, uncertainty about being in charge of life, telling family about
HIV status, not getting help when sick in bed and not having money for basic needs. Non-attendance (period
of disengagement from care) was associated with being female, younger, less educated, diagnosed with HIV
for longer, having children, not being registered with a general practitioner (GP), not being a homeowner,
recreational drug use, drug/alcohol dependency issues, telling family about HIV status, not getting help when
sick in bed, not having money for basic needs and not feeling listened to by the nurse.
Phases 2 and 3: analysis of qualitative data
Phase 2 included patient interviews with 10 RAs, 13 IAs and 10 NAs. We conducted two FGs with (1) four
gay men and (2) six black African men and women. Phase 3 involved 19 semistructured interviews with
service providers and funders. We interviewed six health-care professionals, two public health experts,
three academics, six representatives from community support/health promotion and two policy experts.
All qualitative data from phases 2 and 3 were integrated into the findings that follow and presented under
the three headings of capability, motivation and opportunity.
Capability
Capability included physical capability whereby patients missed appointments if they felt unwell, although
feeling ill could provide the impetus to return to care when patients had stopped attending. Psychological
capability to attend was adversely effected when people had used alcohol or recreational drugs and others
said they sometimes simply forgot their appointments. Poor knowledge about HIV increased fear and
self-stigma and better understanding was associated with better EIC. Peer support was a key channel
through which knowledge and empowerment were gained.
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Motivation
Motivation to attend the HIV clinic was challenged when people did not want to think about HIV or felt
well. Depression was particularly prevalent among IAs and NAs who talked about an inability to do anything
when they were depressed. Poor self-efficacy and low self-esteem also undermined EIC. Some patients
avoided the clinic when they had not taken their medication; they felt embarrassed or did not want to be
‘told off’. On the other hand, the clinic provided a safe place where patients could talk about HIV.
Opportunity
Opportunity incorporates social influences and some people were afraid that someone would find out
about their HIV status when they attended the clinic. Most patients had good relationships with clinic staff,
providing good reason to attend, but communication problems could contribute towards disengagement.
Partners could also motivate patients to attend or undermine and de-motivate them. Peers could be very
powerful in helping people engage with care. Opportunity was affected by financial and social issues, child
care and work responsibilities, which meant that some patients did not prioritise their HIV care.
Interventions to improve engagement in care
We identified four interventions based on our findings and put together a preliminary analysis of their
costs. The first three interventions are targeted at people who have disengaged from care or are at risk of
doing so. Intervention one involves structured peer involvement, offering up to eight one-to-one sessions
with a peer worker and costing £538 per patient for 6 months. Intervention two is a one-stop-shop
weekly multidisciplinary clinic including a consultant, nurse specialist, psychologist, social worker and peer
caseworker, costing £398 per patient for 6 months. Intervention three is a weekly clinic with a consultant
and nurse specialist at an alternative location, such as a library, GP surgery or pharmacy, costing £302 per
patient for 6 months. The fourth intervention was proven to be successful in the USA through the use of
clinic-wide co-ordinated messaging to encourage attendance, with a one-off cost of £2 per patient.
Conclusions
The REACH study has shown the adverse health impacts of disengaging from HIV care. We have identified
a range of factors associated with disengaging from care and developed a retention risk tool to help
determine who is at risk of suboptimal EIC. Our findings have demonstrated the importance of the wider
health and social context in managing HIV care effectively and suggest that interventions need to address
broader issues that impact on health-care utilisation. We have developed two complex interventions
providing holistic approaches to care which benefit from the strengths of peer support and aim to manage
the multiple psychological, social and economic issues which deter optimal engagement in HIV care.
We have developed a third intervention that provides an alternative clinic setting for people with concerns
about disclosing their HIV status. Our fourth intervention uses co-ordinated messaging to encourage
attendance and improve communication with all patients.
Future research priorities
1. Full health and economic evaluation of the four interventions that we have identified through
implementation within robust clinical trials.
2. Testing of the predictive power of our retention risk tool across different clinic populations and settings.
3. Analysis of the economic costs of disengaging from HIV care based on a wide range of NHS
resource use.
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Chapter 1 Background
The introduction of combination antiretroviral therapy (ART) has led to a dramatic reduction in humanimmunodeficiency virus (HIV)-associated morbidity and mortality.1 The life expectancy for successfully
treated people living with human immunodeficiency virus (PLWH) in the UK is now similar to that of the
general population2 and ART is also recognised as an effective means of reducing HIV transmission.3
However, the individual and public health benefits of HIV treatment can be achieved only if PLWH are
aware that they are HIV positive, have linked into care and have sustained engagement with care
thereafter. Although interest in this area has increased over the past decade and retention in HIV care
is now a key measure of quality performance for HIV service providers in the UK,4 it remains a major
challenge, with little evidence available on how to optimise engagement in care (EIC).5 The Retention and
Engagement Across Care services for HIV positive patients in the UK (REACH) study set out to explore,
describe and understand attendance of PLWH at HIV outpatient services in order to support the
development of cost-effective interventions to improve EIC.
The Joint United Nations Programme on HIV and AIDS (UNAIDS)6 set a target that, by 2020, 90% of PLWH
should know their HIV status; 90% of those with diagnosed HIV should be on ART; and 90% of people
receiving ART should be virally suppressed. The number of PLWH in the UK is estimated to be 107,800
(2.8 per 1000 population aged 15–59 years),7 and only 75% are estimated to be aware of their infection.
Once diagnosed, however, year-on-year retention in HIV care is generally good, with only 5% of HIV
patients in the UK reported as ‘lost to follow-up’ (LTFU) in any 1 year. On the other hand, cumulative drop
over a 10-year period could be as high as one in five patients8 and an analysis of UK cohort data has shown
that 17.4% of HIV patients are potentially LTFU.9 Although the majority of those in HIV care (90%) are on
ART and 90% are virally suppressed, we should consider the serious consequences for those who drop out
of care. Published studies show that poorer health outcomes, including failure to suppress the viral load,
increased drug resistance, reduced cluster of differentiation 4 (CD4) response and acquired immunodeficiency
syndrome (AIDS)-defining illness, are consistently reported among HIV patients who engage poorly with
care.5,10,11 Furthermore, poor engagement in HIV care is associated with increased mortality.12–14
The REACH study is particularly timely in the current context of expanded HIV testing and the development
of ‘test and treat’ as a form of secondary HIV prevention.15 Innovative models of care to improve early
diagnosis of HIV must be complemented by strategies to promote long-term integration into care in order
to realise the benefits of wider testing and treatment on the future spread of HIV in the UK.
The REACH study set out to examine those who are attending clinics but not at the optimal level, as well
as those LTFU. Missed outpatient appointments also have significant resource implications for service
providers, with the financial cost of missed appointments to the NHS estimated to be between £585M and
£1B.16–18 National outpatient non-attendance rates, which vary from 5% to 16%, are higher among
younger patients and those in deprived areas18 and unpublished data from London HIV clinics indicate that
outpatient non-attendance for PLWH can be as high as 25%. Retaining HIV patients in care may also
reduce emergency department visits and hospitalisation,19,20 and the resultant financial costs.
In order to explore patterns of retention and engagement in HIV care, it is essential to adopt a valid and
reliable measure, and yet there is no gold standard measure of engagement in HIV outpatient care.
Researchers have assessed retention in care in a number of different ways.21–25 These measures have
their own strengths and weaknesses,26 but none of them takes into account the fact that frequency of
attendance is related to changes in treatment and health status and may also be affected by external
forces or changes in clinic policy. In the UK, for example, guidelines at the time the REACH study was
conducted indicated that patients should be seen within 2–4 weeks of starting ART and every 3–6 months
for routine monitoring on ART if they were considered ‘stable’, with good adherence and an undetectable
viral load.27 Given that frequency of monitoring is dependent on treatment and health status and that gaps
between clinic visits may vary quite considerably within the current guidelines, the REACH study aimed to
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develop a measure of EIC that would be sensitive to changes at an individual or clinic level over time. This
measure was then to be applied to an investigation of the health and economic impacts of disengaging
from HIV care.
A better understanding of the factors associated with retention in HIV care and a means to predict
disengagement is essential for both individual and public health benefit. Previous studies have examined
the association between engagement in HIV care, as defined by one of the measures described above, and
background characteristics. Although health service provision and populations of PLWH vary from country
to country, these studies suggest that PLWH are less likely to disengage from care if they are male,8
older,8,21,28,29 white8,22 and men who have sex with men (MSM)22,23 and have started ART.8,21 Socioeconomic
factors and education have been highlighted in relation to disparities in EIC30,31 and complex patient
groups, such as intravenous drug users, migrants and the newly diagnosed, are more likely to disengage
from care.23 Although recent diagnosis is associated with poor retention in care,8 there is also an indication
that EIC can diminish over time.22
Some studies have used qualitative methods and psychometric measures to try and understand why patients
do not engage with care. HIV stigma is found to be a significant barrier32–35 and health beliefs may also deter
people from attending for care.36 A qualitative study on non-attendance of HIV clinics in Scotland highlighted
issues of mental health, isolation, stigma, poverty and complex social circumstances as contributing to
disengagement from care.37 The REACH study set out to collect extensive quantitative and qualitative data
and bring this evidence together to better understand who disengages from HIV care and why.
There have been, to our knowledge, no trials to evaluate interventions to improve engagement in HIV care
in the UK. Although a number of interventions have been tested in the USA, a recent systematic review
found only 13 published studies on which to base its analysis.38 The population of PLWH and health-care
system are very different in the USA and REACH provides the data to develop interventions for the UK
context. Simple changes in the way services are delivered may be effective16 and the REACH study also helps
us understand whether or not and how previous interventions to improve EIC in other health-care settings
are likely to meet the diverse needs of PLWH in the UK. In this way, REACH provides a crucial bridge from
research that purely describes the associations with engagement in HIV care to the development of
innovative strategies to maintain patient retention. The data were used, first, to develop a diagnostic
retention risk tool to help clinicians identify newly diagnosed patients at risk of disengaging from care and,
second, to design and cost behaviour change interventions aimed at improving engagement in HIV care.
Retention in HIV care is vital for treatment success at both individual and population levels. Good
engagement is associated with improved adherence, virological and immunological outcomes and
survival.15 It is important to develop NHS services that are flexible and responsive to the needs of the
service users and that align to the wider NHS priorities of driving and achieving quality and efficiency
within service delivery. The ultimate aim of the REACH study is to ensure the effective use of resources to
improve engagement in HIV care and optimise health outcomes.
Aims and objectives
The REACH study aimed to explore, describe and understand HIV outpatient attendance in PLWH, in order
to develop cost-effective interventions to optimise their EIC.
Its objectives were to:
1. examine HIV outpatient attendance patterns among PLWH
2. identify predictive factors of disengagement
3. investigate the potential health and financial costs of disengaging from care
4. develop a retention risk assessment tool
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5. understand the situational, environmental, behavioural and social factors influencing outpatient attendance
6. develop intervention models to improve EIC, to be tested in future studies.
The full protocol has been published on the National Institute and Health Research Health Service and
Delivery Research Programme website. The REACH Management Team met quarterly and benefited from
an Advisory Group made up of a clinician from each of the recruitment sites and a patient representative,
and a Study Steering Committee made up of four independent experts (see Appendix 1). The Advisory
Group met every 6 months and the Study Steering Committee met once a year. In between meetings,
communication was electronic, including a quarterly progress update.
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Chapter 2 Methods
This chapter describes the methods used to address the aims and objectives of the study. Differentmethodologies were adopted to address the broad range of objectives that the study sought to address
and the following description of them is divided up according to the three key phases of the study:
Phase 1: analysis of the UK Collaborative HIV Cohort database and
predictive modelling
During this phase, we explored HIV outpatient attendance (objective 1), identified predictive factors of
disengagement (objective 2) and investigated the potential health and financial costs of disengagement
(objective 3).
Phase 2: examining patient experience
The second phase of this study comprised quantitative and qualitative methods to understand the factors
that influence outpatient attendance (objective 5). Findings contributed to the development of a retention
risk assessment tool (objective 4) and informed development of intervention models to improve EIC
(objective 6).
Phase 3: key informant study
The final phase of the study aimed to understand the factors that influence outpatient attendance
(objective 5) from the service providers’ perspective. It informed development of intervention models to
improve EIC (objective 6).
After this, we describe how we calculated the costs for our proposed intervention models and the patient
and public involvement in the study.
Phase 1: analysis of the UK Collaborative HIV Cohort data
In this section, we describe phase 1 of the study, which consisted of a detailed analysis of the UK
Collaborative HIV Cohort (UK CHIC) database, including an exploration of attendance patterns and factors
associated with disengagement from care.
Outpatient attendance patterns among people living with HIV
The UK CHIC collates routine data relating to the clinical care and treatment of PLWH aged ≥ 16 years
across many of the UK’s largest HIV services (the data set utilised for the present analyses included data
from 15 HIV clinics) since 1 January 1996. The UK CHIC records incorporate additional mortality data
provided by Public Health England.
We explored the use of group-based trajectory modelling for identifying clusters of individuals following
similar, distinctive progressions of attendance over age or time.39–41 These methods were applied to the UK
CHIC data set in order to distinguish distinct broad groupings of individuals according to their pattern of
engagement with the aim of identifying a unique, statistical snapshot of the key characteristics of this
complex population. We collaborated with Dr Tracy Glass at the Basel Institute for Clinical Epidemiology
and Biostatistics, who has utilised a similar technique to explore and describe patient adherence to ART in
the Swiss HIV Cohort Study.42 Once the trajectories are identified, logistic regression analysis can then be
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used to predict the probability of an individual being in a particular group according to a particular set of
risk factors.
Group-based trajectory analysis is usually applied to a fixed period of time during which individuals are
exposed to a condition or data are collected at fixed points in time and a measure of their response can be
plotted over time. We therefore developed an EIC algorithm in order to define whether patients were in
care or out of care for each month of follow-up.
Development of engagement in care algorithm
As we know that frequency of HIV clinic attendance is related to changes in treatment and health status,
our aim was to incorporate clinical factors into our new measure of retention in HIV care.
In the absence of complete data on clinic attendances in the UK CHIC data set, we used CD4 counts, viral
loads, haemoglobin measures and ART treatment start or switch dates as markers of clinic attendance.
Patients often return for repeat laboratory tests over a short period of time to confirm unexpected findings,
resulting in clusters of attendances around a single ‘index’ date. As we did not want to consider each
attendance within a cluster as an independent visit and wanted to be able to plot whether patients were
in care or out of care for each month of follow-up, we grouped attendances into ‘care episodes’, defined
as months (period of 30.4 days since entry into the study) where at least one visit occurred. For each care
episode, we established the lowest CD4 count measured in that month (and the change from the previous
value), the highest HIV viral load (and the status of this measurement relative to other consecutive values)
and the patient’s treatment status.
In order to decide which key clinical factors should be incorporated the EIC algorithm, semistructured,
face-to-face interviews were conducted with eight HIV physicians (from August 2013 to February 2014)
who had a range of clinical experience and were selected from five of the HIV outpatient clinics where we
planned to conduct our primary data collection. We asked physicians to tell us when they planned to see
each of their last 10 patients again (number of weeks/months) and why.
A total of 73 patients were discussed in these interviews. One patient was excluded from the analysis
because the time of their next appointment was dependent on awaited test results. The time of the next
scheduled appointment was missing for another patient and not available for a further five patients who
had not attended their last scheduled appointment at the time of the physician interviews. We conducted
a content analysis of these qualitative data. For each patient, we noted the time to the next scheduled
appointment and the key reason given by their physician. We then identified factors under which to code
the key reasons.
The time of the next scheduled appointment in the 66 patients included in the analysis ranged from
1 week to 6 months, with a median of 3 months. Five factors were identified from the content analysis
of the interview data as instrumental to the timing of the next scheduled appointment. The first factor can
be summarised as ‘routine’ where patients were stable and required routine follow-up. These appointments
were mostly arranged for 4–6 months after the previous visit. A routine follow-up appointment was
arranged for 3 months’ time for one pregnant woman. Physicians talked about how they extended routine
visits to every 6 months when patients were well and stable, both on treatment and in their psychosocial
circumstances. The second factor is summarised as ‘virological’ where the next appointment was based on
change in viral load (uncontrolled or virological breakthrough). Changes in viral load brought the next
scheduled appointment forward to 1–2 months after the last. The third factor, ‘treatment’, described
where the next appointment was related to starting ART or changing an existing ART regimen. Patients
were given a next appointment date between 2 and 12 weeks later, depending on the treatment start
date and virological response or when treatment was planned to start. The fourth and fifth factors were
‘psychosocial’ where mental health or psychosocial issues were identified as instrumental and ‘physical
comorbidities’ where a range of physical comorbidities were given as the key reason for the timing of the
next appointment. Follow-up appointments of between 1 week and 4 months were arranged depending on
METHODS
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psychosocial issues (from specific concerns about mental health to more general needs for social support)
and comorbidities: both of which required earlier follow-up even when patients were otherwise stable
on treatment.
The data from the physician interviews were used as the basis for developing the EIC algorithm. Although
psychosocial well-being and comorbidities were key factors in determining the expected time between
patients’ visits, data on these variables are not captured in the UK CHIC data set. We therefore used the
clinical data that were available (HIV diagnosis, AIDS diagnosis, treatment start dates, CD4 count and viral
load) to determine the patient’s treatment and health status. These data were then used to estimate the
expected time to the next scheduled care episode, in accordance with the data collected in the physician
interviews. Table 1 shows when the next care episode was expected, according to the specified conditions.
Using the EIC algorithm, we cannot consider follow-up after the patient’s last reported care date and it
therefore focuses on intermittent periods of disengagement rather than LTFU. It should furthermore be
noted that treatment guidelines introduced in the UK in October 2015 (after our physician interviews had
been conducted) recommend starting ART irrespective of CD4 count.43 This should be incorporated into
the EIC algorithm when applied to EIC after October 2015.
The EIC algorithm gives the shortest expected gap between care episodes at 2 months. This is to allow for
the fact that clinic visits might occur at any point during the month or care episode into which they are
grouped. If the patient was within 1 month of diagnosis, had an AIDS diagnosis, started ART or changed
ART at the initial care episode, the next care episode was expected within 2 months. If the patient was not
TABLE 1 Conditions associated with the expected time of next scheduled care episode
Conditions at time of initial care episodea
Next care episode
expected within
Within 1 month of HIV diagnosis 2 months
AIDS diagnosis 2 months
Started ART 2 months
Started new combination ART regimen 2 months
Not on ART
CD4 ≤ 350 cells/mm3, any drop in CD4 2 months
CD4 ≤ 350 cells/mm3, no drop in CD4 4 months
CD4 = 351–499 cells/mm3 4 months
CD4 ≥ 500 cells/mm3, CD4 drop≥ 100 cells/mm3 4 months
CD4 ≥ 500 cells/mm3, CD4 drop< 100 cells/mm3, viral load ≥ 100,000 copies/ml 4 months
CD4 ≥ 500 cells/mm3, CD4 drop< 100 cells/mm3, viral load < 100,000 copies/ml 6 months
Already started ART
Viral load > 200 copies/ml 2 months
Viral load = 51–200 copies/ml, does not appear to be a blipb 2 months
Viral load = 51–200 copies/ml, appears to be a blip 4 months
Viral load ≤ 50 copies/ml, CD4≤ 200 cells/mm3 4 months
Viral load ≤ 50 copies/ml, CD4> 200 cells/mm3 6 months
a If more than one condition applies at time of care episode, next care episode is expected within least number of months
associated with those conditions.
b Blips are defined as having a viral load of between 50 and 200 copies/ml following a previous viral load of < 50 copies/ml.
Adapted from Howarth et al.44 This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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on ART at the initial care episode, the next care episode was expected within 2–6 months, depending
mainly on CD4 count. If the patient had started ART, it was expected within 2–6 months, depending
on viral load. We used 6 months as the maximum time between visits, as described in the physician
interviews. If more than one condition applied at the time of the initial care episode, the next care episode
was expected within the least number of months associated with those conditions.
Figure 1 shows an example of how the EIC algorithm is applied to an individual case. The date of the next
observed care episode determines whether or not the patient has attended before or after the expected
date, and each patient-month is then classified as being in care (where it occurs on or before the time of
the next expected care episode) or out of care (where it occurs after the time of the next expected care
episode) accordingly. This example begins in July 2005 when the patient was not pregnant, not recently
diagnosed, did not have an AIDS diagnosis and was not on ART. Because she was not on ART, we are
interested in her CD4 count – which was < 350 cells/mm3 and which had dropped (although that is
not shown here), so we expect to see her again within 2 months. However, she did not reattend until
6 months later. Thus, July and August are defined as being in care (blue shading), but September to
December are out of care (green shading). At the visit in January 2006, her CD4 count had continued to
drop, so we expect to see her again within 2 months. She reattended in March 2006 so January and
February are defined as being in care. In March 2006 she started ART, so we expect to see her within
2 months and she comes back within a month, remaining in care.
Group-based trajectory analysis
We then applied the EIC algorithm to the group-based trajectory analysis. Patients with complete laboratory
data who attended a participating UK CHIC clinic on at least two occasions between 1 January 2000 and
31 December 2011 were included in the analysis. Follow-up for each person was considered until the last
recorded laboratory marker or clinic visit prior to (or on) 31 December 2011. As we were interested in
patterns of attendance from diagnosis onwards, we excluded patients who had been diagnosed before
1 January 2000.
Whereas group-based trajectory analysis is usually applied to a fixed period of time, the exposure period
(or time since diagnosis) was highly variable in our analysis and related to the outcome measure of being
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8
in care or out of care. It was difficult to apply patterns of engagement to the 12-year period of follow-up
for the whole cohort because individuals contributed longer and shorter periods of follow-up, which also
varied according to the time that the patient entered or left the cohort. In an attempt to overcome this,
we examined patterns of attendance for people diagnosed over three 3-year periods (2000–2, 2003–5 and
2006–8). Although this controls the start point for the analysis to some extent, it does not account for the
fact that patient end points will vary over the course of the trajectories. We excluded attendance over
the last year of follow-up from the analysis, as this may skew the trajectories.
With group-based trajectory analysis, the researcher determines the number of trajectories each time the
analysis is run in order to test which number of trajectories gives the best fit. Models were tested with
one to five trajectories for each of the three diagnosis periods and the optimal model (which indicates
the optimal number of trajectories) was selected for each of the three diagnosis groups. This was based
on statistical fit, by comparing the Bayesian information criterion (BIC), and interpretability. Twice the
difference between the BIC for the two models under comparison is used for this purpose.39 The plots and
patterns of attendance from our group-based trajectory analysis are presented and described in Chapter 3.
However, this analysis resulted in three different models (one for each of the 3-year diagnosis periods),
which we consider to be the minimum number of models to reflect the range of diagnosis dates over a
12-year period. This makes their use in further analysis of associated factors and outcome problematic.
Association with clinical outcomes
In view of the limitations of using the findings from our group-based trajectory analysis in further analysis
to examine the associated clinical outcomes, we decided to use the proportion of time in care as a more
straightforward and fitting measure of engagement in HIV care for further analysis. The individual case
shown in Figure 1, for example, was out of care for 4 of her 10 months’ follow-up and in care for 6 of her
10 months’ follow-up = 60% of months. The EIC measure, furthermore, provides an alternative to the idea
that disengagement from care requires an individual to be LTFU for a specified period of time which does
not lend itself to quantifying the typical length of disengagement or proportion of patients that re-engage
with care, as described in our protocol.
In the following analysis, all patients who attended a participating UK CHIC clinic on two or more
occasions between 1 January 2000 and 31 December 2012 were included. The proportion of months in
which patients were engaged in HIV care was calculated overall and for patient subgroups defined by
gender, age group (< 25, 25–45 and > 45 years), ethnic group (white, black African, other and unknown),
mode of HIV acquisition (sex between men, sex between men and women, injection drug use and other/
unknown), currently on ART (yes, no), nadir and current CD4 count (both classified as < 200, 200–349 and
≥ 350 cells/mm3), participating clinic, calendar year (2000–3, 2004–7, 2008–12) and time since entry in
the study (< 1, 1–5, 5–10 and > 10 years). Each patient-month was then treated as a separate entry
in a multivariable logistic regression model with the aim of identifying demographic and clinical factors
associated with that month being in care. The analyses were performed using PROC GENMOD in SAS
version 9.4 (SAS Institute Inc., Cary, NC, USA) with generalised estimating equations used to take account
of the repeated entries within each individual patient.
Cox models were used to assess the association between mortality and (i) the cumulative proportion of
months a person had been in care; and (ii) the cumulative proportion of months a person was in care prior
to ART. For analysis (i), patient follow-up started on the date of entry to the UK CHIC study and ended at
the date of death or 6 months after the patient’s last clinic attendance, whichever occurred first. Each
person’s total period of follow-up was split into consecutive monthly intervals (as described above) and
the cumulative proportion of previous months a patient had been in care at the start of the month was
calculated for each month of follow-up. In this way, we were able to include the EIC covariate as a
continuous time-updated covariate with each person’s EIC evolving over time in the model. One of the
main limitations of analyses that investigate associations between EIC and mortality, particularly where a
time-updated covariate is used, is the potential for reverse causality whereby those who are sickest may
attend for care more frequently in the months leading up to death. This may make it appear that higher
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levels of EIC are associated with an increased risk of mortality. In order to reduce the potential for this to
bias our analyses, all measures of EIC were lagged by 12 months to separate the assessment of EIC and
the mortality outcome by a period of 1 year. At any given time over follow-up (i.e. at the start of each
patient-month that is included in the model), therefore, the lagged value of EIC that was entered into the
model was the value that was available 12 months earlier. Thus, our estimate of the relative hazard (RH)
associated with EIC will provide a description of the ability of our EIC measure to predict mortality events that
occur at least 1 year into the future. Note that, by definition, this approach will necessarily restrict analyses to
those who had attended clinic for > 1 year, as individuals who die within the first 12 months of follow-up
will not contribute any EIC values to the model and will therefore be excluded. In our primary analyses,
we adjusted for the demographic factors of age, year, gender, mode of acquisition and ethnic group
(all fixed covariates). This was followed by additional adjustment for receipt of ART as a binary time-updated
covariate. We next adjusted for the latest CD4 count, as a continuous time-updated covariate and lagged
by 12 months, to investigate whether or not any association seen was explained by the fact that those
with the lowest EIC values already had lower CD4 counts at the time of measurement of EIC. Finally, we
adjusted for the unlagged values of CD4 – this analysis explored whether or not any residual association
between EIC and mortality was mediated by lower CD4 counts over the following 12 months.
For analysis (ii), we calculated the EIC prior to ART in the subset of patients who initiated ART and who had
been under follow-up at the clinic for at least 1 year prior to ART start (to ensure that the estimate of EIC was
based on sufficient patient-months to provide a robust estimate). To explore the potential for confounding,
patients were first stratified into six groups based on their pre-ART EIC. The groups (< 50%, 50–69.9%,
70–79.9%, 80–89.9%, 90–99.9% and 100%) were chosen primarily for ease of clinical interpretation and to
ensure that each group was of sufficient size to permit robust analyses. Associations between the pre-ART EIC
value and the various demographic and clinical factors at ART start were then identified. Next, Cox models
considered the association between EIC (as a fixed baseline covariate) and mortality after ART initiation;
follow-up started at ART initiation and ended at 6 months after the patient’s last visit or death – whichever of
the two occurred first. We first adjusted for age, year, gender, mode of acquisition and ethnic group, then
type of ART received [protease inhibitor (PI)-based regimen, non-nucleoside reverse-transcriptase inhibitor
(NNRTI)-based regimen, other regimen (including those on both a PI and NNRTI)], then the CD4 count and
viral load at ART start (fixed covariates) and then, finally, the latest CD4 count and viral load (as time-updated
covariates) measured after ART start. As before, these last analyses investigate whether or not any associations
between pre-ART EIC and post-ART mortality can be explained by poorer CD4/viral load responses on ART.
Association with laboratory tests and costs
For our health economic analysis, we planned to measure the impact of disengagement on HIV management
costs. As noted in our study protocol, such an analysis was likely to be difficult as it would be limited by the
lack of NHS resource utilisation data captured in UK CHIC. Given the limited data for some but not all clinics
on outpatient clinic attendances and inpatient stays we therefore limited our study to a descriptive analysis to
selected laboratory test costs, which are reliably collected in UK CHIC across participating clinics.
Using the ART data set from analysis (ii), we calculated the total number of laboratory tests performed
within each pre-ART EIC group within each 3-month period of follow-up after ART start until the end of
the fourth year after starting ART. We included the following tests:
l CD4
l HIV viral load
l liver function tests
l cholesterol
l high-density lipoprotein
l low-density lipoprotein
l triglycerides
l full blood count
l urea
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l creatinine
l glucose
l bone health.
Liver function tests included one or more of the following blood tests: alkaline phosphatase, alanine
transaminase, aspartate aminotransferase or bilirubin. Full blood counts included haemoglobin and/or
platelets. A patient was recorded as having a liver function test or full blood count if they had one or more
of the constituent tests on the same day. Bone health profiles were identified when a patient had a
phosphate test.
We divided the number of tests by the group size in each 3-month period (which declined over time) to
calculate the mean number of tests per patient per quarter, with the group size in each period determined
on the basis of the patient’s first and last visit dates, regardless of whether or not she/he had actually
attended for care in that period. Unit costs were applied to each laboratory test and summed across all
tests, and the mean cost per patient was calculated within each EIC and time stratum. The unit costs were
mean costs from two HIV clinics in London, measured in 2016 GBP. The unit costs are summarised in
Table 2.
Mean costs for the six pre-ART EIC groups were then plotted by quarter in the 4 years following ART start.
Given the limitations of the data we do not undertake formal tests of differences between groups over
time, but focus on descriptive trends. We were particularly interested in investigating whether or not
pre-ART EIC affected testing and test costs after starting ART, and in particular whether or not costs
became higher in the less engaged groups over time if their health declined, at a more rapid rate than in
those who had a higher pre-ART EIC value.
Although we had planned to incorporate the development of a retention risk tool into the first phase of
the study, the Management Team agreed that the REACH survey would provide a richer source of data
than the UK CHIC data set to identify clinical and non-clinical factors that may predict disengagement.
This analysis was therefore moved into phase 2 of the study and is described as follows.
TABLE 2 Unit cost of tests
Test Test cost (£)
CD4 22.27
Viral load 32.91
Liver function tests 4.68
Cholesterol 0.75
High-density lipoprotein 0.94
Low-density lipoprotein 0.47
Triglycerides 0.78
Full blood count 3.65
Urea 0.59
Creatinine 0.55
Glucose 0.76
Bone health 1.33
Costs are in 2016 GBP.
Source: two HIV clinics in London.
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Phase 2: survey, patient interviews, focus groups
Phase 2 of the study consisted of a quantitative survey followed by a nested qualitative substudy. Ethical
approval for this phase of study was obtained from the National Research Ethics Service Committee
London – City Road & Hampstead (reference 14/LO/0039). NHS permission for research (research and
development approval) was granted by the local NHS trusts.
Phase 2a: quantitative component – questionnaire and clinical
data collection
Population and setting
A cross-sectional self-completion survey was conducted with adult men and women (aged ≥ 18 years)
attending seven London clinics for HIV care between May 2014 and August 2015. Patients were excluded
from the study if they had been diagnosed with HIV within the previous 4 months or were unable to
provide informed consent. The cohort sizes, composition and models of service delivery varied across the
recruitment centres, contributing to the generalisability of the findings:
l Ambrose King Centre, The Royal London Hospital
l Bloomsbury Clinic, Mortimer Market Centre
l Clifden Centre, Homerton University Hospital
l Greenway Centre, Newham University Hospital
l Harrison Wing, St Thomas’ Hospital
l Ian Charleson Day Centre, Royal Free Hospital
l Kobler Day Care Unit, Chelsea and Westminster Hospital.
Survey sample size
The target sample size was 1000 patients from HIV clinics across London. We aimed to recruit a total of
250 irregularly attending patients and 250 non-attending patients with a comparison group of 500
regularly attending patients (definitions are given in Survey recruitment), providing over 80% power when
either disengaged group is compared with the control group to detect a difference in the prevalence of a
suspected predictor of disengagement when the population difference is 56% versus 44% or 14% versus
7%, at a 5% significance level.
Survey recruitment
Five of the seven clinics began recruitment in May 2014 and two additional sites began in November and
December 2014. Each site recruited patients until they reached their target of 200 patients or 14 August 2015,
whichever was the sooner.
Originally it was planned to apply the patterns of attendance identified in phase 1 to our survey sampling.
We had envisaged using patient records and electronic/clinical databases to derive an attendance pattern to
each patient. However, we decided against this strategy for three reasons. First, we did not find group-based
trajectory analysis to be a useful method of identifying patterns of patient attendance that could be used
for sampling. Second, applying the EIC algorithm to recruiting patients in each of the clinics would be too
complex to undertake. Third, although the UK CHIC analysis explores patterns of attendance over time, we
needed to be able to capture current behaviour for the purposes of the survey. We therefore developed a
simple algorithm that could be used by research staff in the clinics to recruit patients based on their recent
attendance behaviour.
Each clinic aimed to recruit a total of 200 patients who had attended in the following way in the past year:
l 100 regularly attending patients
¢ who had attended all intended HIV clinical appointments in the past year
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l 50 irregularly attending patients
¢ who had missed one or more intended HIV clinical appointments (which had not been rescheduled
within 1 month) in the past year
l 50 non-attending patients
¢ who had experienced a period of non-attendance for a year or more at any HIV service that ended
within the past year or continued to the present day.
Patients were approached by a member of the local research team and asked if they would like to take
part in the study. They were given an information sheet summarising the study and its key objectives, and
including contact details for the Project Management Team. The local research staff explained the purpose
of the study and answered any questions, and patients provided informed consent to participate. Patients
were encouraged to complete the questionnaire at the clinic but if they did not have time to do this, they
could take the questionnaire with them and return it using a pre-paid envelope. There was also the option
to complete the questionnaire online, but very few patients were offered this alternative and only two
responses were returned in this way.
Patients who completed a questionnaire at the clinic, handed it back to local research staff in a sealed
envelope in order to keep their responses confidential. The completed questionnaires were collected from
clinics on a regular basis.
Towards the end of the data collection period, when targeting non-attending patients, clinics were able to
send out a letter approved by the Ethics Committee inviting them to participate along with a copy of the
questionnaire and return envelope.
Study questionnaire
The anonymised pen-and-paper questionnaire was completed in clinics where it was linked to clinical data. It
contained 80 questions and took about 20–30 minutes to complete (see Appendix 2). Questions were based
on variables from the COM-B (‘capability’, ‘opportunity’, ‘motivation’ and ‘behaviour’) model (Figure 2),
Capability
Opportunity
Motivation
Behaviour
Psychological or physical ability
to enact the behaviour
Physical and social environment
that enables the behaviour
Reflective and automatic mechanisms 
that activate or inhibit behaviour
FIGURE 2 The COM-B model of behaviour. Adapted from the original figure (see Michie et al.45) through inclusion
of description of the three domains. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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which proposes that behaviour occurs as an interaction between three necessary conditions of capability,
opportunity and motivation.45 The COM-B model is at the centre of an integrative framework of behaviour
change interventions, the behaviour change wheel comprising nine intervention functions and seven policy
categories. It provides a framework for developing, evaluating and synthesising interventions, including
selecting behaviour change techniques in the development process.
A framework for REACH primary research (see Appendix 3) was created to aid our variable selection.
The framework brought together the COM-B model, the associated domains of behavioural influence
from the theoretical domains framework46 and related constructs, as well as factors associated with
engagement requiring change that were identified in an in-depth report on non-attendance of HIV services
in Scotland.37 Thus, when selecting which items should be included in the questionnaire, we could ensure
that we had adequate measures from the different sections of the framework, including the three key
domains of capability, opportunity and motivation.
Whenever possible, the questionnaire incorporated validated items used in other large-scale behavioural
surveys but new questions were developed where we were unable to find published measures. Items from
the following scales were included: three items from Household Food Insecurity Access Scale;47 all seven
items from the Strive Internalised Stigma scale;48 three items from the environmental mastery subscale of
the Psychological Well-Being Scales (PWB);49,50 five items from the Duke-UNC Functional Social Support
Questionnaire (DUFSS);51 all four items from the Patient Health Questionnaire (PHQ4);52 all three items from
the European AIDS Clinical Society screening questions for neurocognitive impairment;53 and two items
from the Health Information Competence Scale.54,55 We used the following five items from the 11-item
Belief about Medicines Questionnaire (BMQ):56,57
1. my health, at present, depends on these medicines
2. having to take these medicines worries me
3. my health in the future will depend on these medicines
4. I sometimes worry about becoming too dependent on these medicines
5. these medicines give me unpleasant side effects.
We used all five items from the Medication Adherence Report Scale (MARS).58 We did not use any of the
framing statements from the BMQ or MARS due to the limited amount of space in the questionnaire.
The questionnaire content was piloted to test feasibility and acceptability among five PLWH, including a
patient representative with extensive experience of working with people who have difficulties engaging in
HIV care. The questionnaire was piloted to test keywords and constructs with five PLWH. The content was
modified in the light of this feedback.
The final questionnaire was a 24-page printed A5 booklet. In addition, a computer-assisted self-interview
(CASI) version was developed, programmed in survey software and tested for the study. However, most of
the clinics preferred to use the paper version and the CASI version was only offered to a minority of
patients at two of the clinics and electronic responses were returned by two patients. The questionnaire
was divided into the following sections:
General information: gender, age, ethnic group, country of birth, immigration status, language,
relationship status, children, pregnancy, work status, education, religion, sexual orientation, poverty,
accommodation and hunger.
Life with HIV: date of diagnosis, place of diagnosis, activity, HIV disclosure, stigma, environmental mastery,
caring responsibilities, domestic abuse, social support, support groups and recreational drug use.
Health and health care: health status, mental health, professional support, neurocognitive impairment,
general practitioner (GP) registration, inpatient stays, health information competence.
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Human immunodeficiency virus care: reasons for missed appointments, number of clinics attended,
frequency of attendance, time at present clinic, travel to clinic, clinic hours, mode of consultations, clinic
recommendation, appointment booking, reasons for attending, communication with reception staff, nurse
and doctor, and treatment explanation.
Medicines: beliefs about medicines, ART status, home delivery service, medication adherence and reasons
for not taking ART.
Linked clinical data
Consent to participate included linking questionnaire responses to routine clinical data. The clinical data
consisted of:
Background data: age, gender, transmission group, country of birth, date of diagnosis, ART status.
These variables were checked against the questionnaire data and final variables were derived for analysis.
Clinical data: patient complexity according to category 3 criteria of the HIV and AIDS Reporting System
(HARS),59 pregnancy at diagnosis, HIV-related inpatient stays, CD4 count at diagnosis or first recorded,
CD4 count at ART initiation, most recent CD4 count, viral load at diagnosis or first recorded, most recent
viral load, AIDS-defining illness, hepatitis C coinfection, hepatitis B coinfection, mental health and
drug/alcohol dependency.
Survey data processing
Clinics were asked to keep a log of all patients who were approached to take part in the study. Each
patient was given a unique study number that was written on the front of their questionnaire and entered
into a study log. The study log was maintained securely at the clinic. In addition to the unique study
number, it contained the date of attendance, clinic number and some basic demographics (age, gender,
ethnic group), as well as the outcome of the approach. Local research staff checked the patients’
attendance pattern over the past year to assign them to one of the three attendance groups and this
information was added to the study log. Local staff transferred an anonymised version of the clinic log
(without clinic number) to the Project Management Team on a monthly basis.
The completed paper questionnaires were entered into IBM SPSS Statistics version 22 (IBM Corporation,
Armonk, NY, USA) by a data entry clerk and a randomly selected sample of one-third of the questionnaires
were checked for accuracy of data inputting.
Survey analysis
Survey data were analysed using IBM SPSS Statistics version 22 and Stata 14 (StataCorp LP, College
Station, TX, USA). The following description of the survey analysis begins with the analytical approach used
in developing the retention risk tool, followed by the analytical approach used to explore factors associated
with poor retention to care.
Analysis for retention risk tool
The retention risk tool is an equation that can be used to calculate the predicted probability that a patient
will disengage from care. If the tool or algorithm that we have developed here is externally validated in an
independent population, it could be used to help clinicians identify newly diagnosed patients at risk of
disengaging from care. It would ultimately be a practical diagnostic tool that could be incorporated into
clinical practice for multidisciplinary caregivers of HIV patients. Although we had originally planned to use
UK CHIC data to develop the tool, the REACH survey provides a richer data set for this purpose.
Univariable associations were explored (using the chi-squared test and the Student’s t-test) between
variables derived from responses to the questionnaire and clinical data from patients’ notes and whether or
not individuals had recently disengaged from care. For this analysis, we compared regular attenders (RAs)
with a combined group of irregular attenders (IAs) and non-attenders (NAs). The decision to combine IAs
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and NAs was made because the key purpose of the tool in the clinical setting will be to identify someone
at risk for any type of disengagement at the point of diagnosis. This should then be followed up with a
needs assessment for those identified as being at risk in order to intervene appropriately.
Variables were considered for inclusion in the retention risk tool (and thus included in the univariable
analysis) if they were potentially predictive of future disengagement at the time of diagnosis (i.e. variables
that pre-exist or may pre-exist diagnosis). As the tool will be tested and used in clinics not included in this
study, we excluded the clinic currently attended from the model. We excluded variables that would have
occurred after HIV diagnosis, such as HIV service use or HIV disclosure but we included time taken to get
to clinic and mode of transport, as these are more likely to remain fixed after HIV diagnosis. We also
excluded variables if they were not applicable to all patients or had very high levels of missing data
(> 40%). We excluded scales because the incorporation of several items may result in missing data that
would be problematic for their use in a practical tool. Responses to psychometric measures, in addition,
may change over time. We excluded measures of recent physical or mental health that were current or
had reference periods of < 6 months, as these may have been caused by HIV. We excluded variables with
very low prevalence (< 5%), as this may not provide sufficient variability to be appropriate for modelling.
All items needed to be suitable for collection at the patient’s baseline assessment with a HIV clinician.
Investigation of the 27 candidate variables for inclusion in the model indicated that the mean number of
missing data was 2.9% and the maximum number was 7.9%. The majority of variables (n = 21) had < 5%
missing data and six had 5–10% missing data. In view of the complicated nature of data imputation and
the small number of missing data, we conducted the analysis excluding missing data listwise, whereby all
data are removed for cases that have one or more missing values.
Variables that met the above criteria and were significantly associated (p < 0.05) with disengagement from
HIV care were included in logistic regression modelling. We used backwards-stepwise binary logistic
regression to select the best set of predictive variables associated with disengagement from care. It is
important to bear in mind that, when testing models, the general rule of thumb for not over fitting the
model is that there should at least 10 cases per covariate in the model.60 To this end, we fitted the models
by adding variables in blocks, which followed a chronological order. First, we fitted the block 1 variables to
determine which combination had the best predictive power, then we added the block 2 variables and so
on, until all blocks and all 27 variables had been added. The following blocks were applied:
l block 1: fixed sociodemographic variables
l block 2: sociodemographic variables that are subject to change over time
l block 3: variables about circumstances of HIV diagnosis
l block 4: health, mental health and drug use, ever reported
l block 5: mental health and drug use, within the past 5 years
l block 6: variables about potentially transient circumstances
l block 7: variables about getting to the clinic.
Standard methods for assessing model effectiveness were used.61–64 The Hosmer–Lemeshow goodness-of-fit
test was used to measure model calibration. A p-value that is above the threshold for statistical significance,
in this case p > 0.05, indicates that the data predicted by the model are not significantly different from the
observed data. Model discrimination was tested using the c-statistic or area under the receiver operating
characteristic (AUROC) curve. A value of 0.9–1.0 is considered excellent, 0.8–0.9 is good, 0.7–0.8 is fair,
0.6–0.7 is poor and ≤ 0.6 is worthless. The c-statistic, pseudo-R2 and minus twice the log-likelihood (–2LL)
were used to examine effectiveness and compare models. When comparing models, the Cox–Snell pseudo-R2
gives an estimation of the proportion of the outcome variable explained by the predictive variables and a
smaller value of –2LL indicates that the model is a better fit. The regression coefficients were used to calculate
each person’s probability of disengagement and this was compared with their observed risk in order to
examine the sensitivity and specificity of the model.
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The face validity of the model was tested by asking clinicians whether or not the predictive variables
corresponded to their clinical experience. As the model was developed using the complete REACH survey
data set in order to ensure sufficient statistical power, its external validity will need to be tested in a future
study by applying the tool to a sample of patients to be followed over a 24-month period to determine if it
predicts future disengagement from care.
Analysis of factors associated with engagement in HIV care
We used univariable analysis (chi-squared and the Student’s t-test) to examine associations between variables
derived from responses to the questionnaire and clinical data from patients’ notes and membership of
attendance groups: RAs, IAs and NAs. Multivariable analysis was used to derive parsimonious sets of variables
that are independently associated with engagement in HIV care. As different proportions of RAs, IAs and NAs
were recruited from each of the clinics, multivariable analysis also allowed for adjustment by clinic where the
respondents were recruited. In addition to clinic, we adjusted for background factors in all models. We used
backwards-stepwise multinomial logistic regression to select the best sets of predictive variables associated
with irregular and non-attendance, compared with regular attendance. The stepwise method takes standard
confounding between variables into account by including and excluding explanatory variables from the model,
according to the degree of correlation with the dependent variable. It controls for the effects of the other
independent variables as they are entered and can therefore be used to establish the most parsimonious
model. Interaction terms were not included in this analysis. We included predictive variables that were
significantly associated (p < 0.05) with the attendance groups in the univariable analysis in the models.
We collapsed categories where this did not change the statistical association with the dependent variable.
We excluded significantly associated variables that did not have any predictive value such as how often
respondents expected to have a routine consultation. In order to avoid overfitting the data, we used separate
models to explore the association between attendance and background factors, HIV diagnosis and health
service use, factors relating to capability, motivation, opportunity (relating to social influences), opportunity
(relating to barriers), use of ART and clinical data.
In order to derive two final models for variables associated with irregular and non-attendance, we included
variables that the above multinomial logistic regressions indicated were associated with irregular and
non-attendance in binary logistic regression. Variables were added to the models in the following order,
as described above:
l block 1: clinic attended and demographic variables
l block 2: other background variables
l block 3: mental and physical health in the past year or more
l block 4: other variables.
The final two models were selected on the basis of having the highest Cox–Snell pseudo-R2 and thereby
explaining the highest proportion of the outcome variables.
Phase 2b: qualitative component – individual patient interviews
Exploratory, face-to-face, semistructured interviews were undertaken with a purposively selected sample
of men and women who had attended the HIV clinics where survey recruitment was taking place from
June 2014 to February 2015. Eligible participants were men and women living with HIV aged ≥ 18 years.
Patients were excluded from the individual interviews if they were unable to provide informed consent or if
they had acquired HIV through vertical transmission as another study [Adolescents and Adults Living with
Perinatal HIV (AALPHI) cohort study of HIV-infected young people]65 was recruiting these patients for
individual interviews concurrently.
Patient interview sample size
We planned to recruit a sample of up to 40 men and women. Table 3 shows the quota matrix describing
the sampling plan to ensure maximum diversity in terms of attendance pattern and key characteristics.
Our primary quotas were attendance pattern and combined gender and sexual orientation. We wanted to
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oversample IAs and NAs to ensure that a range of their experiences were captured in our interview data.
We also wanted to recruit sufficient numbers of gay and bisexual men, heterosexual men and women in
order to provide sufficient data to explore their potentially diverse experiences.
Our secondary quotas were age, ethnicity, injecting drug use, treatment status and recent diagnosis.
Examination of the literature suggests that age might impact on attendance and we therefore wanted
to recruit participants who were both younger and older than 35 years of age. We wanted to ensure
adequate representation of black Africans, who are particularly affected by HIV but, as black Africans form
a very small minority of gay and bisexual men, we sought diversity in this group by recruiting men born in
the UK and those born outside the UK. We also aimed to recruit small numbers of injecting drug users,
people who had not started ART and those diagnosed within the past 2 years, to understand their
experiences, as the literature indicates that they are at risk of disengaging from care.
Patient interview recruitment
Posters were displayed and fliers were available in the study clinics. Local research staff gave patients an
information sheet and explained what the interview entailed to ascertain whether or not they were
interested in taking part. If patients agreed, their contact details were passed on to the Project Management
Team and AH contacted them to discuss the interview. Some patients contacted AH directly, having seen a
flier or poster at their clinic. Two interviewees took part in a follow-up interview after participating in one of
the focus groups (FGs) (see Phase 2c: community focus groups). AH checked eligibility according to a set
of screening questions (see Appendix 4) and patients were selected to ensure a range of characteristics
and experiences. Clinics were kept informed of the patients who had been interviewed; as the cells in the
quota matrix were completed, they targeted patients with particular characteristics.
Interviews were arranged at a mutually convenient time. They were conducted face to face and took place
on university or NHS trust premises. One patient was interviewed at their work place. At the beginning of
each interview, the information sheet was explained, any questions were answered and patients provided
informed consent to participate. Interviews took about 60–90 minutes. All participants were given a
TABLE 3 Quota matrix for individual interviews
Irregularly attending (n= 20) Gay male (n= 6–7) Heterosexual male (n= 6–7) Female (n= 6–7)
PWID (n= 1–2) UK born (n= 3–4) Black African (n= 3–4) Black African (n= 4–5)
Not on treatment (n= 1–2) Non-UK born (n = 3–4) Other ethnicity (n = 3–4) Other ethnicity (n = 2–3)
Diagnosed in past 2 years (n= 1–2) Younger (n = 3–4) Younger (n= 3–4) Younger (n= 3–4)
Older (n= 2–3) Older (n= 2–3) Older (n= 2–3)
Non-attending (n= 10) Gay male (n= 3–4) Heterosexual male (n= 3–4) Female (n= 3–4)
PWID (n= 1–2) UK born (n= 2–3) Black African (n= 1–2) Black African (n= 2–3)
Not on treatment (n= 1–2) Non-UK born (n = 1–2) Other ethnicity (n = 1–2) Other ethnicity (n = 1–2)
Diagnosed in past 2 years (n= 1–2) Younger (n = 2–3) Younger (n= 2–3) Younger (n= 2–3)
Older (n= 1–2) Older (n= 1–2) Older (n= 1–2)
Regularly attending (n= 10) Gay male (n= 3–4) Heterosexual male (n= 3–4) Female (n= 3–4)
PWID (n= 1–2) UK born (n= 2–3) Black African (n= 1–2) Black African (n= 2–3)
Not on treatment (n= 1–2) Non-UK born (n = 1–2) Other ethnicity (n = 1–2) Other ethnicity (n = 1–2)
Diagnosed in past 2 years (n= 1–2) Younger (n = 2–3) Younger (n= 2–3) Younger (n= 2–3)
Older (n= 1–2) Older (n= 1–2) Older (n= 1–2)
PWID, people who inject drugs.
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£20 high street shop voucher at the end of the interview to cover any transport costs and as a small token
of thanks. They were offered a copy of the interview transcript and a copy of the findings from the study.
Patient interview content
Interviews were based on a topic guide (see Appendix 5) that was developed with reference to the COM-B
model, as described in the questionnaire development. The sections covered:
Human immunodeficiency virus diagnosis and link to services – HIV diagnosis, starting HIV care, use of
other HIV services, change over time and frequency of attendance.
Current HIV clinic attendance – expectations, appointment booking, travel to clinic, facilities,
communication with reception staff, nurse and doctor, peer support and suggested improvements.
Reasons for attending regularly and irregularly – last appointment missed and suggestions.
Living with HIV – physical and emotional impacts, HIV disclosure, social support, stigma and other barriers.
Taking ART – adherence and home delivery service.
Other NHS services – GP.
Other barriers and facilitators to HIV care – off-putting experiences, agencies and individuals.
Interview data processing
Interviews were digitally recorded (with permission) and transcribed verbatim by a professional
transcription service.
Interview analysis
We used framework analysis, a method for analysing qualitative data, developed on the basis of the
extensive experience of researchers at the National Centre for Social Research, London.66 It aims to
condense what respondents say in their interviews into a format that facilitates inspection of data across
themes and within individuals. At the same time the analyst aims to maintain closeness to the original
data, by adopting respondent terminology as far as possible.
Four researchers read through three interview transcripts that were selected to represent different participant
characteristics (one RA, one IA and one NA). They marked thoughts and possible themes, and met to discuss
these. An index was drawn up covering the themes derived from this discussion and it was circulated for
comment and revised in the light of these comments. Themes were categorised according to the COM-B
model under the headings identified in the framework for REACH primary research (see Appendix 3).
Two of the above researchers coded the data using computer-assisted qualitative data analysis software,
NVivo version 10 (QSR International, Warrington, UK). The use of this software facilitates flexible and
effective data management and enables easy retrieval of pieces of text from material that can be
voluminous and unstructured.67
Two researchers coded each transcript individually. During this process, they checked each other’s coding
and discussed refinements to the index.66 Where it became clear that data were not sufficient to support a
theme, categories were collapsed or where there were associations between themes, they were combined.
NVivo generates a complete list of quotations for each respondent under each theme heading, providing
an overview of each theme while encapsulating the respondent’s contribution to it. Relevant data were
retrieved using NVivo and reference was made to the original transcripts where necessary, to ensure that
data from each respondent are not taken out of context or misunderstood. The data were then summarised
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under the theme headings, which included placing data for more complex themes into the framework
using a Microsoft Excel spreadsheet (2010; Microsoft Corporation, Redmond, WA, USA), with the themes
across the top and respondents listed down the left hand side. The aim of this process was to fill each cell
with a summary of the relevant data, keeping as closely as possible to the original data by condensing its
meaning and using respondent terminology as far as possible.
The next stage of the analysis was to pull together the key themes in the data to address the objective of
this part of the study that is to understand the factors that influence outpatient attendance.
Phase 2c: community focus groups
The individual interviews were supplemented by community FGs. These groups were used to uncover
alternative perceptions that may be articulated in a different, non-medicalised setting. Their stated purpose
was to explore patients’ experiences, service preferences and perceived barriers to accessing HIV services.
For this part of the study, we considered recruiting up to four FGs of six to eight adults who did not attend
the HIV clinic regularly or had stopped going to the clinic (now or in the past). We decided to recruit a
total of three groups to represent the two main groups that are affected by HIV (gay men and black
African men and women) and a third group to represent other people affected by HIV. These groups were
to consist of:
l gay and bisexual men
l African men and women
l non-African men and women.
Focus group recruitment
The FGs were facilitated by a UK Community Advisory Board (UK-CAB) representative and coinvestigator
who recruited participants via community contacts (including the UK-CAB forum, YMCA, Positive East,
Positively UK, African HIV Policy Network, African Eye Trust, Africa Advocacy Foundation, Terrence Higgins
Trust, Body & Soul, NAZ, Organisation of HIV Positive African Men, GMFA and Metro). Posters were sent
to community venues and those who were interested in taking part contacted MS directly. MS checked
their eligibility according to a set of screening questions. They were eligible to take part if (i) they had not
seen a doctor or nurse specialist at a HIV clinic for at least a year; or (ii) if they had ever not seen a doctor
about their HIV for a year or more; or (iii) they had missed and not rescheduled at least one appointment
at their HIV clinic in the past year. They were asked about their country of birth, ethnic group and sexual
orientation but chose to participate in the FG with which they identified. As there were no volunteers for
the non-African men and women’s group, this group was cancelled.
The two remaining groups took place in the evening in the Mortimer Market Centre, central London, in
January 2015. They were jointly facilitated and refreshments were provided. As with the patient interviews,
the information sheet was explained at the beginning of the group and participants had the opportunity to
ask questions before signing the consent form. All participants were given £30 at the end of the group
to cover expenses and as a token of thanks, and were offered a copy of the findings from the study.
Focus group content, processing and analysis
The FGs were based on a topic guide covering the same key topics as the patient interviews: link to
services, experience of using current HIV clinic, reasons for attending regularly and irregularly, reasons for
stopping attending, taking ART, stigma, social support, other NHS services. The gay and bisexual men’s
group took just over an hour and the African men and women’s group took just over 2 hours. They were
digitally recorded and transcribed verbatim.
It was intended that the FGs may serve to access people who fail to engage with medical services but
continue to engage with an extended community network. However, all participants were currently
engaged in HIV care and, as the data from the FGs were very similar to that from the individual interviews,
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they were combined for the purposes of analysis. The same index that had been developed for the
interviews was applied to their coding and the same analysis procedures were adopted, as described above.
Phase 3: key informant study
We aimed to conduct semistructured interviews with up to 25 service providers and funders to explore
ways to optimise patient engagement and potential costs. The sampling frame was defined according to
key constituencies in the field of HIV service provision: clinical services, public health, academia, voluntary
sector, health promotion and policy.
Key informant recruitment
Organisations and individuals within them were identified for each of the key constituencies. All prospective
informants were approached by e-mail and, if they agreed, a 30-minute interview was arranged and
conducted by telephone, Skype™ (Microsoft Corporation, Redmond, WA, USA) or face to face. All face-to-face
interviews were conducted at mutually convenient locations. Participants were offered a copy of the interview
transcript and a copy of the findings from the study. At the time of conducting the interviews, all participants
were informed that their contribution would be anonymous. However, it became clear that some participants
might prefer for their contribution to be acknowledged. They were therefore asked if they would prefer to be
named in any publication of the findings and nine of the participants said that they would like to be identified.
Key informant content, processing and analysis
A topic guide was used to explore why patients miss appointments, what interventions or service
improvements would help and what resources were needed (see Appendix 6). The interviews took about
30 minutes. Again, they were digitally recorded and transcribed verbatim.
As the key informant data were much shorter and less in-depth than the patient data – with participants
talking about their professional experiences rather than in-depth and more lengthy discussion of their
personal experiences – we used a more expedient method of analysis. Rather than coding all the transcripts
in NVivo, we moved straight to summarising the data under theme headings that emerged from the data.
AH conducted this analysis, reading and rereading the transcripts and organising the emerging data within
the context of the COM-B model. In order to validate this analysis, FB and AE each read three transcripts
(a total of six between them) and then examined the summary to see whether or not it fitted their
understanding of the data.
Intervention costs
Using the methods described above, we put together four interventions that might be tested to improve
engagement with care. We then undertook a preliminary evaluation of the costs of the four proposed
interventions, after developing detailed descriptors of each. All costs were calculated according to 2015/16
GBP figures. Costs were calculated from a NHS and personal social services perspective.68 The interventions
would each incur a mixture of staff and non-staff costs. The former would include a range of staff types from
consultants to unpaid peer support workers. The descriptors for each intervention included estimates of the
amount of time each member of staff would spend on that intervention. To these we then applied unit costs
per staff type obtained from published sources.69 We valued the estimated non-staff costs (e.g. transport
allowance, food allowance, telephone allowance, room hire, production of posters, leaflets and pocket
guides) using market prices. We calculated the total cost of each intervention and then divided this by an
estimate of the number of patients likely to receive the intervention to calculate the mean cost per patient.
For three of the interventions, we calculated the costs over a 6-month period making assumptions about the
number of contacts made by each patient during this time; for the fourth intervention, we calculated mean
one-off costs per patient making assumptions about clinic size. The output is a series of indicative costs for
each intervention, which can then be evaluated more formally in subsequent prospective studies.
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Patient and public involvement
We have engaged with the public and patients at all stages of our project. Our patient and community
engagement has been facilitated through the UK-CAB, a network for community HIV treatment advocates
across the UK. Since the inception of the project, a representative from the UK-CAB has been involved
as a co-applicant and member of our Management Team. She was responsible for recruiting PLWH to
participate in our FGs and contributed to the design of the publicity material and the content of the FG
topic guide. Our community representative and researcher/project manager jointly facilitated the FGs.
In addition, our Study Steering Committee and Advisory Group have both included community
representatives who have contributed to the design and management of the research through these
channels. They have provided valuable individual feedback our patient materials, including the content of
the questionnaire and topic guides.
The questionnaire was also piloted on five PLWH and considerably revised on the basis of their input.
We have interviewed three patient representatives who have contributed their expertise to the study as
key informants.
At the time of writing, our findings have only recently been finalised but we will feed back to service user
groups from the participating clinics over the coming months and lay summaries of our research findings
will be available to patients attending for HIV care at participating sites. We will also host a dissemination
and networking event for all key stakeholders in the coming months.
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Chapter 3 Findings: patterns and associations
with engagement in HIV care
In this chapter, we present findings from our analysis of UK CHIC data to explore patterns ofengagement in HIV care, factors associated with poor engagement and the associated health and
financial costs. We begin with the findings from the group-based trajectory analysis that we explored as a
method for describing attendance patterns of attendance over time. The findings address the following
objectives of the study, to:
l examine HIV outpatient attendance patterns among PLWH
l identify predictive factors of disengagement
l investigate the potential health and financial costs of disengaging from care.
Group-based trajectory analysis of patterns of engagement
We examined patterns of attendance for patients who were divided up into three groups: 6110 patients
diagnosed between 2000 and 2002; 6747 patients diagnosed between 2003 and 2005; and 5615 patients
diagnosed between 2006 and 2008. We compared the fit of the models for plots with one to five trajectories
for each of these three diagnosis periods using the BIC and examined the interpretability of the trajectory
plots. A total of 15 models of attendance trajectories were examined (five models for each of the three
diagnosis groups).
The patterns of trajectories for the five models (with one to five trajectories) were similar across diagnosis
groups. The proportions of patients following these trajectories were also similar across the three diagnosis
groups. Figures 3–5 illustrate the similarity of the shape of the trajectories and proportion of patients
following each of the trajectories when models with four trajectories were specified. This similarity provides
a measure of confidence in the robustness of the models. Although the lowest BIC indicates the best
model, as the number of trajectories increased, the BIC gradually decreased for all three diagnosis groups,
as did twice the difference between the BIC for the alternative (more complex) model and the null (simpler)
model (Table 4). This method did not help to determine the best model for this analysis and we therefore
selected the final models on the basis on interpretability.
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FIGURE 3 Attendance trajectories for four groups, diagnosed 2000–2.
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TABLE 4 Bayesian information criterion for models with one to five trajectories
Number of
trajectories in
model
Patients grouped according to time of diagnosis
Diagnosed 2000–2 (n= 6110) Diagnosed 2003–5 (n= 6747) Diagnosed 2006–8 (n= 5615)
BIC 2 × diffa BIC 2 × diff BIC 2 × diff
1 –161,085.9 –128,142.0 –55,608.4
2 –122,569.4 77,033.0 –97,366.4 61,551.3 –41,745.1 27,726.6
3 –114,602.5 15,933.8 –91,340.6 12,051.4 –39,447.8 4594.5
4 –110,540.6 8123.8 –88,026.2 6628.8 –38,235.3 2425.1
5 –108,123.9 4833.4 –86,285.8 3480.9 –37,924.3 621.9
2 × diff, twice the difference.
a Twice the difference between the BIC for this model and the BIC for a model with one fewer trajectory.
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FIGURE 4 Attendance trajectories for four groups, diagnosed 2003–5.
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We found that increasing the number of trajectories from four to five did not add to the interpretability and we
therefore selected models with four trajectories (see Figures 3–5). The x-axis shows the number of months since
the start of the analysis and the number on the y-axis is equivalent to the proportion of patients in care during
each month. For all diagnosis periods, the largest group of patients consists of those who are consistently in
care over time (62.3–69.8%). There is a second group which starts off in care and whose attendance drops
somewhat over time, a third group whose attendance drops off more rapidly before getting better, and a
fourth group which represents the smallest proportion of patients (6.6–8.2%) who appear to disengage from
care almost completely with a very low proportion in care, before gradually returning to care.
At the end of the period of follow-up, the trajectories suggest that about one-fifth of patients from each
of the diagnosis groups are not fully engaged in care and the longer the time since diagnosis, the greater
the proportion of time in care at the end of our follow-up period.
Associations with the engagement in care measure
As described above, the group-based trajectory analysis resulted in the three different models shown in
Figures 3–5. This makes their use in further analysis of associated factors and outcome problematic.
We therefore decided to use the proportion of time in care as a more straightforward and fitting measure
of engagement for the following analysis.
A total of 44,432 patients from UK CHIC (2000–12) were included in the initial analysis, as shown in Table 5.
Women represented 27.8% of the sample. Half were white (53.3%), one-third were black African (28.9%),
8.7% were of other ethnicity and 9.2% had unknown ethnicity. Around half had acquired HIV through sex
between men (50.5%), with 39.1% acquiring HIV through sex between men and women, 3.0% through
injection drug use and the remaining 7.4% through other or unknown routes. Their median age at entry
TABLE 5 Characteristics of patients at study entry and ART start
Characteristic All patients At ART start
n 44,432 8730
Gender, %
Male 72.2 78.2
Female 27.8 21.8
Age (years), median (IQR) 36 (30–42) 37 (32–43)
Exposure, %
MSM 50.5 62.3
Heterosexual 39.1 31.1
PWID 3.0 2.9
Other/unknown 7.4 3.7
Ethnic group, %
White 53.3 63.4
Black African 28.9 20.9
Other 8.7 8.9
Unknown 9.2 6.8
CD4 count (cells/mm3), median (IQR) 355 (214–520) 280 (202–368)
IQR, interquartile range; PWID, people who inject drugs.
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into the study was 36 years [interquartile range (IQR) 30–42 years] and the median start date of follow-up
was December 2004 (range January 2000–October 2012). The median CD4 count at start of follow-up was
355 (IQR 214–520) cells/mm3; patients were followed for a median of 61 (range 2–156) months with a total
follow-up of 3,021,224 patient-months.
Patients contributed 3,021,224 months of follow-up. Overall, patients were engaged in care for 83.9% of
the total follow-up patient-months. Figure 6 shows that this was relatively stable over time and that women
had consistently somewhat poorer EIC over time. Table 6 shows the proportion of months that were engaged
in care stratified by the various demographic and clinical factors, as well as the results of univariable and
multivariable regression models. In univariable analysis, EIC was higher in men, in those aged > 45 years, in
those of white ethnicity, in those who acquired HIV through sex between men, in those with higher nadir and
current CD4 counts, in later calendar years and in those who had only recently (within the last year) between
first seen at the clinic. After adjustment for other factors in the model, most of these associations were
unchanged with four main exceptions. First, there was no strong association between gender and EIC after
controlling for the other factors. Second, although current use of ART did not appear to be associated with EIC
in unadjusted analysis, after adjustment it became apparent that those currently on ART had higher levels of
engagement. Third, a lower rate of EIC among those of black African origin was attenuated (and became
non-significant) after adjustment, with lower rates of EIC only remaining in those of ‘other’ ethnic origins
(which included those of black Caribbean, Asian and mixed race among others). Finally, including adjustment
for the nadir CD4 count showed that current CD4 count did not provide any independent association with EIC.
Health outcomes and the engagement in care measure
Table 7 shows the association between EIC and mortality, first without adjustment, then including fixed
covariates (age, CD4, year of entry, gender, mode of acquisition and ethnic group), then adding ART
status, then the lagged CD4 count and finally the unlagged CD4 count. Table 7 shows the same modelling
process with the outcome of AIDS or death. The data with adjustment for fixed covariates and ART status
show that higher EIC is associated with improved outcomes (for both the mortality and combined AIDS/
mortality outcomes) at least 1 year into the future. Adjustment for the lagged CD4 count resulted in an
attenuation of the association between EIC and each outcome, suggesting that a proportion of the
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TABLE 6 Unadjusted and adjusted associations with retention in care in any particular month
Factor Person-months % EIC
Unadjusted Adjusteda
OR 95% CI p-value OR 95% CI p-value
Gender
Male 2,235,135 85.1 1.36 1.31 to 1.40 0.0001 1.10 0.98 to 1.23 0.11
Female 786,089 80.7 1.00 – – 1.00 – –
Age group (years)
< 25 83,116 77.1 0.63 0.42 to 0.93 0.02 0.67 0.42 to 1.06 0.09
25–45 1,960,061 82.5 0.66 0.53 to 0.81 0.0001 0.74 0.59 to 0.93 0.008
> 45 978,023 87.4 1.00 – – 1.00 – –
Ethnic group
White 1,760,442 85.5 1.00 – – 1.00 – –
Black African 802,477 81.2 0.74 0.71 to 0.76 0.0001 0.96 0.83 to 1.11 0.55
Other 239,190 81.8 0.77 0.73 to 0.81 0.0001 0.79 0.68 to 0.92 0.002
Unknown 219,115 83.6 0.87 0.82 to 0.92 0.0001 0.87 0.73 to 1.03 0.11
Route of acquisition
MSM 1,687,095 86.2 1.00 – – 1.00 – –
PWID 94,014 76.3 0.52 0.48 to 0.56 0.0001 0.56 0.44 to 0.71 0.0001
Heterosexual 1,127,473 81.4 0.70 0.68 to 0.73 0.0001 0.84 0.73 to 0.98 0.02
Other/unknown 112,642 82.2 0.77 0.71 to 0.83 0.0001 0.80 0.67 to 0.95 0.01
Currently on ART
No 616,201 74.6 1.00 – – 1.00 – –
Yes 2,405,023 86.3 0.95 0.79 to 1.15 0.62 1.44 1.15 to 1.81 0.002
Nadir CD4 count (cells/mm3)
< 200 1,528,352 87.8 0.51 0.40 to 0.65 0.0001 0.55 0.41 to 0.74 0.0001
200–349 821,951 84.3 0.33 0.25 to 0.45 0.0001 0.37 0.28 to 0.50 0.0001
≥ 350 571,445 76.7 1.00 – – 1.00 – –
Current CD4 count (cells/mm3)
< 200 256,512 80.8 0.68 0.53 to 0.87 0.002 0.82 0.64 to 1.05 0.12
200–349 587,648 82.7 0.81 0.69 to 0.94 0.006 0.93 0.81 to 1.08 0.34
≥ 350 2,077,588 85.7 1.00 – – 1.00 – –
Calendar year
2000–3 553,178 82.5 0.59 0.50 to 0.70 0.0001 0.61 0.51 to 0.72 0.00011
2004–7 1,500,392 85.2 1.00 – – 1.00 – –
2008–12 967,654 82.8 1.68 1.45 to 1.94 0.0001 1.71 1.47 to 1.98 0.0001
Time since entry in UK CHIC (years)
< 1 351,190 87.4 1.80 1.34 to 2.40 0.0001 1.53 1.09 to 2.15 0.01
1–5 1,137,979 82.5 1.19 0.89 to 1.59 0.24 1.24 0.89 to 1.71 0.20
5–10 1,020,656 83.4 1.22 0.92 to 1.61 0.16 1.13 0.85 to 1.51 0.41
> 10 511,399 85.8 1.00 – – 1.00 – –
CI, confidence interval; OR, odds ratio; PWID, people who inject drugs.
a Adjusted for clinic.
Adapted from Howarth et al.44 This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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association seen can be explained by the fact that those with lower EIC values also have lower CD4
counts. Further adjustment for the unlagged CD4 counts led to further attenuation of the estimate
towards 1, suggesting that in addition to poorer CD4 counts at the time of EIC assessment, those with
lower EIC values also had lower CD4 counts over the subsequent 12-month period.
Next we explored EIC before starting ART among patients who started ART. Table 5 includes the
characteristics of these 8730 individuals at the time that they started ART, with Table 8 showing
associations between their pre-ART EIC and these characteristics. These data indicate that males are more
likely than females to have spent a greater proportion of time in care before starting ART. The same was
true for patients who acquired HIV through sex between men, were of white ethnicity, had a higher
median CD4 count at start of ART and who started on a NNRTI regimen.
We examined the association between the proportion of time in care before starting ART and mortality
after starting ART. Table 9 shows the association between pre-ART EIC and post-ART mortality, after
adjusting for fixed covariates (age, gender, mode of acquisition, ethnic group, calendar year, pre-ART CD4
count and viral load), then adding the latest CD4 count and viral load. As in the previous analyses, the
strong association between pre-ART EIC and post-ART mortality that is apparent in unadjusted analyses
and analyses that control for the baseline covariates is substantially attenuated towards 1 after further
adjustment for the post-ART CD4 counts and viral loads.
Overall, the data from these analyses indicate that higher levels of engagement in HIV care are strongly
associated with reduced mortality at all stages of infection.
TABLE 8 Characteristics of patients at ART start, stratified by EIC percentage prior to ART
% months EIC
prior to ART % of group Male, % MSM, % White, %
CD4 (cells/mm3),
median
Regimen
PI, % NNRTI, %
< 50 14.7 73.1 46.2 53.5 250 32.1 60.8
50–69.9 14.2 76.0 59.5 60.9 259 25.3 66.4
70–79.9 11.6 77.7 62.8 62.1 280 25.5 67.5
80–89.9 18.2 80.1 65.6 64.9 283 26.2 67.1
90–99.9 24.0 79.3 66.4 65.6 290 23.0 68.6
100 17.3 81.0 68.6 70.3 299 21.4 70.0
TABLE 7 Association between EIC with mortality and AIDS/death
Mortality AIDS/death
Total number (%) of events 2279 (5.1) 6685 (15.1)
Adjustment for:
Nonea 0.91 (0.88 to 0.95) 0.89 (0.87 to 0.92)
Fixed covariatesa 0.91 (0.88 to 0.95) 0.89 (0.87 to 0.92)
+ ART statusa 0.90 (0.87 to 0.93) 0.90 (0.87 to 0.92)
+ latest CD4 count (lagged)a 0.96 (0.92 to 1.00) 0.93 (0.91 to 0.96)
+ latest CD4 count (unlagged)a 1.00 (0.96 to 1.04) 0.97 (0.94 to 1.00)
a RH (95% confidence interval)/10% higher EIC.
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Laboratory test costs and the engagement in care measure
The number of patients under follow-up declined over time in each EIC group, mainly due to the censoring
date in the analysis of the UK CHIC data (Figure 7), but this may also be due to differential survival
between groups (see Health outcomes and the engagement in care measure).
Figures 8 and 9 show the trends over time in mean CD4 count and viral load tests per person per quarter
since starting ART, stratified by pre-ART EIC group (< 50%, 50–69.9%, 70–79.9%, 80–89.9%, 90–99.9%
and 100%). Figures for the other tests are in Appendix 7. Note that separate unit costs were applied for
cholesterol, high-density lipoprotein, low-density lipoprotein and triglycerides, but for simplicity we present
a figure for all lipid tests combined (defined as when the patient had one or more of these tests on the
same day).
Trends are similar for the other types of test (see Appendix 7). Several themes emerge, and for most types
of test the pattern is the same:
l Across all tests and pre-ART EIC groups the number of tests per patient is highest in the first quarter
and then declines thereafter, levelling out by quarters 9 and 10 after starting ART.
l Generally there does not seem to be much variation in the number of tests per patient by pre-ART
EIC group.
l There is some suggestion that people in the most engaged groups have more tests per patient in each
quarter, and those who are least engaged seem to have fewer – but the differences are small.
l There does not seem to be any appreciable crossover between pre-ART EIC groups in later quarters.
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TABLE 9 Association between EIC percentage pre-ART and mortality post-ART
Death
Total number (%) 237 (2.7)
No adjustmenta 0.29 (0.18 to 0.47)
Adjustment for fixed covariatesa 0.36 (0.21 to 0.61)
+ latest CD4 count and VLa 0.74 (0.42 to 1.30)
VL, viral load.
a RH (95% confidence interval)/10% higher EIC.
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Trends for test costs are in Figure 10; these reflect findings for the individual tests. As with the individual
tests, costs are highest in the first quarter and then decline thereafter, levelling out by quarters 9 and 10.
Mean costs per person in the 100% EIC group range from £131 in the first quarter after ART start to £50
per quarter in quarter 16. For the < 50% EIC group they range from £93 to £41, a difference of £38 and
£9 per quarter compared with the 100% EIC group. There does not seem to be any crossover in test costs
between pre-ART EIC groups in later quarters. In all groups and quarters, 80–85% of the test costs is
accounted for by the cost of CD4 count and viral load tests.
Overall these trends indicate that differences in testing costs between EIC groups are small in absolute
terms and reflect pre-ART engagement with no crossover during the 4-year follow-up period under
observation.
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Summary of findings from Chapter 3
l Group-based trajectory analysis indicated that four trajectories provide the best fit for the data for each
of the three diagnosis groups.
l Engagement in HIV care is higher in later calendar years, in those aged > 45 years, who acquired HIV
through sex between men, with a higher nadir CD4 count, who had recently been first seen at the
clinic and were currently on ART; there was some suggestion that EIC was lower in those of ‘other’
ethnicities (i.e. non-white, non-black African).
l Engagement in HIV care is strongly associated with mortality at all stages of infection.
l Absolute differences in the cost of lab tests by EIC are small.
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Chapter 4 Findings: retention risk tool
In this chapter, we describe how the items for the retention risk tool were selected. The purpose of thetool is to identify newly diagnosed patients who are at risk of disengaging from care. The tool is for
use in HIV care services and is one of the key outputs of the study. The chapter will address our fourth
objective, to:
l develop a retention risk assessment tool.
After excluding variables that were not suitable for inclusion in the analysis, 27 candidate variables
remained. Table 10 is a list of all the variables that were considered for inclusion in the tool, grouped into
blocks, and the proportion of RAs and not regular attenders (NRAs: IAs and NAs) according to each factor.
It is possible that some variables, particularly from block 4 onwards, may change as a result of the physical
and psychological effects of living with HIV, and it is therefore important that the retention risk tool should
be tested in future studies to see how well it predicts future disengagement among newly diagnosed
HIV patients.
Variables from among the 27 candidates that were significantly associated (p < 0.05) with disengagement
from HIV care, as shown in Table 10, were included in logistic regression modelling. We used backwards-
stepwise binary logistic regression to select the best set of predictive variables associated with
disengagement from care. To summarise, the following variables were considered. The proportion of
missing data is shown in (brackets):
l block 1: fixed sociodemographic variables
¢ gender and sexual orientation (3.2%)
¢ ethnic group (1.6%)
¢ age at diagnosis (0.0%)
l block 2: sociodemographic variables that are subject to change over time
¢ education (5.8%)
¢ has children (0.9%)
l block 3: variables about circumstances of HIV diagnosis
¢ none
l block 4: health, mental health and drug use, ever reported
¢ ever injected drugs (2.3%)
¢ ever diagnosed with depression (7.7%)
l block 5: mental health and drug use, within the past 5 years
¢ recreational drug use (past 5 years) (2.6%)
¢ mental health issues (past year) (7.4%)
¢ drug/alcohol dependency (past year) (7.9%)
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TABLE 10 Candidate variables for the retention risk tool
Factor All patients, n RA, % NRA, % p-value
Block 1: fixed sociodemographic variables
Gender and sexual orientation
Female 271 24.8 32.4 0.027
Heterosexual male 122 12.7 12.7
Gay or bisexual male 570 62.6 54.9
Ethnic group
White 518 57.2 48.9 0.010
Other ethnic group 449 42.8 51.1
Age group at diagnosis (years)
≤ 30 458 38.5 56.8 < 0.001
31–45 422 47.8 36.7
≥ 46 103 13.6 6.5
Born in the UK
No 582 59.9 58.4 0.635
Yes 400 40.1 41.6
Block 2: sociodemographic variables that are subject to change over time
Education post 18 years old
No 276 27.1 33.3 0.043
Yes 650 72.9 66.7
Religion
No 316 31.7 33.7 0.510
Yes 653 68.3 66.3
Main language
Not English 196 21.5 18.3 0.224
English 780 78.5 81.7
Has children
No 668 72.8 63.3 0.001
Yes 306 27.2 36.7
Block 3: variables about circumstances of HIV diagnosis
Where diagnosed
GP 98 10.6 9.7 0.914
Sexual health clinic 460 46.8 49.1
Hospital 170 17.8 17.5
HIV testing service 110 12.1 10.6
Elsewhere 124 12.6 13.2
First recorded CD4 count (cells/mm3)
< 200 262 28.8 25.5 0.432
200–349 234 23.2 26.0
≥ 350 461 48.0 48.4
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TABLE 10 Candidate variables for the retention risk tool (continued )
Factor All patients, n RA, % NRA, % p-value
First recorded viral load (log-copies/ml)
< 4.00 333 32.5 38.6 0.100
4.00–4.99 320 34.2 33.3
≥ 5.00 293 33.3 28.0
Block 4: health, mental health and drug use, ever reported
Long-standing condition affecting access
No 819 85.1 86.2 0.654
Yes 138 14.9 13.8
Ever injected drugs
No 832 88.9 83.8 0.022
Yes 128 11.1 16.2
Ever diagnosed with depression
No 617 70.9 64.4 0.039
Yes 290 29.1 35.6
Ever had inpatient stay
No 284 29.9 28.5 0.655
Yes 686 70.1 71.5
Block 5: mental health and drug use, within the past 5 years
Recreational drug use (past 5 years)
No 597 66.9 56.6 0.001
Yes 360 33.1 43.4
Mental health issues (past year)
No 723 82.2 76.0 0.023
Yes 187 17.8 24.0
Drug/alcohol dependency (past year)
No 806 94.1 82.6 < 0.001
Yes 99 5.9 17.4
Block 6: variables about potentially transient circumstances
Caring responsibilities
No 725 77.4 72.0 0.052
Yes 241 22.6 28.0
Work status
Working 563 60.8 56.4 0.011
Student 45 3.4 6.4
Unemployed 208 19.4 24.8
Other 140 16.4 12.4
Money for basic needs
Not all of the time 553 50.5 65.1 < 0.001
All of the time 419 49.5 34.9
continued
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l block 6: variables about potentially transient circumstances
¢ work status (2.7%)
¢ money for basic needs (1.1%)
¢ homeowner (1.0%)
¢ cohabiting (3.1%)
¢ GP registered (1.0%)
l block 7: variables about getting to the clinic
¢ public transport (6.6%)
¢ journey > 30 minutes (2.1%).
The 17 variables were introduced into the model using the above blocks. Across the 17 variables, missing
cases accounted for 0.0–7.9% of the data. Although this is not a large number of missing data for
univariable analysis, incorporation of several variables with this level of missing data into multivariable
analysis can result in a reduced sample size and unstable models. Therefore, if variables were not
significantly associated with disengagement from HIV care when introduced within their block into the
model, they were not included as the subsequent block of variables was introduced.
TABLE 10 Candidate variables for the retention risk tool (continued )
Factor All patients, n RA, % NRA, % p-value
Homeowner
No 702 66.7 79.0 < 0.001
Yes 271 33.3 21.0
Cohabiting
No 627 62.4 70.2 0.012
Yes 326 37.6 29.8
Immigration status
British citizen 625 67.5 67.0 0.203
EU citizen 141 16.6 13.3
Indefinite leave to remain 103 10.6 11.7
Temporary or no status 60 5.2 8.0
Registered with GP
No 44 3.3 6.1 0.038
Yes 929 96.7 93.9
Block 7: variables about getting to the clinic
Travelled to clinic by public transport
No 210 26.5 18.0 0.002
Yes 708 73.5 82.0
Journey > 30 minutes
No 374 41.8 35.1 0.035
Yes 588 58.2 64.9
EU, European Union.
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Table 11 shows the changing values of the –2LL, the pseudo-R2 and the c-statistic, as the blocks of
variables are added to the model and Table 12 includes the descriptive data and the odds ratios for
variables included in each of the models.
The final model has a –2LL of 999.55, a pseudo-R2 of 0.13 and the AUROC curve is 0.71, which is
considered as fair (Figure 11). All these measures indicate that this was the best model achieved during the
testing process. The Hosmer–Lemeshow goodness-of-fit test indicates that the data predicted by the model
were not significantly different from the observed data (p = 0.54). The equation for this model, using the
beta value from the analysis rather than the odds ratio values that are included in Table 12, is:
Log–odds of disengagement from care = 0:17 + ½age at diagnosis × −0:05 + ½has children × 0:79
+ ½recreational drug use × 0:56 + ½drug/alcohol dependency × 0:88 + ½money for basic needs
× 0:34 + ½public transport to clinic × 0:51. (1)
TABLE 11 Estimates of effectiveness for consecutive models
Model
Number of
cases
Number of
variables –2LL Pseudo-R2 c-statistic
Hosmer–Lemeshow
p-value
Block 1 983 1 1295.83 0.05 0.63 0.35
+ block 2 921 3 1192.99 0.07 0.66 0.68
+ block 3 – – – – – –
+ block 4 952 3 1230.21 0.08 0.66 0.21
+ block 5 872 4 1094.14 0.11 0.69 0.97
+ block 6 864 5 1072.66 0.12 0.70 0.83
+ block 7 813 6 999.55 0.13 0.71 0.54
TABLE 12 Adjusted associations with EIC for consecutive models
Factor % RA (mean) % NRA (mean) aOR 95% CI p-value
Block 1
Age at diagnosis (34.9) (30.3) 0.95 0.94 to 0.97 < 0.001
+ block 2
Age at diagnosis (years) (34.9) (30.3) 0.95 0.94 to 0.96 < 0.001
No post-18 years education 27.1 33.3 1.36 1.01 to 1.83 .042
Has children 27.2 36.7 1.85 1.37 to 2.48 < 0.001
+ block 4
Age at diagnosis (years) (34.9) (30.3) 0.95 0.94 to 0.96 < 0.001
Has children 27.2 36.7 1.98 1.47 to 2.65 < 0.001
Ever injected drugs 11.1 16.2 1.79 1.20 to 2.67 0.004
+ block 5
Age at diagnosis (years) (34.9) (30.3) 0.95 0.94 to 0.97 < 0.001
Has children 27.2 36.7 2.37 1.71 to 3.28 < 0.001
Recreational drug use 33.1 43.4 1.53 1.10 to 2.13 0.011
Drug/alcohol dependency 5.9 17.4 2.88 1.74 to 4.76 < 0.001
continued
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Summary of findings from Chapter 4
l Our retention risk tool indicates that people who are newly diagnosed with HIV may be at greater risk
of disengaging from care if they are younger at the time of diagnosis, have children, have used
recreational drugs, have drug/alcohol dependency issues, do not have not enough money for basic
needs and use public transport to get to the clinic.
TABLE 12 Adjusted associations with EIC for consecutive models (continued )
Factor % RA (mean) % NRA (mean) aOR 95% CI p-value
+ block 6
Age at diagnosis (years) (34.9) (30.3) 0.95 0.94 to 0.97 < 0.001
Has children 27.2 36.7 2.13 1.52 to 2.99 < 0.001
Recreational drug use 33.1 43.4 1.65 1.18 to 2.30 0.004
Drug/alcohol dependency 5.9 17.4 2.70 1.62 to 4.52 < 0.001
No money for basic needs 50.5 65.1 1.47 1.08 to 1.99 0.014
+ block 7: the final model
Age at diagnosis (years) (34.9) (30.3) 0.95 0.94 to 0.97 < 0.001
Has children 27.2 36.7 2.20 1.55 to 3.13 < 0.001
Recreational drug use 33.1 43.4 1.76 1.24 to 2.49 0.001
Drug/alcohol dependency 5.9 17.4 2.41 1.43 to 4.07 0.001
No money for basic needs 50.5 65.1 1.40 1.02 to 1.93 0.038
Public transport to clinic 73.5 82.0 1.66 1.15 to 2.41 0.007
aOR, adjusted odds ratio; CI, confidence interval.
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FIGURE 11 Receiver operating curve for the final model.
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Chapter 5 Findings from survey: factors associated
with engagement in HIV care
In this chapter, we examine the data from our survey of HIV patients to explore the factors associated withengagement in HIV care. The findings from this analysis informed the development of intervention models
to improve EIC that are described in Chapter 7. The findings address the following objective of the study, to:
l understand the situational, environmental, behavioural and social factors influencing
outpatient attendance.
Respondents
The sample included a total of 983 respondents. It was made up of 550 RAs (56.0%), 269 IAs (27.4%)
and 164 NAs (16.7%). Although we succeeded in recruiting our target samples of 500 RAs and 250 IAs,
we were unable to reach our target of 250 NAs. Despite including two additional recruitment sites and
encouraging clinics to recruit NAs, this group was very hard to reach. NAs form a small minority of the
patient population, which makes them statistically hard to recruit, with one of our participating clinics
estimating that NAs constituted only 1–2% of the clinic cohort. They are also patients who have
experienced difficulties with engaging in HIV care and need to be treated sensitively, which may make
them more difficult to recruit into the study. In order to check whether or not a smaller sample would be
sufficient, we recalculated the statistical power for a more realistic and achievable sample size, which
indicated that there would be a small impact on statistical power: comparing 150 non-attending patients
with 500 regularly attending patients would provide over 80% power to detect a difference in the
prevalence of a predictor of 57% versus 43% (83% power) or 14% versus 6% (81% power).
The participating clinics had different success rates at achieving a sample of 200 questionnaires completed
by 100 RAs (50%), 50 IAs (25%) and 50 NAs (25%), as shown in Table 13. There was a significant
difference between the proportion of questionnaires completed by RAs, IAs and NAs at each of the clinics
(p < 0.001). Clinics 4 and 5 achieved samples of < 100 respondents who were mainly RAs. Clinics 1, 3
and 7 did not reach their targets of 200 respondents but were more successful at recruiting IAs and NAs.
Clinics 2 and 6 reached their targets of 200 respondents, which were divided up according the proportions
required. It should be noted that clinic 2 was working towards an earlier target of 40% RAs, 30% IAs and
30% NAs, before this was revised to proportions of 50%, 25% and 25%, respectively.
TABLE 13 Clinic attended at time of survey completion by attendance pattern
Factor
All patients
RA, % IA, % NA, % p-valuen %
Clinic
1 95 9.7 60.0 22.1 17.9 < 0.001
2 207 21.1 38.6 34.3 27.1
3 149 15.2 66.4 25.5 8.1
4 70 7.1 75.7 12.9 11.4
5 83 8.4 77.1 12.0 10.8
6 226 23.0 48.7 27.4 23.9
7 153 15.6 56.9 37.9 5.2
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Men who identified as gay or bisexual represented 59.2% of the sample; 12.7% were heterosexual men and
28.1% were female. The mean age was 44.5 years [standard deviation (SD) 10.4 years]. Over half of the
respondents reported white ethnicity (53.6%), 28.1% were black African and 18.3% were of another
ethnicity. The majority were born outside the UK (59.3%) including 30.9% in Africa, 16.3% in another
European country and 7.9% in the Americas, but only 20.1% did not speak English as their main language.
Among those born outside the UK, two-thirds had arrived in the UK since 1995, with 23.7% having arrived
since 2005 and a further 44.1% between 1995 and 2004. Most had completed some full-time education
after the age of 18 years (70.2%) and 58.9% reported that they were employed, 21.8% were unemployed
and 4.7% were students. We identified the score of the Index of Multiple Deprivation for the neighbourhood
in which respondents lived, based on their postcode. Only 56.2% of respondents provided a usable postcode
but among them, 43.5% of respondents lived in a neighbourhood that was among the most deprived
(quintile 5) in England, and a further 37.9% lived in a neighbourhood that was somewhat less deprived
(quintile 4). Two-thirds of respondents (67.4%) reported belonging to a religion, most of whom were
Christian (87.0%).
Factors associated with attendance pattern
In the following sections we examine the association between the three attendance patterns used to
recruit respondents with the responses that patients reported in our questionnaire and the clinical data
that were collected from their notes.
Background factors
The associations between background factors and attendance pattern are shown in Table 14. Just over a
quarter of respondents were female (27.6%) and IAs and NAs were more likely than RAs to be female
(IA 30.5% and NA 34.1% vs. RA 24.2%; p = 0.020). There was a significant association with age, with
RAs more likely to be in the older age group (≥ 45 years, 53.3%) than IAs (40.9%) or NAs (37.8%)
(p < 0.001) and IAs and NAs more likely to be younger. There was no significant difference between
attendance groups when comparing white ethnicity, black African and other ethnicity, but RAs were more
likely to be white than any other ethnicity (RA 57.2% vs. IA 50.0% and NA 47.2%; p = 0.032). NAs
were more likely to have left full-time education by the age of 18 years (38.8%) than RAs (27.1%) or IAs
(29.9%) (p = 0.021). There were no significant associations between attendance and sexual orientation,
region of birth, year of arrival in the UK or religion.
In multivariable analysis, we used the continuous variable for age, with the adjusted odds ratio (aOR)
relating to each 1-year increase in age. Adjusting for the clinic where respondents were recruited, indicated
that increasing age was associated with decreasing likelihood of irregular attendance [aOR 0.96, 95%
confidence interval (CI) 0.95 to 0.98; p < 0.001] and being female was associated with increased likelihood
of irregular attendance (aOR = 1.94, 95% CI 1.32 to 2.87; p = 0.001). Increasing age was also associated
with decreasing likelihood of non-attendance (aOR 0.96, 95% CI 0.95 to 0.98; p < 0.001), whereas being
female (aOR 2.29, 95% CI 1.46 to 3.61; p < 0.001) and lower education (aOR 1.81, 95% CI 1.21 to 2.71;
p = 0.004) were associated with increased likelihood of non-attendance.
Factors relating to HIV diagnosis and health service use
The associations between factors relating to HIV diagnosis and health service use are shown in Table 15.
Three-quarters of the respondents had been diagnosed with HIV for > 5 years, with over half diagnosed
for ≥ 10 years (53.2%) and a quarter (23.7%) diagnosed for 5–10 years. There was a significant
association between time since diagnosis and attendance. IAs and NAs were more likely to have been
diagnosed for ≥ 10 years than RAs (IA 59.5% and NA 55.5% vs. RA 49.5%; p = 0.002). One-quarter of
women had been diagnosed with HIV during pregnancy (25.3%), but this was not significantly associated
with attendance. Neither was place of diagnosis related to attendance, with about half of respondents
diagnosed at a sexual health clinic (47.8%), 17.7% in hospital, 11.4% at a HIV testing service and 10.2%
at the GP.
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TABLE 14 Background factors by attendance pattern
Factor
All patients
RA, % IA, % NA, %
Overall
p-valuen %
Gender
Male 712 72.4 75.8 69.5 65.9 0.020
Female 271 27.6 24.2 30.5 34.1
Age group (years)
≤ 29 86 8.7 6.0 13.0 11.0 < 0.001
30–44 432 43.9 40.7 46.1 51.2
≥ 45 465 47.3 53.3 40.9 37.8
Ethnic group
White 518 53.6 57.2 50.0 47.2 0.138
Black African 272 28.1 25.9 29.9 32.5
Other 177 18.3 16.9 20.1 20.2
Sexual orientation
Heterosexual 351 37.9 35.1 40.0 43.9 0.106
Gay or bisexual 576 62.1 64.9 60.0 56.1
Gender and sexual orientation
Female 271 28.1 24.8 30.8 35.0 0.069
Heterosexual male 122 12.7 12.7 12.0 13.8
Gay or bisexual male 570 59.2 62.6 57.1 51.2
Region of birth
UK 400 40.9 40.1 42.7 40.7 0.503
Europe (non-UK) 159 16.3 16.6 15.4 16.7
Americas 77 7.9 8.6 7.9 5.6
Africa 302 30.9 29.5 31.8 34.0
Western Pacific 24 2.5 3.1 1.9 1.2
Eastern Mediterranean 6 0.6 0.9 0.4 0.0
South-east Asia 10 1.0 1.3 0.0 1.9
Year of arrival in UK
1984 and before 37 7.4 9.6 3.7 6.2 0.216
1985–94 123 24.7 22.0 28.4 28.4
1995–2004 219 44.1 44.7 41.0 46.9
2005–14 118 23.7 23.8 26.9 18.5
Education post 18 years old
No 276 29.8 27.1 29.9 38.8 0.021
Yes 650 70.2 72.9 70.1 61.2
Religion
No 316 32.6 31.7 35.0 31.7 0.630
Yes 653 67.4 68.3 65.0 68.3
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TABLE 15 Factors relating to HIV diagnosis and health service use by attendance pattern
Factor
All patients
RA, % IA, % NA, %
Overall
p-valuen %
Time since diagnosis (years)
< 1 37 3.8 5.6 2.2 0.0 0.002
1–5 190 19.3 20.4 19.0 16.5
5–10 233 23.7 24.5 19.3 28.0
> 10 523 53.2 49.5 59.5 55.5
Diagnosis in pregnancy
No 201 74.7 76.3 78.0 66.1 0.237
Yes 68 25.3 23.7 22.0 33.9
Where diagnosed
GP 98 10.2 10.6 10.7 8.0 0.857
Sexual health clinic 460 47.8 46.8 50.0 47.5
Hospital 170 17.7 17.8 16.0 19.8
HIV testing service 110 11.4 12.1 11.5 9.3
Elsewhere 124 12.9 12.6 11.8 15.4
Attended one or more HIV clinics
No 671 69.9 72.6 66.4 66.5 0.118
Yes 289 30.1 27.4 33.6 33.5
Years at current clinic
< 1 63 7.0 8.6 3.6 7.2 0.241
1 to < 5 241 26.8 27.3 27.0 24.5
5 to < 10 226 25.1 24.6 24.6 28.1
≥ 10 369 41.0 39.5 44.8 40.3
How often expects routine consultations
Every month 50 5.3 3.6 7.7 7.0 < 0.001
Every 3 months 257 27.2 22.3 37.5 26.6
Every 4 months 121 12.8 13.8 13.5 8.2
Every 6 months 456 48.2 53.7 38.6 45.6
Every year 62 6.6 6.6 2.7 12.7
Recommendation of clinic
Extremely likely 753 80.6 80.8 80.2 80.5 0.854
Likely 143 15.3 15.6 14.2 16.2
Neither 21 2.2 2.1 3.2 1.3
Unlikely 17 1.8 1.5 2.4 1.9
Registered with GP
No 44 4.5 3.3 3.0 11.0 < 0.001
Yes 929 95.5 96.7 97.0 89.0
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The majority of respondents had only ever attended one HIV clinic (69.9%), with two-thirds having
attended their current clinic for at least 5 years, including 41.0% who had attended the same clinic for
≥ 10 years. There was no significant association between number of clinics attended or number of years at
current clinic and attendance pattern. Respondents were asked how often they expected to have a routine
consultation at their HIV clinic. Just over half the RAs expected 6-monthly visits (RA 53.7% vs. IA 38.6%
TABLE 15 Factors relating to HIV diagnosis and health service use by attendance pattern (continued )
Factor
All patients
RA, % IA, % NA, %
Overall
p-valuen %
Last attended GP
In past year 739 79.5 80.5 81.7 72.7 0.020
1–5 years ago 141 15.2 14.8 14.7 17.3
> 5 years ago 29 3.1 2.1 2.8 7.3
Never 20 2.2 2.7 0.8 2.7
At last visit
Booked appointment
No 93 10.3 9.7 8.9 14.5 0.162
Yes 806 89.7 90.3 91.1 85.5
Routine consultation
No 102 12.2 10.0 11.9 21.3 0.003
Yes 732 87.8 90.0 88.1 78.7
Felt unwell
No 642 84.7 86.4 83.8 80.3 0.226
Yes 116 15.3 13.6 16.2 19.7
Advice about HIV
Very important 566 64.6 66.5 60.1 65.4 0.319
Somewhat important 173 19.7 18.0 21.9 22.2
Not important 137 15.6 15.5 18.0 12.4
Other advice
Very important 322 38.7 38.4 42.5 33.6 0.373
Somewhat important 252 30.3 29.2 29.2 35.7
Not important 258 31.0 32.4 28.3 30.7
Practical support
Very important 170 21.4 19.9 24.2 21.7 0.687
Somewhat important 115 14.4 13.9 14.4 16.3
Not important 511 64.2 66.2 61.4 62.0
More HIV medication
Very important 645 73.0 73.8 79.6 59.0 < 0.001
Somewhat important 92 10.4 9.0 10.4 15.3
Not important 147 16.6 17.2 10.4 25.7
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and NA 45.6%), whereas half of the IAs expected visits every 3–4 months (IA 50.1% vs. RA 36.1% and
NA 34.8%); NAs were the most likely to expect yearly visits (NA 12.7% vs. RA 6.6% and IA 2.7%;
p < 0.001). Most respondents were either extremely likely (80.6%) or likely (15.3%) to recommend their
clinic and this did not vary significantly between attendance patterns.
Although the majority of respondents were registered with a GP (95.5%), NAs were less likely to be
registered (NA 89.0% vs. RA 96.7% and IA 97.0%; p < 0.001). Similarly, RAs and IAs were more likely to
have attended their GP in the last year (RA 80.5% and IA 81.7%) than NAs (72.7%; p = 0.020).
We were interested in what brought the respondents into the clinic and we asked them about the
circumstances and purpose of their last appointment. The majority had a booked appointment (89.7%) and
reported that they did not feel unwell (84.7%). These circumstances were not significantly associated with
attendance pattern. However, RAs and IAs were more likely than NAs to be attending a routine consultation at
last visit than NAs (RA 90.0% and IA 88.1% vs. NA 78.7%; p = 0.003). Needing more HIV medication was
reported as a very important reason for attending (73.0% of respondents) compared with wanting advice
about HIV (64.6%), wanting other advice (38.7%) or needing practical support (21.4%). Reasons for attending
did not vary significantly by attendance pattern except for medication requirement, with RAs and IAs more
likely to need medication than NAs (RA 73.8% and IA 79.6% vs. NA 59.0%; p< 0.001).
The multivariable analysis, using the continuous variable for number of years since diagnosis and adjusting for
the clinic, age, gender and education, indicated that increasing number of years since HIV diagnosis was
associated with irregular attendance (aOR 1.05, 95% CI 1.02 to 1.07; p < 0.001). It indicated that increasing
number of years since HIV diagnosis was associated with increasing likelihood of non-attendance (aOR 1.05,
95% CI 1.02 to 1.08; p = 0.001), and not being registered with a GP was associated with non-attendance
(aOR 3.92, 95% CI 1.79 to 8.58; p = 0.001).
Factors relating to capability
In this section we look at factors relating to respondents’ capability of attending the clinic (Table 16).
Only one-fifth of respondents did not speak English as their main language (20.1%) and this was not
significantly associated with attendance pattern. Symptoms of neurocognitive impairment (memory loss,
feeling mentally slower, difficulty paying attention) were reported by 41.3% of respondents and this was
more likely among IAs (52.5%) than RAs (37.3%) or NAs (36.9%; p < 0.001). IAs were also less likely than
IAs or NAs to report excellent or very good health in the past 4 weeks (IA 35.2% vs. RA 50.6% and NA
42.2%) and more likely to report fair or poor health (IA 38.3% vs. RA 24.5% and NA 24.2%; p < 0.001).
More than two-thirds of respondents had ever had an inpatient stay (70.7%), one-fifth had been
hospitalised in the past year (19.7%), nearly half reported that HIV affected their day-to-day activity to
some extent (46.3%), and 14.4% reported a long-standing condition that caused difficulty with accessing
buildings, streets or vehicles. None of these factors was significantly associated with attendance.
The majority of respondents had never injected drugs (87.0%) and this was not significantly associated
with attendance pattern, but recreational drug use in the past 5 years was more common (37.6%)
and more likely to be reported by IAs (41.7%) and NAs (46.2%) than by RAs (33.1%; p = 0.003).
We included two items measuring health information competence and three-quarters of respondents both
understood where to get health information (76.6%) and felt in control of health information (75.4%),
which did not vary significantly by attendance.
The multivariable analysis, adjusting for the clinic and background factors, indicated that respondents
who reported symptoms of neurocognitive impairment were more likely to be IAs (aOR 1.79, 95% CI 1.26 to
2.55; p = 0.001), as were those who reported poorer health compared with very good or excellent health
(aOR 1.89, 95% CI 1.25 to 2.85; p = 0.002). Non-attendance was associated with reporting recreational drug
use in the past 5 years (aOR 2.03, 95% CI 1.27 to 3.25; p = 0.003) and weakly associated with reporting
good health compared with very good or excellent health (aOR 1.57, 95% CI 98 to 2.50; p = 0.059).
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TABLE 16 Factors relating to capability by attendance pattern
Factor
All patients
RA,
%
IA,
%
NA,
%
Overall
p-valuen %
Main language
Not English 196 20.1 21.5 17.5 19.8 0.406
English 780 79.9 78.5 82.5 80.2
Neurocognitive impairment
No 569 58.7 62.7 47.5 63.1 < 0.001
Yes 401 41.3 37.3 52.5 36.9
Health (past 4 weeks)
Excellent, very good 434 45.0 50.6 35.2 42.2 < 0.001
Good 258 26.8 24.9 26.4 33.5
Fair or poor 272 28.2 24.5 38.3 24.2
Ever had inpatient stay
No 284 29.3 29.9 25.6 33.3 0.211
Yes 686 70.7 70.1 74.4 66.7
Last inpatient stay
In past year 124 19.7 17.9 24.6 17.3 .390
1–5 years ago 253 40.1 41.9 36.0 40.8
> 5 years ago 254 40.3 40.2 39.4 41.8
HIV affects activity
No 522 53.7 55.1 46.6 60.5 0.062
Yes, a little 311 32.0 30.7 37.2 27.8
Yes, a lot 139 14.3 14.2 16.2 11.7
Long-standing condition affecting access
No 819 85.6 85.1 84.2 89.3 0.323
Yes 138 14.4 14.9 15.8 10.7
Last time injected drugs
< 1 year 74 7.8 5.8 10.9 9.6 0.107
1–5 years ago 20 2.1 1.7 3.1 1.9
> 5 years ago 30 3.2 3.2 2.3 4.5
Never 827 87.0 89.4 83.7 84.1
Recreational drug use (past 5 years)
No 597 62.4 66.9 58.3 53.8 0.003
Yes 360 37.6 33.1 41.7 46.2
Rating of health information competence (two items)
Understanding of where to get information
Disagree 105 11.0 10.9 10.6 11.9 0.940
Uncertain 118 12.4 11.7 13.3 13.2
Agree 731 76.6 77.4 76.1 74.8
Feeling in control about getting information
Disagree 116 12.2 12.2 13.6 10.0 0.670
Uncertain 118 12.4 11.4 13.2 14.4
Agree 717 75.4 76.4 73.2 75.6
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Factors relating to motivation
Motivation describes the mechanisms that activate or inhibit a behaviour and, in this section, we explore how
items relating to motivation are associated with attendance, as shown in Table 17. One-third of respondents
said that religion was very important in their life (30.3%), but this was not significantly associated with
attendance pattern. We asked patients if they had experienced any of a list of seven feelings in the past 12
months because of their HIV status. At least one of the seven items relating to internalised HIV stigma had
been experienced by 43.8% of participants; the most likely to be reported was low self-esteem (34.1%),
followed by self-blame (28.8%) and shame (28.7%); only 4.9% of respondents ticked, ‘I feel I should be
punished’. IAs were more likely than RAs or NAs to report low self-esteem (IA 40.0% vs. RA 32.6% and NA
29.4%; p = 0.046) and feeling suicidal (IA 16.5% vs. RA 9.4% and NA 11.9%; p = 0.013), but there was no
significant difference between the attendance patterns on an overall internalised stigma summative score.
TABLE 17 Factors relating to motivation by attendance pattern
Factor
All patients
RA, % or
mean (SD)
IA, % or
mean (SD)
NA, % or
mean (SD)
Overall
p-valuen
% or
mean (SD)
Importance of religion
Very 229 30.3 30.2 29.6 31.7 0.975
Somewhat 95 12.6 12.9 11.7 13.0
Not very 116 15.3 16.2 15.0 13.0
No religion 316 41.8 40.7 43.7 42.3
Internalised stigma (seven items)
I feel ashamed
No 687 71.3 71.6 71.2 70.6 0.966
Yes 276 28.7 28.4 28.8 29.4
I blame myself
No 686 71.2 72.0 70.0 70.6 0.827
Yes 277 28.8 28.0 30.0 29.4
I have low self-esteem
No 635 65.9 67.4 60.0 70.6 0.046
Yes 328 34.1 32.6 40.0 29.4
I feel suicidal
No 850 88.3 90.6 83.5 88.1 0.013
Yes 113 11.7 9.4 16.5 11.9
I feel guilty
No 770 80.0 80.8 76.9 81.9 0.345
Yes 193 20.0 19.2 23.1 18.1
I blame others
No 903 93.8 94.5 94.6 90.0 0.097
Yes 60 6.2 5.5 5.4 10.0
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We asked respondents about symptoms of anxiety and depression using the PHQ4 scale.52 None of our
respondents reported severe levels of anxiety and depression, although it would not have been appropriate
for clinics to approach patients with severe symptoms about participation. There was an indication that IAs
were less likely than RAs or NAs to report normal levels (IA 70.1% vs. RA 79.5% and NA 79.1%; p = 0.057);
they were also more likely to report that they had ever been diagnosed with depression (IA 38.2% vs. RA
29.1% and NA 31.4%; p = 0.043).
TABLE 17 Factors relating to motivation by attendance pattern (continued )
Factor
All patients
RA, % or
mean (SD)
IA, % or
mean (SD)
NA, % or
mean (SD)
Overall
p-valuen
% or
mean (SD)
I should be punished
No 916 95.1 95.6 93.5 96.3 0.328
Yes 47 4.9 4.4 6.5 3.8
No internalised stigma
No 541 56.2 54.7 58.5 57.5 0.563
Yes 422 43.8 45.3 41.5 42.5
Internalised stigma
summative score
963 1.3 (1.6) 1.3 (1.6) 1.5 (1.8) 1.3 (1.5) 0.166
Environmental mastery (three items)
Life gets me down
Disagree 431 45.2 48.6 39.2 43.3 0.076
Uncertain 142 14.9 15.3 14.6 14.0
Agree 381 39.9 36.1 46.2 42.7
Good at managing life
Disagree 148 15.5 15.4 15.0 16.5 0.322
Uncertain 135 14.1 12.1 17.3 15.8
Agree 673 70.4 72.5 67.7 67.7
In charge of life
Disagree 175 18.4 17.8 17.6 21.7 0.044
Uncertain 171 18.0 15.5 23.8 16.6
Agree 606 63.7 66.7 58.6 61.8
Environmental mastery
summative score
936 10.5 (2.8) 10.7 (2.8) 10.1 (2.7) 10.3 (2.7) 0.027
PHQ4: anxiety and depression (past 2 weeks)
Normal 699 76.8 79.5 70.1 79.1 0.057
Mild 113 12.4 10.6 16.7 11.5
Moderate 98 10.8 10.0 13.1 9.5
Ever diagnosed with depression
No 617 68.0 70.9 61.8 68.6 0.043
Yes 290 32.0 29.1 38.2 31.4
DOI: 10.3310/hsdr05130 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Howarth et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
47
We included three items from a scale measuring environmental mastery in our questionnaire. Although
findings from this a subscale of the PWB49,50 are reported here under motivation, environmental mastery is
also likely to affect capability. IAs scored lower on a summative score of environmental mastery than RAs
or NAs (IA 10.1 vs. RA 10.7 and NA 10.3; p = 0.027); they were more likely to report that the demands of
life often got them down (IA 46.2% vs. RA 36.1% and NA 42.7%) and less likely to feel in charge of the
situation in which they lived (RA 58.6% vs. RA 66.7% and NA 61.8%, p = 0.027).
In multivariable analysis, irregular attendance was associated with ever being diagnosed with depression
(aOR 1.61, 95% CI 1.11 to 2.33; p = 0.012) and with being uncertain rather than agreeing about being in
charge of life (aOR 1.75, 95% CI 1.13 to 2.72; p = 0.013).
Factors relating to opportunity: social influences
Social influences shape an individual’s opportunity to enact behaviours. In this section, we explore
respondents’ social environment in terms of the people they interact with both within and outside the HIV
clinic, as shown in Table 18.
TABLE 18 Factors relating to opportunity (social influences) by attendance pattern
Factor
All patients
RA, % IA, % NA, %
Overall
p-valuen %
Length of relationship
Not in relationship 486 51.3 49.3 52.9 55.6 0.895
< 1 year 46 4.9 4.5 5.7 4.6
1–5 years 121 12.8 13.0 12.5 12.4
5–10 years 90 9.5 10.4 8.4 8.5
> 10 years 204 21.5 22.8 20.5 19.0
Cohabiting
No 627 65.8 62.4 69.8 70.8 0.041
Yes 326 34.2 37.6 30.2 29.2
Partner has HIV
Yes 210 45.2 44.1 46.7 46.5 0.835
No 231 49.7 51.5 47.5 46.5
Do not know 24 5.2 4.4 5.7 7.0
Abused by or afraid of partner (past year)
No 578 79.4 81.3 76.5 77.6 0.336
Yes 150 20.6 18.7 23.5 22.4
Told anyone about HIV
No 127 13.1 11.6 14.7 15.4 0.304
Yes 843 86.9 88.4 85.3 84.6
Told partner about HIV
No 62 11.3 10.1 11.3 15.6 0.351
Yes 486 88.7 89.9 88.7 84.4
FINDINGS FROM SURVEY: FACTORS ASSOCIATED WITH ENGAGEMENT IN HIV CARE
NIHR Journals Library www.journalslibrary.nihr.ac.uk
48
TABLE 18 Factors relating to opportunity (social influences) by attendance pattern (continued )
Factor
All patients
RA, % IA, % NA, %
Overall
p-valuen %
Told family about HIV
Some or all 494 58.0 54.2 62.9 63.2 0.035
None 357 42.0 45.8 37.1 36.8
Told friends about HIV
Some or all 622 70.0 70.7 71.4 65.5 0.421
None 266 30.0 29.3 28.6 34.5
Told GP about HIV
No 82 10.7 11.3 8.9 11.4 0.634
Yes 685 89.3 88.7 91.1 88.6
Rating of social support (five items)
People who care
Not enough 252 26.8 25.0 30.4 26.9 0.270
Enough 689 73.2 75.0 69.6 73.1
Love and affection
Not enough 311 33.3 32.0 34.4 36.1 0.579
Enough 622 66.7 68.0 65.6 63.9
Chances to talk
Not enough 337 35.9 33.0 38.9 40.9 0.101
Enough 601 64.1 67.0 61.1 59.1
Invitations to go out
Not enough 314 33.7 31.7 36.7 35.3 0.347
Enough 618 66.3 68.3 63.3 64.7
Help when sick
Not enough 340 37.2 33.7 41.8 41.6 0.046
Enough 574 62.8 66.3 58.2 58.4
Social support score
Low (≤ 12) 147 16.5 15.2 18.9 17.1 0.435
Higher (12+) 744 83.5 84.8 81.1 82.9
Received support group information from clinic
Yes 660 67.9 71.6 62.9 63.8 0.084
No 182 18.7 16.9 22.0 19.6
Cannot remember 130 13.4 11.6 15.2 16.6
Used support group
Yes 298 30.9 31.8 32.6 25.3 0.056
No, would like to 159 16.5 14.3 20.7 17.1
No, do not want to 422 43.8 46.1 38.3 44.9
Not aware of groups 84 8.7 7.7 8.4 12.7
continued
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Half of the respondents were not currently in a relationship (51.3%), whereas 31.0% had been in a
relationship for at least 5 years. Although this was not significantly associated with attendance pattern,
RAs were more likely to be cohabiting (37.6%) than IAs (30.2%) or NAs (29.2%; p = 0.041). Among
respondents with a partner, almost half had a partner who was also HIV positive (45.2%) and most had
told their partners about their HIV status (88.7%), neither of which varied significantly by attendance
pattern. One-fifth of respondents had been abused by, or afraid of, a partner or ex-partner in the past year
(20.6%) but this was not significantly associated with attendance.
TABLE 18 Factors relating to opportunity (social influences) by attendance pattern (continued )
Factor
All patients
RA, % IA, % NA, %
Overall
p-valuen %
Found group helpful
Yes, definitely 147 53.1 57.9 44.3 51.3 0.327
Yes, to some extent 98 35.4 32.7 41.8 33.3
No 32 11.6 9.4 13.9 15.4
At last visit
Friendly reception staff
Yes, definitely 795 82.1 83.1 81.3 80.4 0.308
Yes, to some extent 158 16.3 15.1 16.8 19.6
No 15 1.5 1.8 1.9 0.0
Understood explanation of treatment
Yes, completely 828 90.1 91.7 87.4 89.0 0.351
Yes, to some extent 75 8.2 6.6 10.5 9.7
No 16 1.7 1.7 2.0 1.3
Doctor was friendly
Yes, definitely 913 95.3 95.5 94.7 95.7 0.840
Not definitely 45 4.7 4.5 5.3 4.3
Doctor listened
Yes, definitely 902 94.0 93.8 94.3 93.9 0.969
Not definitely 58 6.0 6.2 5.7 6.1
Confidence in doctor
Yes, definitely 881 91.9 93.3 90.8 88.9 0.157
Not definitely 78 8.1 6.7 9.2 11.1
Nurse was friendly
Yes, definitely 892 93.9 94.9 94.6 89.5 0.037
Not definitely 58 6.1 5.1 5.4 10.5
Nurse listened
Yes, definitely 875 92.4 93.2 94.6 86.4 0.006
Not definitely 72 7.6 6.8 5.4 13.6
Confidence in nurse
Yes, definitely 855 90.7 90.9 92.6 86.9 0.143
Not definitely 88 9.3 9.1 7.4 13.1
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Although most respondents had told someone about their HIV status (86.9%), 42.0% had not told any
family members and 30.0% had told none of their friends. RAs were more likely to have told none of their
family members about their HIV status (RA 45.8% vs. IA 37.1% and NA 36.8%; p = 0.035) but there was
no significant difference between groups on telling friends about their HIV status. Most respondents had
told their GP (89.3%) and this did not vary significantly by attendance.
We included five items from the DUFSS.51 Across the attendance patterns, the majority of respondents
reported that they had enough people who cared about what happened to them (73.2%). Somewhat
fewer felt that they got enough love and affection (66.7%), enough invitations to go out (66.3%) and
enough chances to talk (64.1%). IAs and NAs were less likely than RAs to report getting enough help
when they were sick in bed (IA 58.2% and NA 58.4% vs. RA 66.3%; p = 0.046), although there was no
significant difference between the attendance groups on an overall score for level of social support. Two-
thirds of respondents overall had received information from their clinic about HIV support groups (67.9%),
but only 30.9% had used a support group in their local area and 16.5% had not used a group but would
like to. Among those who had used a group, 53.1% definitely found it helpful compared with 11.6% who
did not find it helpful. None of these variables was significantly associated with attendance pattern.
We asked respondents a range of questions about their interactions with clinic staff on the last occasion that
they came to the clinic. Most reported that the reception staff were definitely friendly and approachable
(82.1%), that they completely understood explanations for any treatment or action (90.1%), that the doctor
was definitely friendly and approachable (95.3%), the doctor definitely listened to them (94.0%) and that they
definitely had confidence and trust in the doctor (91.9%). This did not vary significantly between attendance
groups. All respondents were similarly likely to report that they had confidence and trust in the nurse (90.7%),
but NAs were less likely than RAs or IAs to report that the nurse was friendly (NA 89.5% vs. RA 94.9% and
NA 94.6%; p= 0.037) or listened to them (NA 86.4% vs. RA 93.2% and IA 94.6%; p = 0.006).
In multivariable analysis, irregular attendance was associated with having told family members about their
HIV status (aOR 1.52, 95% CI 1.06 to 2.20; p = 0.025) and with not having enough help when sick in
bed (aOR 1.64, 95% CI 1.14 to 2.37; p = 0.008). Non-attendance was associated with having told family
members about their HIV status (aOR 1.63, 95% CI 1.02 to 2.60; p = 0.043), not having enough help
when sick in bed (aOR 1.76, 95% CI 1.12 to 2.79; p = 0.015) and not being listened to by the nurse
(aOR 2.17, 95% CI 1.06 to 4.42; p = 0.034).
Factors relating to opportunity: barriers
In the same way that social influences shape an individual’s behaviour, structural factors can also enable or
hinder attendance at the HIV clinic. In this section, we explore these barriers and facilitators of HIV care,
as shown in Table 19.
Regular attenders were less likely to have children (25.4%) than IAs (31.8%) or NAs (37.7%; p = 0.003).
However, there was no significant difference between attendance groups on responsibility for looking after
children, family members or others that was reported by 24.9% of respondents. Two-thirds of respondents
were British citizens (67.3%), 15.2% were European Union citizens, 11.1% had indefinite leave to remain
and 6.5% had temporary or no official immigration status. This was not significantly associated with
attendance pattern. The majority of respondents were working (58.9%) and there was some indication
that RAs were less likely than IAs or NAs to be students (RA 3.4% vs. IA 5.8% and NA 7.5%) and less
likely to be unemployed (RA 19.4% vs. IA 25.8% and NA 23.1%; p = 0.056).
Several indicators of economic status were included in the questionnaire, which showed that respondents
were generally financially disadvantaged but that this was more likely among IAs and NAs. Less than
half of the respondents had enough money for their basic needs all the time (43.1%) and this was less
likely among IA (35.3%) and NAs (34.2%) than among RAs (49.5%; p < 0.001). Moderate or severe
hunger was reported by 13.6% of RAs, compared with 28.5% of IAs and 23.8% of NAs (p < 0.001).
One-third of RAs (33.3%) were homeowners, compared with 22.1% of IAs and 19.1% of NAs (p < 0.001).
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TABLE 19 Factors relating to opportunity (barriers) by attendance pattern
Factor
All patients
RA, % IA, % NA, %
Overall
p-valuen %
Number of children
None 668 70.8 74.6 68.2 62.3 0.003
One 100 10.6 7.9 14.0 14.3
Two 91 9.7 10.5 6.6 11.7
Three or more 84 8.9 7.0 11.2 11.7
Caring responsibilities
No 725 75.1 77.4 73.3 69.8 0.109
Yes 241 24.9 22.6 26.7 30.2
Immigration status
British citizen 625 67.3 67.5 68.0 65.4 0.458
EU citizen 141 15.2 16.6 12.5 14.7
Indefinite leave to remain 103 11.1 10.6 10.9 12.8
Temporary or no status 60 6.5 5.2 8.6 7.1
Work status
Working 563 58.9 60.8 56.5 56.3 0.056
Student 45 4.7 3.4 5.8 7.5
Unemployed 208 21.8 19.4 25.8 23.1
Other 140 14.6 16.4 11.9 13.1
Money for basic needs
Not all of the time 553 56.9 50.5 64.7 65.8 < 0.001
All of the time 419 43.1 49.5 35.3 34.2
Hunger scale
Little or none 734 80.7 86.4 71.5 76.2 < 0.001
Moderate or severe 176 19.3 13.6 28.5 23.8
Homeowner
No 702 72.1 66.7 77.9 80.9 < 0.001
Yes 271 27.9 33.3 22.1 19.1
Time in accommodation
< 6 months 88 10.1 9.7 10.7 11.0 0.090
6 months–1 year 72 8.3 8.0 9.0 8.2
1–5 years 263 30.3 26.5 36.3 33.6
> 5 years 444 51.2 55.9 44.0 47.3
Deprivation quintile
1: least deprived 14 2.5 2.5 1.4 4.7 0.425
2 26 4.7 5.2 5.6 1.2
3 63 11.4 12.7 9.9 9.3
4 209 37.9 36.1 37.3 45.3
5: most deprived 240 43.5 43.5 45.8 39.5
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TABLE 19 Factors relating to opportunity (barriers) by attendance pattern (continued )
Factor
All patients
RA, % IA, % NA, %
Overall
p-valuen %
Mode of transport to clinic
Public transport 723 78.8 75.2 82.0 86.0 0.022
Car or motorbike 96 10.5 11.1 11.5 6.7
On foot or bicycle 90 9.8 12.6 5.7 6.7
Other 9 1.0 1.1 0.8 0.7
Time to get to clinic
< 30 minutes 374 38.9 41.8 36.0 33.7 0.363
30–60 minutes 412 42.8 41.6 43.7 45.4
1–2 hours 150 15.6 14.3 16.5 18.4
> 2 hours 26 2.7 2.2 3.8 2.5
Clinic opening hours
Very convenient 603 62.7 64.6 61.7 58.0 0.218
Fairly convenient 311 32.3 31.7 31.4 35.8
Not convenient 48 5.0 3.7 6.9 6.2
Convenient additional clinic opening hours
Early morning (Monday–Friday)
No 759 77.2 76.0 79.2 78.0 0.572
Yes 224 22.8 24.0 20.8 22.0
Evening (Monday–Friday)
No 654 66.5 70.0 61.7 62.8 0.033
Yes 329 33.5 30.0 38.3 37.2
Saturday
No 649 66.0 68.0 65.4 60.4 0.188
Yes 334 34.0 32.0 34.6 39.6
Sunday
No 836 85.0 84.9 85.9 84.1 0.879
Yes 147 15.0 15.1 14.1 15.9
Experience of consultations with doctor or nurse (in the past)
Face to face
No 59 6.4 5.4 7.2 8.4 0.331
Yes 862 93.6 94.6 92.8 91.6
Telephone
No 580 63.0 62.4 63.9 63.6 0.906
Yes 341 37.0 37.6 36.1 36.4
Text messaging
No 773 83.9 81.7 85.9 88.3 0.085
Yes 148 16.1 18.3 14.1 11.7
E-mail
No 748 81.2 80.9 77.9 87.7 0.049
Yes 173 18.8 19.1 22.1 12.3
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There were a lot of missing postcode data to create and Index of Multiple Deprivation score for
respondents’ neighbourhoods, but 43.5% lived in a neighbourhood that was among the most deprived in
England. Time in accommodation was not significantly associated with attendance group and 51.2% had
lived in their current accommodation for > 5 years.
We asked respondents several questions relating to the convenience of the clinical service provision. RAs
were less likely than IAs and NAs to travel to the clinic by public transport (RA 75.2% vs. IA 82.0% and
NA 86.0%) and were more likely to go on foot or by bicycle (RA 12.6% vs. IA 5.7% and NA 6.7%),
whereas NAs were less likely to use a car or motorbike than RAs or IAs (NA 6.7% vs. RA 11.1% and IA
11.5%; p = 0.022). There were no significant differences by attendance on the time it took to get to the
clinic or convenience of the opening hours. The majority took < 1 hour to get to the clinic (81.7%), with
38.9% taking < 30 minutes, but 15.6% took 1–2 hours and 2.7% took > 2 hours. Most respondents
TABLE 19 Factors relating to opportunity (barriers) by attendance pattern (continued )
Factor
All patients
RA, % IA, % NA, %
Overall
p-valuen %
Skype or similar
No 918 99.7 99.6 100.0 99.4 0.504
Yes 3 0.3 0.4 0.0 0.6
Preference for consultations with doctor or nurse (in the future)
Face to face
No 140 15.0 12.7 17.4 19.0 0.072
Yes 791 85.0 87.3 82.6 81.0
Telephone
No 478 51.3 50.8 52.2 51.9 0.924
Yes 453 48.7 49.2 47.8 48.1
Text messaging
No 688 73.9 75.0 73.1 71.5 0.647
Yes 243 26.1 25.0 26.9 28.5
E-mail
No 564 60.6 60.0 57.7 67.1 0.153
Yes 367 39.4 40.0 42.3 32.9
Skype or similar
No 715 76.8 78.3 73.1 77.8 0.266
Yes 216 23.2 21.7 26.9 22.2
Last appointment booked
In person 641 68.0 75.7 63.5 49.1 < 0.001
By telephone 289 30.6 23.4 36.1 46.5
By e-mail or text 13 1.4 0.9 0.4 4.4
Ease of booking last appointment
Very easy 618 72.5 74.7 70.4 68.6 0.197
Fairly easy 192 22.5 21.8 22.6 25.0
Not easy 42 4.9 3.5 7.1 6.4
EU, European Union.
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found the opening hours very or fairly convenient (95.0%). A minority of all respondents wanted Sunday
opening (15.0%) and somewhat more wanted weekday early morning opening (22.8%). One-third of all
respondents wanted Saturday opening (34.0%) and mid-week evening opening (33.5%), with the latter
more popular among IAs and NAs than RAs (IA 38.3% and NA 37.2% vs. RA 30.0%; p = 0.033).
In terms of previous and desired mode of communication for consultations, the only significant difference was
that NAs were less likely to have used e-mail than RAs or IAs for this purpose (NA 12.3% vs. RA 19.1% and
IA 22.1%; p = 0.049). Comparison of previous and desired mode of communication indicates that 93.6% of
respondents have had face-to-face consultations and 85.0% would like face-to-face consultations in the
future; 37.0% have had telephone consultations and 48.7% would like telephone consultations; 16.1% have
had consultations by text and 26.1% would like this in the future; 18.8% have had e-mail consultations and
39.4% would like consultations by e-mail in the future; and only three respondents reported consultations by
Skype or similar and 23.2% would like this type of consultation in the future.
Three-quarters of RAs booked their last appointment in person (75.7%), compared with 63.5% of IAs and
49.1% of NAs, whereas NAs were more likely than RAs and IAs to book by telephone (NA 46.5% vs. RA
23.4% and IA 36.1%) or by e-mail/text (NA 4.4% vs. RA 0.9% and IA 0.4%; p < 0.001). However, there
were no significant differences between attendance groups on ease of booking, which was mostly
reported as being very easy (72.5%).
In multivariable analysis, irregular attendance was associated with having children (aOR 2.11, 95% CI
1.39 to 3.20; p < 0.001) and not having enough money for basic needs (aOR 1.74, 95% CI 1.19 to 2.56;
p = 0.005). Non-attendance was associated with having children (aOR 2.76, 95% CI 1.69 to 4.50;
p < 0.001), not having enough money for basic needs (aOR 1.63, 95% CI 1.02 to 2.61; p = 0.042) and
not owning one’s own home (aOR 1.87, 95% CI 1.09 to 3.20; p = 0.023).
Use of and beliefs about antiretroviral therapy
Table 20 shows the respondents’ use of, and beliefs about, ART. There were no significant differences
between attendance groups on their scores relating to their belief about medicines, either for the general
benefit subscale or for the general distrust subscale. RAs were more likely to be taking ART than IAs or
NAs (RA 94.2% vs. IA 90.7% and NA 64.6%), whereas NAs were more likely than RAs or IAs to have
taken ART in the past (NA 15.9% vs. RA 0.9% and IA 4.5%) or not at all (NA 19.5% vs. RA 4.9% and
IA 4.8%; p < 0.001). Multivariable analysis, adjusting for the clinic, age, gender and education, indicated
that IAs were more likely to have been on ART previously than those who were currently on ART (aOR 3.83,
95% CI 1.29 to 11.40; p = 0.016), but they were not more likely to have never been on ART. NAs were
more likely to have been on ART previously (aOR 18.17, 95% CI 6.44 to 51.28; p < 0.001) and were more
likely to have never been on ART (aOR 5.35, 95% CI 2.89 to 9.90; p < 0.001).
TABLE 20 Use of and beliefs about ART by attendance pattern
Factor
All patients
RA, % or
mean (SD)
IA, % or
mean (SD)
NA, % or
mean (SD)
Overall
p-valuen
% or
mean (SD)
Belief about medicines
General benefit score 940 8.8 (2.2) 8.8 (2.2) 8.9 (2.1) 8.6 (2.3) 0.422
General distrust score 874 10.1 (3.3) 9.9 (3.1) 10.2 (3.7) 10.4 (3.2) 0.206
Currently taking ART
Yes 868 88.3 94.2 90.7 64.6 < 0.001
No: but have done 43 4.4 0.9 4.5 15.9
No: never have 72 7.3 4.9 4.8 19.5
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Table 21 shows that, among those on ART, IAs and NAs were more likely than RAs to have been taking it
for longer: 5–10 years (IA 31.7% and NA 32.0% vs. RA 24.6%) or > 10 years (IA 39.4% and NA 45.9%
vs. RA 35.9%; p = 0.005). RAs on ART were more likely to be using the home delivery service (59.5%)
than IAs (46.6%) or NAs (38.7%) on ART (p < 0.001). IAs and NAs reported poorer adherence to ART
with lower scores on the MARS than RAs (IA 22.6 and NA 22.3 vs. RA 24.0; p < 0.001) and greater
likelihood of missing a dose on 1 or more days in the past week (IA 35.5% and NA 38.5% vs. RA 12.8%;
p < 0.001). They reported lower scores on the ART necessity subscale (IA 17.4 and NA 17.2 vs. RA 18.0;
p = 0.040) and higher scores on the ART concerns subscale (IA 10.0 and NA 9.8 vs. RA 9.1; p = 0.005).56,57
Among the minority of respondents (n = 102) who were not taking ART and responded to the follow-up
questions, 46.1% said that they had been advised to take ART. NAs made up the largest proportion of
respondents who were not taking ART against the doctor’s advice (NA 60.0% vs. RA 13.3% and IA
26.7%). Table 22 shows the reasons that these respondents gave for not taking ART against advice at this
time. As the numbers are small, they are not divided up by attendance group. The reason that was most
likely to be reported as very important was the side effects of medication (61.7%), followed by feeling
depressed or overwhelmed (54.3%), not wanting to think about being HIV positive (32.6%) and not
wanting anyone to see the medication (29.8%). Reasons that were very important for a smaller proportion
of respondents were homelessness (11.4%), harmfulness of medication (9.1%), use of alcohol or drugs
(8.9%), information from the media (8.7%), information from friends (8.5%), complication of taking
medication (6.8%) and, finally, use of alternative therapy (2.3%).
TABLE 21 People currently taking ART: use of and beliefs about ART by attendance pattern
Factor
All patients
RA, % or
mean (SD)
IA, % or
mean (SD)
NA, % or
mean (SD)
Overall
p-valuen
% or
mean (SD)
Years since starting ART
< 1 year 84 9.7 11.6 8.1 4.9 0.005
1–5 years 212 24.4 27.9 20.7 17.2
5–10 years 240 27.6 24.6 31.7 32.0
> 10 years 333 38.3 35.9 39.4 45.9
Whether or not clinic has ART delivery service
Yes: using it 444 53.2 59.5 46.6 38.7 < 0.001
Yes: used before 86 10.3 8.3 14.2 11.3
Yes: have not used 171 20.5 19.6 21.1 23.6
No 51 6.1 5.2 5.6 11.3
Do not know 82 9.8 7.5 12.5 15.1
MARS 784 23.4 (2.5) 24.0 (1.8) 22.6 (3.2) 22.3 (3.0) < 0.001
Missed dose (past week)
No 642 77.6 87.2 64.5 61.5 < 0.001
On 1+ days 185 22.4 12.8 35.5 38.5
Belief about medicines
ART necessity score 820 17.7 (3.5) 18.0 (3.2) 17.4 (3.7) 17.2 (3.8) 0.040
ART concerns score 805 9.4 (3.8) 9.1 (3.5) 10.0 (4.1) 9.8 (4.0) 0.005
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TABLE 22 People not on ART: reasons for not taking ART
Factor n %
Advised to take ART
No 55 53.9
Yes 47 46.1
Reasons for not taking ART against advice (11 items)
Side effects
Very important 29 61.7
Somewhat important 9 19.1
Not important 9 19.1
Feeling depressed
Very important 25 54.3
Somewhat important 15 32.6
Not important 6 13.0
Not wanting to think about HIV
Very important 15 32.6
Somewhat important 9 19.6
Not important 22 47.8
Alcohol or drugs
Very important 4 8.9
Somewhat important 12 26.7
Not important 29 64.4
Not wanting medication to be seen
Very important 14 29.8
Somewhat important 10 21.3
Not important 23 48.9
Homelessness
Very important 5 11.4
Somewhat important 3 6.8
Not important 36 81.8
Using alternative therapy
Very important 1 2.3
Somewhat important 5 11.6
Not important 37 86.0
Too complicated to take
Very important 3 6.8
Somewhat important 6 13.6
Not important 35 79.5
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TABLE 22 People not on ART: reasons for not taking ART (continued )
Factor n %
Harmful
Very important 4 9.1
Somewhat important 9 20.5
Not important 31 70.5
Information from friends
Very important 4 8.5
Somewhat important 16 34.0
Not important 27 57.4
Information from media
Very important 4 8.7
Somewhat important 8 17.4
Not important 34 73.9
Clinical data
In addition to fielding our questionnaire, we collected clinical data from patients’ notes. The item above on
whether or not patients were currently taking ART is an amalgamation of patient-reported and clinical
data, and the item on years since starting ART is from the clinical data set. Both items are included in the
above description of the data, as they fit into the section on use of and beliefs about ART. All other data
taken from patients’ notes are reported below and shown in Table 23.
Although the majority of patients (80.5%) did not meet any of the HARS 3 categories for being classified as
complex patients, almost one in five did. RAs were less likely than IAs or NAs to be reported to meet any of the
HARS 3 complex patient criteria (RA 16.0% vs. IA 24.5% and NA 23.2%; p= 0.007). NAs were more likely
than RAs or IAs to be pregnant (NA 5.5% vs. RA 0.5% and IA 0.4%; p< 0.001), suggesting that pregnancy
had brought them back into care; and IAs and NAs were more likely than RAs to have persistent viraemia after
6 months on ART (IA 8.6% and NA 8.5% vs. RA 4.0%; p= 0.012). IAs were more likely than RAs or NAs to
have ever had a HIV-related inpatient stay (IA 30.9% vs. RA 21.4% and NA 26.3%; p= 0.022).
There were no significant differences between attendance groups in CD4 count at diagnosis or the first
recorded CD4 count (where the CD4 count at diagnosis was not available), or on CD4 count at ART
initiation. One-third of patients had a CD4 count of < 200 cells/mm3 at diagnosis (33.0%), one-fifth had a
first recorded CD4 count of < 200 cells/mm3 (19.2%), and 39.9% had a CD4 count of < 200 cells/mm3 at
ART initiation. RAs and IAs were more likely to have a current CD4 count of > 350 cells/mm3 than NAs
(RA 88.6% and IA 84.7% vs. NA 67.3%; p < 0.001). NAs were less likely than RAs or IAs to have a viral
load of > 5.0 log-copies/ml at diagnosis (NA 16.9% vs. RA 42.5% and IA 40.8%; p < 0.001). There was
no significant difference between groups for first recorded viral load. RAs were more likely to have a
current viral load that was undetectable (RA 86.2% vs. IA 76.9% vs. NA 45.1%; p < 0.001).
About one-fifth of patients had ever had an AIDS-defining illness (22.9%) and this did not vary significantly
according to attendance group. The most commonly reported AIDS-defining illness was Pneumocystis carinii
pneumonia in 6.6% of patients, followed by pulmonary tuberculosis in 4.6%, Kaposi’s sarcoma in 3.1%,
oesophageal candidiasis in 2.7% and herpes simplex virus in 2.0%, none of which varied significantly by
attendance pattern. A minority of patients had hepatitis C current coinfection (5.8%) or hepatitis B coinfection
(3.6%), but neither was significantly associated with attendance. One-fifth of patients had experienced mental
health issues in the past year (20.5%) and this was not statistically associated with attendance. Whereas 5.9%
of RAs had issues of drug or alcohol dependency in the past year, this was true of 16.7% of IAs and 18.5% of
NAs (p< 0.001).
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TABLE 23 Clinical data by attendance pattern
Factor
All patients
RA, % IA, % NA, %
Overall
p-valuen %
HARS 3: complex patient criteria (10 items)
Current tuberculosis 6 0.6 0.4 1.1 0.6 0.431
Chronic viral liver disease 35 3.6 3.6 3.3 3.7 0.975
Oncological treatment 5 0.5 0.5 0.7 0.0 0.564
Active AIDS diagnosis 10 1.0 0.7 1.1 1.8 0.459
Advanced end-organ disease 11 1.1 0.9 1.5 1.2 0.755
Current pregnancy 13 1.3 0.5 0.4 5.5 < 0.001
Under psychiatric care 54 5.5 5.1 7.4 3.7 0.203
Persistent viraemia 59 6.0 4.0 8.6 8.5 0.012
Under care of social worker 9 0.9 0.5 1.9 0.6 0.162
None of these 791 80.5 84.0 75.5 76.8 0.007
Ever had HIV-related inpatient stay
No 638 75.1 78.6 69.1 73.7 0.022
Yes 211 24.9 21.4 30.9 26.3
CD4 count at diagnosis (cells/mm3)
< 200 187 33.0 35.7 31.8 25.5 0.300
200–349 131 23.1 23.7 22.3 22.3
≥ 350 249 43.9 40.6 45.9 52.1
First recorded CD4 count (cells/mm3)
< 200 75 19.2 18.3 19.8 21.3 0.253
200–349 103 26.4 22.5 32.8 27.9
≥ 350 212 54.4 59.2 47.4 50.8
CD4 count (cells/mm3) at diagnosis or first recorded CD4 count
< 200 262 27.4 28.8 26.5 23.9 0.615
200–349 234 24.5 23.2 26.9 24.5
≥ 350 461 48.2 48.0 46.6 51.6
CD4 count at ART initiation (cells/mm3)
< 200 279 39.9 40.7 35.6 45.1 0.489
200–349 222 31.7 32.1 33.7 26.5
≥ 350 199 28.4 27.2 30.7 28.4
Current CD4 count (cells/mm3)
< 200 67 7.0 4.8 7.6 13.0 < 0.001
200–349 98 10.2 8.5 7.6 19.8
≥ 350 798 82.9 88.6 84.7 67.3
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TABLE 23 Clinical data by attendance pattern (continued )
Factor
All patients
RA, % IA, % NA, %
Overall
p-valuen %
Viral load at diagnosis (log-copies/ml)
< 4.00 133 25.0 18.8 28.2 42.2
< 0.001
4.00–4.99 197 37.0 38.6 31.0 41.0
≥ 5.00 203 38.1 42.5 40.8 16.9
First recorded viral load (log-copies/ml)
< 4.00 200 48.4 51.3 48.3 39.1 0.283
4.00–4.99 123 29.8 28.1 32.5 30.4
≥ 5.00 90 21.8 20.5 19.2 30.4
Viral load (log-copies/ml) at diagnosis or first recorded viral load
< 4.00 333 35.2 32.5 37.4 40.8 0.115
4.00–4.99 320 33.8 34.2 31.7 36.2
≥ 5.00 293 31.0 33.3 30.9 23.0
Current viral load
Undetectable 741 76.7 86.2 76.9 45.1 < 0.001
Detectable 225 23.3 13.8 23.1 54.9
Ever had AIDS-defining illness
No 690 77.1 78.7 74.8 75.6 0.447
Yes 205 22.9 21.3 25.2 24.4
AIDS-defining illnesses (20+ patients)
Herpes simplex virus 20 2.0 1.8 1.9 3.0 0.601
Oesophageal candidiasis 27 2.7 3.3 1.5 3.0 0.329
Kaposi’s sarcoma 30 3.1 2.4 4.5 3.0 0.261
Pulmonary tuberculosis 45 4.6 4.4 4.8 4.9 0.936
Pneumocystis carinii pneumonia 65 6.6 6.9 6.7 5.5 0.812
Hepatitis C coinfection
No 917 94.2 95.4 92.9 92.7 0.222
Yes 56 5.8 4.6 7.1 7.3
Hepatitis B coinfection
No 938 96.4 96.9 96.6 94.5 0.357
Yes 35 3.6 3.1 3.4 5.5
Mental health issues (past year)
No 723 79.5 82.2 75.9 76.1 0.074
Yes 187 20.5 17.8 24.1 23.9
Drug/alcohol dependency (past year)
No 806 89.1 94.1 83.3 81.5 < 0.001
Yes 99 10.9 5.9 16.7 18.5
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In multivariable analysis, irregular attendance was associated with being a complex patient according to
the HARS 3 criteria (aOR 1.76, 95% CI 1.16 to 2.67; p = 0.008), having a HIV-related inpatient stay (aOR
1.51, 95% CI 1.01 to 2.27; p = 0.045) and drug/alcohol dependency issues (aOR 2.90, 95% CI 1.67 to
5.05; p < 0.001). Non-attendance was only significantly associated with drug/alcohol dependency issues
(aOR 3.95, 95% CI 2.17 to 7.21; p < 0.001).
Factors associated with irregular and non-attendance
Variables that were significantly associated with irregular attendance in the multinomial logistic regression
models were included in binary logistic regression models with backwards-stepwise selection models in the
following order:
Block 1: clinic attended and demographic variables –
1. clinic currently attended
2. gender
3. current age.
Block 2: other background variables –
4. number of years since diagnosis
5. has children.
Block 3: mental and physical health in the past year or more –
6. neurocognitive impairment
7. ever diagnosed with depression
8. HARS 3 (complex patient)
9. ever had HIV-related inpatient stay
10. drug/alcohol dependency, past year.
Block 4: other variables –
11. health, past 4 weeks
12. told family about HIV
13. get help when sick in bed
14. enough money for basic needs, currently
15. in charge of life.
The final model is shown in Table 24 (adjusting for clinic attended) where the Cox–Snell R2 = 0.165.
Variables that were significantly associated with non-attendance were included in binary logistic regression
models with backwards-stepwise selection models in the following order:
Block 1: clinic attended and demographic variables –
1. clinic
2. gender
3. age
4. education.
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Block 2: other background variables –
5. number of years since diagnosis
6. has children
7. not registered with GP
8. not homeowner.
Block 3: mental and physical health in the past year or more –
9. recreational drug use, past 5 years
10. drug/alcohol dependency, past year.
Block 4: other variables –
11. told family about HIV
12. get help when sick in bed
13. enough money for basic needs, currently
14. nurse did not listen.
The final model is shown in Table 25 (adjusting for clinic attended) where the Cox–Snell R2 = 0.215.
TABLE 24 Adjusted associations with irregular attendance at HIV clinic
Factor aOR 95% CI p-value
Age 0.94 0.92 to 0.96 < 0.001
Years since diagnosis 1.04 1.02 to 1.07 0.002
Has children 2.53 1.69 to 3.80 < 0.001
Neurocognitive impairment 1.54 1.08 to 2.19 0.016
Drug/alcohol dependency 2.44 1.37 to 4.34 0.002
Health
Excellent 1.00
Good 1.44 0.95 to 2.19 0.086
Poor 1.96 1.30 to 2.96 0.001
TABLE 25 Adjusted associations with non-attendance at HIV clinic
Factor aOR 95% CI p-value
Age 0.95 0.93 to 0.98 < 0.001
Years since diagnosis 1.05 1.02 to 1.09 0.002
Has children 4.37 2.65 to 7.20 < 0.001
Not registered with GP 4.85 2.13 to 11.06 < 0.001
Not homeowner 2.18 1.31 to 3.65 0.003
Drug/alcohol dependency 3.36 1.74 to 6.50 < 0.001
Nurse did not listen 2.88 1.47 to 5.65 0.002
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Reasons given for missed appointments
Respondents were asked to report how often they had missed appointments since their HIV diagnosis for
14 given reasons. In addition, we asked respondents whether or not they had missed appointments
because of drinking alcohol or taking recreational drugs. All 16 reasons for missed appointments are
shown in Table 26, with the ‘no’ and ‘yes’ responses to the items about alcohol and drugs incorporated
into the table under the ‘never’ and ‘often’ columns. The reasons are organised according to the COM-B
model. Only 60.7% of patients had never forgotten an appointment. The key reasons that respondents
gave for missed appointments (sometimes or often) were feeling depressed (21.2%), forgetting (20.5%),
not wanting to think about being HIV positive (19.9%) or feeling too tired (19.0%).
As RAs, by definition, were less likely to have missed appointments, we compared reasons for missed
appointments (sometime or often) given by IAs and NAs. These are also shown in Table 26.
Irregular attenders were more likely than NAs to miss appointments because they felt too sick (24.5% vs.
16.5%; p = 0.047). NAs were more likely to give reasons related to motivation. They were more likely than
IAs to not want to think about being HIV positive (28.7% vs. 19.3%; p = 0.025), to be afraid to be seen at
TABLE 26 Reasons for missed appointments by attendance pattern
Reason
All patients (%) IA, % NA, %
IA vs. NA,
p-value
Never
(no) Rarely Sometimes
Often
(yes)
Sometimes or
often (yes)
Sometimes or
often (yes)
Capability
Forgot 60.7 18.8 16.2 4.3 33.1 31.1 0.668
Depressed 70.8 7.9 14.8 6.4 29.4 25.6 0.398
Too sick 71.1 12.7 14.1 2.1 24.5 16.5 0.047
Too tired 72.6 8.4 15.3 3.7 24.9 23.8 0.791
Alcohol 96.0 4.0 6.4 6.4 0.978
Drugs 93.2 6.8 13.2 12.5 0.841
Motivation
Not wanting to think
about HIV
75.4 4.7 11.0 8.9 19.3 28.7 0.025
Afraid to be seen at
clinic
84.7 3.7 7.4 4.2 10.0 18.9 0.009
Felt well 81.0 4.1 7.9 7.0 13.0 20.7 0.033
Had enough medication 80.5 4.9 8.0 6.6 13.8 24.4 0.005
Doctor could not help 89.9 3.8 4.5 1.8 6.3 10.4 0.129
Opportunity: social influences
Not followed doctor’s
advice
86.2 5.0 6.2 2.6 10.0 14.6 0.150
Opportunity: barriers
No money 77.6 7.5 11.1 3.9 17.8 19.5 0.664
No transport 81.1 6.9 8.1 4.0 14.5 17.1 0.472
No time off work 75.1 10.3 9.2 5.4 16.0 23.2 0.063
Caring responsibilities 88.0 4.0 5.8 2.2 11.2 17.1 0.079
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the clinic (18.9% vs. 10.0%; p = 0.009), to feel well (20.7% vs. 13.0%; p = 0.033) and to have enough
medication (24.4% vs. 13.8%; p = 0.005). There were no significant differences between IAs and NAs on
reasons relating to opportunity.
Summary of findings from Chapter 5
l Irregular attendance is independently associated with being younger, diagnosed with HIV for longer,
having children, symptoms of neurocognitive impairment, drug/alcohol dependency and poorer recent
health. Irregular attendance is also associated with being female, depression, having complex needs
(according to HARS 3), HIV-related hospitalisation, uncertainty about being in charge of life, telling
family about HIV status, not getting help when sick in bed and not having money for basic needs.
l Non-attendance is independently associated with being younger, diagnosed with HIV for longer, having
children, not being registered with a GP, not being a homeowner, drug/alcohol dependency and not
feeling listened to by the nurse. Non-attendance is also associated with being female, less educated,
recreational drug use, telling family about HIV status, not getting help when sick in bed and not having
money for basic needs.
l IAs are more likely than NAs to miss appointments when they feel unwell whereas NAs are more likely
miss appointments because of reasons relating to HIV stigma or when they had enough medication.
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Chapter 6 Findings from qualitative research:
factors associated with engagement in HIV care
In this chapter, we bring together the findings from our qualitative research – individual patientinterviews, FGs and key informant interviews – to explore the factors associated with engagement in HIV
care. We continue to address the fifth objective of the study, to:
l understand the situational, environmental, behavioural and social factors influencing
outpatient attendance.
Participants
Individual patient interviews
We undertook a total of 33 interviews with PLWH. They were made up of 10 RAs, 13 IAs and 10 NAs. We
had originally planned to recruit up to 20 IAs (making an overall total of 40 interviews), but after recruiting
13 IAs, we were hearing similar stories from the participants and decided that we had reached sample
saturation. Our NAs included people who had ever experienced a 1-year period of non-attendance in
comparison with our survey participants who had experienced a recent period of non-attendance. When
we began interviewing people, we found that they were able to talk in detail about their experiences of
non-attendance, even if it had occurred several years before.
In addition to attendance pattern, our other primary sampling criterion was combined gender and sexual
orientation. We aimed to recruit roughly equal proportions of gay or bisexual men and heterosexual men
and women. However, women were more willing to participate and our sample consists of nine gay men,
eight heterosexual men and 16 heterosexual women. No men who identified as bisexual took part in the
interviews and, with regard to ethnicity or country of birth and age, the subsamples were made up
as follows:
Gay men:
l seven UK born; two non-UK born
l two aged ≤ 35 years; seven aged > 35 years.
Heterosexual men:
l four black African; four other ethnicity
l three aged ≤ 35 years; five aged > 35 years.
Women:
l 10 black African; six other ethnicity
l five aged ≤ 35 years; 11 aged > 35 years.
Among these participants, we aimed to recruit between three and six people who had ever injected drugs,
between three and six patients who were not on ART and between three and six who were diagnosed
within the past 2 years. We succeeded in recruiting three people who had injected drugs, two patients
who were not on ART (a long-term non-progressor and a woman who had been diagnosed 3 years before
during pregnancy) and four who had been diagnosed in the past 2 years.
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Participants had been diagnosed for a median of 7 years (ranging from 4 months to 30 years). Their
median age was 40 years (ranging from 25 to 56 years). Almost half were of white ethnicity (45.5%),
39.4% were black African, 9.1% were black Caribbean and 6.1% were of mixed ethnicity. The majority
were born outside the UK (72.7%). Over half were not in a relationship (57.6%), 21.2% were in a
relationship but not living with a partner and 21.1% were living with a partner. Two-thirds had some
further or higher education (66.7%) and the majority were not working (72.7%).
Our participants are reasonably representative of an ageing HIV positive population. We did not manage
to recruit as many young people as we would have liked, but this may be partly explained because we
excluded patients who had acquired HIV through vertical transmission as the AALPHI study was recruiting
these patients at the same time. It should also be noted that almost three-quarters of our participants were
not working. This is not surprising, given that those who are unemployed are more likely to have the time
to take part in an interview, but it means that our qualitative data include fewer perspectives from working
people who may also have difficulties with attendance for this reason.
Focus groups
We conducted two FGs – the first (FG1) consisted of four gay men and the second (FG2) of six black
African men and women (including two men and four women). Although we encouraged discussion
among FG participants, most of their comments were addressed directly to the FG facilitators and the data
were very similar in format to the interview data. The data were therefore incorporated into the interview
analysis, although some different stories may have been elicited by recruiting these participants through
community outreach rather than at their HIV clinics. Participants had been diagnosed for a median of
14 years (ranging from 6 to 27 years). Their median age was 46 years (ranging from 35 to 55 years).
All had experienced periods of a year or more when they had not seen a doctor about their HIV and had
missed and not rescheduled at least one appointment at the HIV clinic in the past year.
The names used below for both individual interview and FG participants are pseudonyms. In order to
provide more context for the data, we will describe whether they were interviewed for the study as a RA,
IA, NA or FG participant (FG1 or FG2); and include the following shorthand to describe them, followed by
their age (no men who identified as gay or bisexual black Africans took part in this part of the study):
l female, black African: Fem-BA
l female, other ethnic group: Fem-Other
l heterosexual male, black African: HetMale-BA
l heterosexual male, other ethnic group: HetMale-Other
l gay male, UK born: GayMale-UK
l gay male, non-UK born: GayMale-NonUK.
Key informant interviews
We conducted a total of 19 semistructured interviews with service providers and funders. The key
constituency of ‘voluntary sector’ was revised to ‘community support’ to reflect the fact that some patient
reps are employed by the NHS to work in HIV clinics. The key informant representation from across the key
constituencies in the field of HIV service provision was as follows:
Clinical:
1. clinical nurse specialist, NHS
2. senior sexual health adviser (Ceri Evans), Chelsea and Westminster Hospital NHS Foundation Trust
3. HIV nurse specialist, NHS
4. HIV consultant, NHS
5. receptionist, NHS
6. consultant in genitourinary medicine (GUM) and HIV (Vanessa Apea), Barts Health NHS Trust.
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Public health:
7. public health expert 1, public sector
8. public health expert 2 (Gillian Holdsworth), SH:24.
Academia (health service researchers):
9. Professor of Medicine (Michael Mugavero), University of Alabama at Birmingham, USA
10. clinical research fellow/Consultant in HIV (Shema Tariq), University College London
11. academic research nurse, university.
Community support/health promotion:
12. patient representative 1
13. patient representative 2
14. chief executive (Juliet Reid), Centre for All Families Positive Health
15. health services manager (Mesfin Ali), Embrace UK
16. patient representative 3 (Chris Sandford), Mortimer Market Centre
17. peer caseworker (Sophie Strachan), Positively UK.
Policy:
18. director of policy, non-governmental organisation
19. NHS manager, NHS.
Key informants are identified by their job title. Their initials are also included if they have agreed to be
identified. In the following description of the findings, we refer to ‘key informants’ who took part in this
part and we refer to ‘patients’ who took part in the individual interviews and FGs. As previously described,
all the people who took part in the individual interviews and FGs were currently engaged in care, and
the word ‘patients’ will therefore be used to distinguish their contribution to the study from that of the
‘key informants’.
Factors associated with HIV clinic attendance
This section explores factors associated with HIV clinic attendance and disengagement from care. In the
same way as we recruited RAs, IAs and NAs for the survey, we recruited RAs for our qualitative study as
well as patients who had difficulties with keeping appointments and those who had disengaged from care
completely. Although it was straightforward to distinguish between attendance patterns over the previous
year for survey recruitment, it became clear during the qualitative data collection that there can be an
overlap between missing appointments and disengaging completely. Some patients had ongoing issues
whereby they both missed appointments and stopped attending altogether, whereas others attributed a
period of disengagement to particular circumstances and did not usually miss appointments. Furthermore,
patients’ behaviour often changed over time, with some participants having disengaged completely in
the past but now fully engaged in care, and others having recently returned to care after a period of
disengagement. Among RAs, eight reported good EIC after diagnosis and one reported poor early
retention; among IAs, eight engaged with care after diagnosis, four had poor early retention and one
disengaged post partum; and among NAs, 10 reported good early engagement, four had poor early
engagement and one disengaged post partum.
The following analysis will explore the key factors associated with poor EIC generally, considering all the
data provided in the individual patient interviews, FGs and key informant interviews. Given the overlap in
attendance behaviour described above, we incorporate data provided by all patient participants into this
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exploration of factors associated with clinic attendance. At the end of the chapter, we summarise the data
on why NAs stop going to the HIV clinic and why they return, drawing on data from patients who had
experienced a period of 1 year or more when they had not attended for care.
The data are again presented in the context of the COM-B model, which provided the framework for this
analysis. Figure 12 summarises the key influences on attendance. It indicates where factors have a positive
(+ve), negative (–ve) and mixed (+ve and –ve) impact on attendance. The findings from the key informant
interviews were found to echo the findings from the patient interviews and FGs. In addition, key informants
described how those who disengaged from care often led complicated lives and particular groups of
vulnerable individuals were identified, including people who inject drugs, young people, those who had
acquired HIV through vertical transmission, people experiencing abuse, people coming out of detention and
those with mental health issues.
Physical capability
Feeling unwell (+ve and –ve)
In thinking about physical capability, we could consider two conditions: physical disability and physical
health. Only two of the patients had visible physical disabilities, and neither of them considered this to be
a barrier to attending for care, although one of them appreciated a recent clinic refurbishment that had
made the clinic more accessible. Physical health or feeling unwell could be a barrier to attending and
patients reported this as one of the reasons for missed appointments. Being diagnosed with hepatitis C
and dealing with the extreme mental and physical effects of its treatment turned Matt (IA, GayMale-UK,
44 years), who had been diagnosed with HIV many years previously, from a RA to somebody who often
found it difficult to turn up for scheduled appointments. On the other hand, feeling unwell could also
provide the motivation to take ART and attend more regularly:
At the moment, I feel that ill that I feel no, this is stupid, it’s not achieving anything so no matter how
down you feel, it’s not going to help feeling ill as well.
Bill (IA, HetMale-Other, 52 years)
Key informants also said how people sometimes felt unwell and not up to attending their appointments.
Opportunity: social influences
• People finding out you have HIV 
   (negative)
• Health-care professionals
   (positive and negative)
• Partner (positive and negative)
• Peer and community support (positive)
Physical capability
• Feeling unwell (positive and negative)
Opportunity: barriers
• Financial difficulties (negative)
• Work responsibilities (negative)
• Caring and child care (negative)
• Homelessness (negative)
• Immigration issues (negative)
Motivation
• Denial (negative)
• Feeling well (negative)
• Depression (negative)
• Low self-esteem (negative)
• Self-efficacy and control (positive)
• Adherence to ART (negative)
• Familiarity with clinic (positive)
• Faith (positive and negative)
Psychological capability
• Forgetting (negative)
• Drug and alcohol use 
   (negative)
• Empowerment through 
   knowledge (positive)
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FIGURE 12 Key influences on HIV clinic attendance.
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When patients felt well, this could prevent them from attending their appointments, as described below
(see Motivation). Thus, the physical capacity to attend was not sufficient in itself to engage with care.
Psychological capability
Forgetting (–ve)
One aspect of psychological capability is memory and patients reported missing appointments because
they forgot about them. As described earlier, the conditions of the COM-B model interact and stigma may
also be implicated in not prioritising HIV care and therefore forgetting to attend, as Veronica said:
I miss it because I forgot but the reason why I forgot, because I don’t want to have HIV.
Veronica (IA, Fem-Other, 54 years)
Depression was also implicated in forgetting to attend. Key informants attributed forgetting appointments
to various causes from infrequent appointments to substance abuse, in the form of alcohol abuse, injecting
drug use and chemsex, or neurocognitive impairment.
All the patients who mentioned text reminders thought they were an excellent idea but they did not all
receive them. Patients who had disengaged from care could be highly responsive to a personal telephone
call from the clinic when it occurred at a time when they were ready to be approached although they had
often ignored calls before this time. Some patients felt the clinic could be more proactive in reaching out
to them:
Yes, I need to accept responsibility but I also need them to help me do that, as it were, perhaps,
so them being more active and chasing a bit was perhaps needed.
Dean (NA, GayMale-UK, 41 years)
Drug and alcohol use (–ve)
Capabilities can also be affected by alcohol and drug use. Only a small proportion of those who took part
in the study had experienced problems with alcohol or drugs, but this could also affect attendance:
So the only thing which would stop me, sometimes stop me coming in for appointments, is if I’d had
drug use and I just wasn’t up to it, and drug use was usually because I was lonely, isolated,
wanted company.
Matt (IA, GayMale-UK, 44 years)
As Matt describes, he had mostly managed to keep up regular attendance until his hepatitis C diagnosis,
apart from when he had taken drugs, which, in itself, was a symptom of other psychological issues.
Empowerment through knowledge (+ve)
Another element of psychological capability is the knowledge or awareness of the existence of something
that enables the enactment of the behaviour. Those who had been diagnosed for many years described the
lack of information in the early days, but the underlying theme of these data was how poor understanding
of HIV still shaped patients’ fear and self-stigma and how empowering knowledge could be. Kelly and Jade
both talked about their lack of knowledge about HIV transmission before they were diagnosed:
And they used to be racist with it as well, like if you was from Africa, and you just . . . you know those
sort of . . . yes. And that’s why as well, I’m not going to lie, I didn’t think I could get it but that’s how
ignorant I was. But only because I had picked that up from school.
Kelly (IA, Fem-Other, 32 years)
I thought HIV was only in Africa. It was a little bit naive of me, but it was the last thing I expected.
Jade (FG2, Fem-BA, 37 years)
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Patients learnt about HIV in various ways. Patients often did their own personal research into HIV on
the internet, Googling or checking specific websites for information about services, HIV or ART. As Bill
describes, however, this was not a replacement for receiving timely information from the clinic:
Then a friend of mine brought a laptop in and there’s wireless network and I googled PCP pneumonia,
only to find out not only did I have HIV, I was in final stage which was AIDS.
Bill (IA, HetMale-Other, 52 years)
In addition, although the clinic provided an important source of information, patients did not always get
what they wanted:
So I never, I felt I wasn’t getting answers and I went elsewhere to get some information and came
back here, and I don’t think I should have had to do that, really.
Stephen (NA, GayMale-NonUK, 48 years)
Most of the patients had been directed to support groups that provided invaluable information. Some felt
that peer support should be available within the clinic or that a more proactive approach from the clinic
would help them engage with support groups, whereas others gave various reasons for not attending.
They thought the groups were not for them, they did not have the time or the money, or they were not
ready to meet other HIV-positive people. Adele (NA, Fem-BA, 27 years) described how she was not
originally bold enough to attend a group and Mary (RA, Fem-BA, 54 years) could not understand the
flyers. Josephine had been too fearful to attend any groups but was really happy with the information that
she received when she returned to care:
Knowing there is a day where I can go and meet other people who are in the same boat as me, I
think is marvellous. But when you are out of this routine, you don’t know whether there is. You don’t
even know where to start . . . yes, they’ve laid everything on the table, which is good for me. I’m
so happy.
Josephine (NA, Fem-BA, 42 years)
Those who had attended support groups praised what they got out of them. In addition to information
provided by professionals, they learnt from their peers about their experiences of using ART, for example,
and had the opportunity to talk about HIV. Seeing people who had lived with HIV for a long time also
made them rethink their understanding and realise it was possible to live well with HIV:
And then I got educated and said no, these people came late for medication. You’ve got chance, you
can prevent that, you don’t have to go that far. Taking your medication protects you from getting
other illnesses.
Amy (FG2, Fem-BA, 55 years)
Patients specifically related the knowledge that they gained from engaging with peer support to the
empowerment that helped them engage with care:
So that kind of gave me the empowerment and the knowledge that I needed to take my life back
on track.
Adele (NA, Fem-BA, 27 years)
You gain more knowledge, you become more knowledgeable, you become wise and you become
mentally strong.
Vincent (FG2, Male-BA, 47 years)
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Motivation
Denial (–ve)
In the same way that stigma contributed to patients stopping attending for care altogether, it also
contributed to their ‘forgetting’ about appointments, as Veronica described, because she did not want to
have HIV. There was a strong theme relating blocking out HIV to disengagement from care that was
expressed by several patients who struggled with attendance, as illustrated by the following patients:
When I was at school, [HIV] was like, it was a really bad, seen as a really bad illness, it was dirty, that’s
why when I had it I just wanted to forget it and block it out.
Kelly (IA, Fem-Other, 32 years)
I don’t know. Like, I just feel, why me? Like, I’m young. I’m young, and that. I don’t need this and
that. Sometimes I think to myself – sometimes I think I don’t have it but I do have it. That’s how I feel.
Julie (NA, Fem-BA, 25 years)
I just thought, oh we’re just going to forget about it, and it’s not real, and it’s not happening, and I
don’t need to . . . you know, I’m not sick, and yes, so I just put it to the back of my mind, and got on
with it, really.
Ben (NA, GayMale-UK, 33 years)
As Ben explains, feeling well, which is described below, could give people a reason for not thinking about
HIV and not engaging with care.
Key informants also described how coming to the clinic could remind people of their HIV status. The
stigma associated with HIV was a key issue:
I think that focusing on or recognising, doing something about stigma, is just, I feel, the real crux of it.
Consultant in GUM and HIV (VA)
They said how patients could be overwhelmed by HIV and in denial, particularly soon after diagnosis.
Feeling well (–ve)
When patients felt well, this could provide a reason for not attending the HIV clinic at all, particularly
before starting ART. Kelly also explained how she only took ART when she felt ill and did not want to
attend when she was healthy:
I stopped coming to clinics because I thought I was all right.
Kelly (IA, Fem-Other, 32 years)
Key informants agreed that feeling well could stop patients from attending. It could also seem like a waste
of time getting to the clinic and waiting for a short appointment and was particularly disruptive for stable
patients to attend clinic appointments only to be told that everything was fine:
If someone travels for one and a half hours or more and sits in the reception for 20 minutes,
30 minutes and they’re seeing a consultant for 10 minutes, it’s – to them, it doesn’t feel productive.
It doesn’t feel satisfying.
Patient representative 2
Similarly, when patients did not need to take ART after giving birth, with the implication that they were
well, this could also contribute to disengagement from care. It should be noted that ART is now
recommended for all HIV patients regardless of CD4 count, and is unlikely to be offered as a temporary
intervention during pregnancy.43
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Depression (–ve)
Depression was a key theme across the participants and many of the patients talked about the depression that
they experienced. It was particularly prominent among IAs and NAs who often related their disengagement
to depression and an inability to do anything when they felt particularly depressed. It made patients feel that
they could not leave the house. It led to feelings of lack of self-worth whereby they did not see the point in
looking after their health, as Bill explains:
I’d fall into these depressions and why would you take life-saving medicine when you’re depressed
about everything, do you know what I mean?
Bill (IA, HetMale-Other, 52 years)
Although patients who were engaged in care also expressed feelings of depression, they were more likely
to find the motivation to get themselves to the clinic:
Sometime you lose confidence, sometimes you feel like you don’t want to talk to nobody but you drag
yourself to come to the clinic because you have to come to the clinic.
Miriam (NA, Fem-BA, 39 years)
Some patients were concerned about the mental health provision within the NHS and how long it could
take to be referred for therapy.
Key informants said that poor mental health was very common and could underpin engagement in HIV
care, although it was often unclear whether it was a cause or a result of HIV. People suffering from
depression could give up hope or sometimes people were just having a bad day and could not face
attending. There was a subpopulation of patients with severe mental illness who had ongoing issues
with EIC.
Low self-esteem (–ve)
A HIV diagnosis is also likely to affect patients’ self-esteem. Patients described low self-esteem as a
powerful cause of disengagement from care that could stop them from attending appointments and/or
taking ART. For example, Kelly (IA, Fem-Other, 32 years) said that she did not value herself and only took
ART during pregnancy for her baby; and Rick (NA, GayMale-UK, 44 years) said that he stopped attending
because he did not want to look after himself and did not think he was worth it.
Self-efficacy and control (+ve)
There was a keen sense of self-efficacy among some of the RAs. Jackie (RA, Fem-Other, 44 years) expressed
strong motivation and desire to take complete responsibility for her health and Peter (RA, GayMale-NonUK,
40 years) said he felt in control of his health and empowered. A sense of self-belief could help to live with
HIV and engage in care:
I choose to fight, you know, and I live with HIV.
Gabriela (RA, Fem-Other, 49 years)
I must make sure that every time I know I have to attend and I have to make sure I’m well.
Daniel (RA, HetMale-BA, 32 years)
If I want to get well, I have to keep up my appointment. I don’t see any big deal in it.
Patricia (RA, Fem-BA, 34 years)
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By comparison, there were indications that lack of engagement in HIV care was associated with feelings of
a lack of control. Stephen felt that he was in a different space now to when he was having difficulties with
engaging and that helped him to attend:
I’m more confident in stating what my needs are. I mean, I know I’m not a sheep being, you know,
herded into one place or another. I can speak up now.
Stephen (NA, GayMale-NonUK, 48 years)
Some key informants described how some people lacked the motivation to take responsibility for their
health care.
Adherence to antiretroviral therapy (–ve)
There was a strong association between non-adherence to ART and missed appointments – some patients
clearly avoided attending when they had not taken their medication. They knew that not taking their
tablets would show up in their laboratory results and might avoid attending if they felt embarrassed or did
not want to be told off:
Sometimes, when I don’t take my medication, and I know that the results might possibly not be so
good, then I will decide not to go because I don’t want to be stressed twice by the doctor asking me
what’s happening, why haven’t you been taking your medicine . . . once I start feeling a bit better,
then they will find me three months later, you know, with my CD4 count back on track.
Jade (FG2, Fem-BA, 37 years)
I haven’t taken my meds for about a month I can’t go. It’s like going into school on Monday morning
when you haven’t done your homework, just like, ah no I’ll phone in sick I won’t go to school on
Monday and then I’ll do my homework and it’ll all be fine by the time I go back in on Tuesday.
Rick (NA, GayMale-UK, 44 years)
Familiarity with clinic (+ve)
The vast majority of the RAs talked very warmly about how comfortable they felt at the HIV clinic and the
friendliness of the staff, and patients, in general, valued getting to know staff and feeling familiar with
the clinic. On the whole, patients tended to stick to the clinic with which they were familiar:
. . . there is a sense almost of community there, I guess, because you are familiar with some other
patients and doctors, I guess, so that helps to engage, I guess, with the clinic.
Leonard (FG1, GayMale, 45 years)
Many patients expressed loyalty towards their clinic. Gabriela felt that her clinic had supported her very
well and she felt an obligation to return this support:
So that pushed me and helped me to be very regular and don’t miss any appointments and to be very
loyal to the clinic, you know, because they showed to me that they was very loyal to me. So it’s the
least I can do, you know.
Gabriela (RA, Fem-Other, 49 years)
Some patients also travelled long distances in order to attend the clinic with which they were familiar.
Jose (IA, HetMale-Other, 50 years) said that he would walk for 2 hours to get to the clinic if he did not
have the money for transport. Clinic appointments provided a rare opportunity for some patients to talk
openly to trusted individuals about their HIV and feel supported. Veronica explained how she was not able
to do this under other circumstances:
You know, it’s strange but it’s like you saying, can you leave your leg at home, you know, part of you
must be cancelled.
Veronica (IA, Fem-Other, 54 years)
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Faith (+ve and –ve)
Faith played a supportive role in patients’ lives although they mostly did not discuss their HIV in this
context. Key informants were more likely to point out the possible negative impacts of stigma within
religious communities. Although certain religious beliefs and a belief that they had been healed might
prevent people coming to the clinic, the HIV nurse specialist that we interviewed said that the spate of
religious ‘cures’ had disappeared.
Opportunity: social influences
People finding out you have HIV (–ve)
Social influences played an important role in shaping patients’ engagement in HIV care. Many patients
were not open about their HIV status, choosing to tell very few members of their circles of friends and
family. Attending the HIV clinic could be a cause for concern because you might bump into someone
who would find out that you had HIV. Opinions were divided over whether the HIV clinic should be
incorporated into sexual health clinics so that HIV patients could not be distinguished from other patients,
or whether or not providing separate space for HIV patients made it feel more secure. Some patients
continued to feel the discomfort of going to the clinic they had been diagnosed for several years. Kelly had
been living with HIV for 6 years:
. . . obviously you don’t want . . . anyone to know, the way it is, is just, you cringe when you’re coming
[in], because you don’t know who’s going to be sitting there. That’s the only thing, I think. And that is
every single time I come, I have that same feeling, even today.
Kelly (IA, Fem-Other, 32 years)
Being part of a black African community gave people particular cause for concern that their HIV status
might be discovered and become the subject of gossip. Sara (IA, Fem-BA, 44 years) changed clinics
because the HIV clinic closest to her home was used by a lot of people from her home country.
It was not always just other patients that they were concerned about. Adele (NA, Fem-BA, 27 years)
disengaged from HIV care completely when she felt threatened by a member of the hospital staff from her
home country. Jose (IA, HetMale-Other, 50 years) used to live close to the hospital and expressed his early
concerns that somebody working at the clinic might turn out to be a neighbour.
Many key informants talked about patients’ fears of being recognised in the clinic either by a member of
your community or by a former partner. Also, people often did not want friends and family who they
had not told about their HIV to be curious about the appointments that they were attending.
Health-care professionals (+ve and –ve)
Various members of the clinic team provided emotional support that could be a strong motivation for
attending the clinic:
They really, really cared about me, you know, and they really care about my health, more than I do,
you know.
Gabriela (RA, Fem-Other, 49 years)
Most patients wanted to see the same doctor and some concern was expressed about non-continuity of
care and a lack of opportunity to build rapport or the mixed messages that could result. Some patients
said that they would attend as frequently as their doctor asked, whereas others wanted a more balanced
relationship and talked about making informed decisions as the outcome of teamwork. Time invested in
the doctor–patient relationship was a good thing although some patients did not feel that they got
enough time with their consultants. Stephen (NA, GayMale-NonUK, 48 years) had ongoing issues with
feeling that he was not being listened to until he started seeing a specialist registrar who had more time
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for him. Nurses were also very highly regarded. Patients appreciated the practical support they got from
clinic staff and peer workers – although they felt more support of this nature would be helpful.
On the negative side, both Dean (NA, GayMale-UK, 41 years) and Stephen (NA, GayMale-NonUK,
48 years) had problems with communication with health-care professionals, which contributed to
their disengagement:
There was no negotiation, there was no way out of that, and I thought, you know, it was just another
problem that I then had to deal with . . . I disengaged somewhat, actually, at that point.
Stephen (NA, GayMale-NonUK, 48 years)
Key informants talked about how bad experiences with clinic staff could put patients off attending.
They said some patients felt that doctors just did not understand them and this could engender distrust.
The doctor–patient relationship might also make it difficult for patients to explain their circumstances or
difficulties with attending. Key informants also found that some patients could feel ashamed when they
had missed an appointment and some felt that they would be ‘told off’ at the clinic for not coming in:
And once people haven’t come once, one thing that we do find is that when they decide to come
back they often feel very ashamed about having been away so they put off coming back because
they’re really worried about what’s going to happen when they come back.
HIV consultant
Key informants highlighted the stigma that people experienced in other health-care settings and a clinical
research fellow/consultant in HIV (ST) described the findings from her research on the widespread
occurrence of negative experiences among women in maternity care at the time of delivery.
Partner (+ve and –ve)
There was a clear impact of partners who could have a protective or destructive effect. Meeting a new
partner after diagnosis could raise self-esteem and provide the motivation and support to attend for care
and take ART. Patients’ experiences with the partners that they already had when they were diagnosed
varied widely from the very positive to the very negative. Four women had experienced abuse from their
partners that they associated directly with their HIV diagnosis. Gabriela (RA, Fem-Other, 49 years) talked
about how her husband used her HIV against her and Lena (RA, Fem-Other, 26 years) was now living in a
refuge after her husband started abusing her verbally and physically – he also threw away her medication.
Sara’s (IA, Fem-BA, 44 years) husband had told people about her HIV which contributed to her depression
and Josephine’s reaction to her HIV diagnosis contributed to her disengagement from care – he refused to
tell her his HIV status, and became abusive and a burden:
The only stigma I’ve faced is from my husband, all the time, all the time, yes. The rejection is only from
him, but outside people, no.
Josephine (NA, Fem-BA, 42 years)
Several patients talked about how having HIV prevented relationships – both from their experience in the
past and looking forward to the future.
Peer and community support (+ve)
Peer support could be very powerful in helping patients on a number of levels. Meeting someone who was
HIV positive could provide hope that you would also live well with HIV, as Michelle explains:
I said, you don’t look HIV, and she said, what do you think the HIV people look like, you know? I said,
well, not you. She said, well, you’ll be like me one day, you know, people will walk past you and
won’t know that you’re HIV. And she kind of gave me inspiration.
Michelle (IA, Fem-Other, 42 years)
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Talking to other people who were HIV positive provided the opportunity to talk about living with HIV and
exchange information that could help guide thoughts and decisions about their health care. It provided the
warmth of emotional support and helped people understand that they were not alone. Patients said how
invaluable peer support had been, particularly soon after they were diagnosed, and the courses for newly
diagnosed patients run by community organisations and clinics were universally praised by those who had
attended and their absence was noted by those who did not:
I think the only sad thing for me was, my early days of diagnosis, I came to the clinics and did what I
had to do and then I was on my own, really. I had to go through all that on my own.
Rob (FG1, GayMale, 45 years)
Peer support continued to provide an important role for many over the years, although some commented
on how provision had been cut. Some patients did not think of themselves as the sort of people who went
to support groups or did not have time to go and it could be daunting to take the first step.
Key informants also highlighted the importance of peer support – which will be discussed further in
Chapter 7.
Opportunity: barriers
Although specific barriers may affect only small numbers of the patients who took part in our study, they
could have a dramatic effect on attendance and were often associated with socioeconomic status. The
barriers to attending were frequently cited by key informants as reasons for disengaging from care. Many
key informants described how attending the clinic was not always a priority when people were struggling
with the pressures of daily life and juggling priorities – their basic needs took precedence:
I think there are structural factors that if folks don’t have a safe place to live, a stable source of
transportation, and a stable source of food, that a lot of times those structural things can take
precedence over coming to the clinic.
Professor of Medicine (MM)
I think in terms of your hierarchy of needs, coming to HIV appointments falls lower and lower when
you’re actually sort of scrabbling to survive.
Clinical Research Fellow/Consultant in HIV (ST)
Sometimes an escalation of difficulties or crisis could prompt disengagement.
Financial difficulties (–ve)
Three-quarters of the interview patients were unemployed (we did not collect these data for FG patients),
many were living on benefits and some talked about their financial difficulties. Daniel (RA, HetMale-BA,
32 years) and Sophie (IA, Fem-BA, 38 years) both said that they sometimes had to cancel appointments
when they did not have money for transport, even though Daniel knew he would get reimbursed. Julie
(NA, Fem-BA, 25 years) said that she did not attend her appointments when she did not have enough
money for transport.
Key informants frequently highlighted financial constraints. Sometimes people could not afford the fare
and they did not always go to their closest clinic so transport could cost them more:
It could be just to do with poverty; they can’t just afford to go for their appointment. Even if the
money is going to be refunded . . . but if they haven’t got the money to go to their appointment, they
can’t go.
Chief Executive (JR)
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In addition to the cost of getting to the clinic, the overall time needed for an appointment could be a
deterrent, especially when patients were well and stable and everything was fine.
Work responsibilities (–ve)
For some patients, a work commitment was one of the key reasons for not attending HIV clinic
appointments. A number of the patients had put work responsibilities before clinic appointments and Jade
(FG2, Fem-BA, 37 years) explained how her schedule changed often and she could not attend if she was
busy at work. For Josephine (NA, Fem-BA, 42 years) and Joyce (NA, Fem-BA, 36 years), a combination of
work and caring responsibilities had contributed to their disengagement from care. Sometimes patients
missed appointments not because they were busy at work but because they did not want to lose their jobs
and Alex (IA, HetMale, 34 years) felt that he could not miss work regularly to come to the clinic for
this reason.
Key informants talked about logistical issues such as child care and work. Some people were busy at work
and others were concerned about losing their jobs if they took time off. It could be difficult to squeeze in
appointments after work and not easy to tell an employer about being HIV positive in order that
appointments could be accommodated around work schedules.
Caring and child care (–ve)
New mothers could find that they had little time to think about themselves and prioritise their HIV care
and, as described by Jade (FG2, Fem-BA, 37 years), the repeat HIV testing of a newborn baby could put
some women off attending for care. The combination of work and child care responsibilities could also
contribute to disengagement from care, as illustrated above. Child care responsibilities could also result in
missed appointments and Brenda (IA, Fem-BA, 39 years) sometimes missed appointments because she
could not afford child care but did not want to bring her children to the HIV clinic and expose them to the
information that was displayed there.
Of the women diagnosed during pregnancy, Patricia (RA, Fem-BA, 34 years) had always been a RA and
appreciated the excellent and continuous care she received from the same doctor during and after her two
pregnancies. Adele (NA, Fem-BA, 27 years) and Josephine (NA, Fem-BA, 42 years) disengaged after their
babies were born, Joyce (NA, Fem-BA, 36 years) disengaged many years later and Kelly (IA, Fem-Other,
32 years) had ongoing problems with engagement. She described taking ART religiously during pregnancy
for the baby – like folic acid. None of these women related their disengagement to the quality of HIV care
they received during and after pregnancy.
Homelessness (–ve)
Seven patients talked about experiencing homelessness, from street homelessness to the insecurity of
staying in temporary accommodation. Two more patients had also lost their homes. There was a clear link
between Charles (NA, HetMale-BA, 47 years) becoming homeless and stopping taking his ART (because it
needed refrigeration) and attending the HIV clinic. Patients who had stayed in hostels had experienced
stigma because of their HIV and receiving letters from the clinic was difficult in temporary accommodation.
At the same time, the HIV clinic could provide some support and facilities when patients were homeless.
Immigration issues (–ve)
Some patients talked about difficulties over their immigration status but only Samuel (IA, HetMale-Other,
56 years) related it to his EIC because he became depressed when he was unable to work and stopped
attending. In other patients, immigration issues were among the personal problems that they faced and
needed to prioritise.
Key informants discussed how issues with immigration status could mean that HIV care was not a priority.
Although none of the patients linked fear of deportation to fear of attending the HIV clinic, key informants
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had found that immigration status could also stop people from attending because they wanted to avoid
institutions or were concerned that they may be charged for health care:
It isn’t always easy to disentangle the HIV care from other bits of care . . . and the threat then of
charges and intrusive questioning as to their status can deter people also from the HIV Service even
though it’s free.
Director of Policy
Clinic facilities
Patients had specific suggestions for service improvements and interventions to improve engagement
in HIV care that are summarised below. Although services could be improved to address the factors
described above, the experiences that patients described indicated that facilities were not a key factor in
disengagement from care. Refurbishments were generally well received although there were some
concerns about spending money and lack of thought in new design. Key informants said that at some
clinics, patients might not feel that they fit in with the other people in the clinic and a feeling of belonging
might help them to feel more connected to the clinic.
Service provision
Patients generally lived fairly close to their clinic and/or found their journey by public transport convenient.
Those who lived further away chose to stay with the clinic with which they were familiar although some
missed appointments were attributed to moving out of the area. Patients’ negative experiences of other
health-care provision generally contrasted with the positive experiences at the HIV clinic.
Patients wanted their care to be integrated. Those with other conditions had experienced differences of
opinion between the HIV service and other NHS services. It could be difficult to understand how services
fitted together and, generally, patients would prefer everything to be in one place:
It would be great if it was, you know, all under one roof.
Bill (IA, HetMale-Other, 52 years)
Key informants also felt that the health-care system could be difficult to negotiate or not easily accessible
with too many appointments to attend and too many clinics.
Why do non-attenders stop going to the HIV clinic?
We have described the factors associated with HIV clinic attendance, including factors relating to missed
appointments and complete disengagement from care. In the following section we disentangle these two
types of disengagement to explore why NAs said that they stopped going to the clinic altogether and what
brought them back in to the clinic, focusing on the data provided by the subsample of patients who had
experienced a period of disengagement for 1 year or more.
Patients often attributed their non-attendance to a range of causes and were able to pinpoint various
triggers for disengagement. With reference to the COM-B model, the key conditions associated with
dropping out of care are related to motivation and opportunity to attend, whereas lack of capability did
not appear to play a key role in non-attendance.
Motivation
Although not everyone articulated a direct cause and effect, there was a clear and pervasive relationship
between the stigma associated with being HIV positive and disengagement from care. This self-stigma was
associated with negative thoughts such as not being able to tell anybody about being HIV positive and not
being able to live the life one wanted to lead. Stigma affected both those who engaged regularly with
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care and those who did not. Stigma was a barrier to people accessing support when it was more
comfortable not to think about HIV or when they worried about been seen at the HIV clinic. Patients
described how the associated depression and low self-esteem could make taking care of oneself seem
pointless. Although patients appeared to be particularly likely to engage with this type of thinking and
dropping out of care when they were newly diagnosed, it could continue to affect engagement for people
like Julie who had been diagnosed for 4 years:
I just think, why should I bother because even though I go there, this thing what I have, is not going
to disappear. It’s not going to disappear. I’ve still got it, so I don’t know. I don’t . . . I just, sometimes
I don’t, like, I don’t put it in my head that I’ve got HIV.
Julie (NA, Fem-BA, 25 years)
The possibility of passing on HIV to a child was also found to be difficult to deal with. For example, Jade
(FG2, Fem-BA, 37 years) did not attend for 18 months after she had her second baby, because she had
found the frequent HIV testing and possible HIV diagnosis of her first baby very stressful.
These feelings of self-stigma were especially strong among the black African patients and could be
exacerbated by stigma experienced or imagined from other community members. Adele (NA, Fem-BA,
27 years) felt threatened by a member of the hospital staff from her home country that she confided in
when she was having her baby and subsequently withdrew from care for 2 years.
Self-stigma was also found to be implicated with not attending the clinic when patients felt well,
particularly before starting ART, even though they knew that they were expected to attend the HIV clinic
for routine check-ups:
I was down, I was still in the process of denial . . . so I completely thought to myself, you know, what’s
the point? I just need to, sort of like, stay strong for the kids as well as myself, and being that I kept
well, I’ve never felt unwell and all that. So I kept thinking, oh, I’m fine. I’ll go next month. I’ll go a
month after, and month turned into months turned into . . . and yes.
Josephine (NA, Fem-BA, 42 years)
However, Charles (NA, Male-BA, 47 years) understood that it was not necessary to attend because he was
well and only attended twice in the 4 years after his diagnosis. Similarly, Miriam explains how the message
she took away when she did not start ART at diagnosis was that she did not need to engage with care:
I just completely forgot, not forgot, just said, OK fine, I’m OK, because if they think if I’m not ready for
medication it means I’m OK, you know, it means I’m fine.
Miriam (NA, Fem-BA, 39 years)
In relation to this, Rick (NA, GayMale-UK, 44 years) said that 6-monthly appointments were the ‘worst
thing that could have happened to me’ because it seemed like he was doing well and could stop taking
his medication.
Once ART was prescribed, patients’ experiences illustrate how their motivation to attend could be shaped
by ART. Cynthia (FG2, Fem-BA, 35 years) stopped attending for a year when she was advised to start
taking ART and was fearful of doing so. Among people who had started ART, the stress of taking it could
result in a conscious decision to stop taking it and stop attending:
Along the way I think emotionally I got fed up with the drugs and stopped taking it without
telling them.
Joyce (NA, Fem-BA, 36 years)
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Jade (FG2, Fem-BA, 37 years) also stopped taking ART because it was ‘permanent persecution every day’,
reminding her about HIV. Difficulties with ART could result in more gradual changes to adherence that
could equally result in disengaging from care:
So I kind of drifted off that. I stopped going into the clinic because I didn’t want to admit to them that
I drifted off that.
Rick (NA, GayMale-UK, 44 years)
As Rick describes, the relationship between non-adherence and non-attendance may be mediated by the
desire to avoid the perceived censure of health-care professionals when not taking medication. The
hierarchical relationship between doctor and patient was apparent across the diverse cultural backgrounds
of the patients, with references to being a good patient who attends regularly and takes their medication
and not wanting to be told off for not doing so. The association between adherence, attendance and the
doctor–patient relationship also illustrates the interaction between the elements of the COM-B model.
Opportunity: social influences
Although patients generally thought well of clinic staff, two of them described how periods of
disengagement resulted from a breakdown in their relationship with health-care professionals at their HIV
clinic. Both felt that they were not listened to and therefore withdrew from care.
Opportunity: barriers
Various barriers were implicated in stopping attending that were often particular to individuals but all resulted
in complete disengagement from care. Charles (NA, HetMale-BA, 47 years) became homeless, which made
it difficult to keep medication that required refrigeration and to keep up attendance. Although Joyce (NA,
Fem-BA, 36 years) made a conscious decision to stop attending when she stopped taking her ART, this was
preceded by changes in her child care arrangements which impacted her working hours. Some patients, such
as Rick (NA, GayMale-UK, 44 years), describe a range of causes, including self-esteem, adherence and working
in a responsible job with erratic hours, which made it difficult to adhere to complicated medical regimes and
attend for HIV care. Barriers to attendance are interwoven with motivational issues, social influences and not
prioritising HIV care. For example, Josephine (NA, Fem-BA, 42 years) was diagnosed during pregnancy – she
was doing two jobs, her husband was not working and abusive, she had four children including the baby and
one with a serious disorder that needed a lot of care:
So whenever I had a free time, I was too exhausted even to think of coming to the clinic . . . I was
always tired and the thing overwhelmed me. My mind was just concentrating at the immediate basic
things in the house. My children, mortgage, work.
Josephine (NA, Fem-BA, 42 years)
Why do non-attenders come back to the HIV clinic?
Patients recognised that when they became disengaged from care, it could be difficult to return to
the clinic:
Just life got in the way, and then, for me, it’s like really hard to make those steps, kind of, back . . .
and the longer you leave it, the harder it gets.
Ben (NA, GayMale-UK, 33 years)
Some patients had been concerned that their doctors might react badly when they returned, but they
reported receiving a positive response. Dean (NA, GayMale-UK, 41 years) described how he actively sought
the help of a community organisation to contact the HIV clinic on his behalf in order to re-establish
communication after disengagement.
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It often took a particular trigger to bring them back into clinic, although Julie (NA, Fem-BA, 25 years)
explains how she came after she ran out of ART:
I know I done bad, but them times I was kind of worried as well so I should just go, and check, like,
for my health and that, if I’m all right. I came back 2 weeks ago.
Julie (NA, Fem-BA, 25 years)
Becoming ill was one of the main reasons why patients returned to care, and social influence also played a
key role. Several patients talked about a nurse or doctor at the clinic who persuaded them to come in.
When this came at a time when they were ready to come back to the clinic, it could provide a welcome
bridge back to HIV care:
I just welcomed the phone call, I felt there was a bit of interest in my situation, so I feel OK about
coming here.
Stephen (NA, GayMale-NonUK, 48 years)
Other patients were supported and advised by trusted professionals from outside HIV to return to care and
starting a new relationship could also give patients additional motivation to make this change in their lives.
Summary of findings from Chapter 6
l Physical capability to attend the HIV clinic is affected if patients feel unwell and psychological capability
is affected when patients forget their appointments or when they have used alcohol or recreational
drugs. Knowledge about HIV can empower patients, enabling better EIC.
l Motivation to attend is affected by not wanting to think about HIV, feeling well, being depressed, low
self-esteem, poor self-efficacy and control, and poor adherence to ART. Familiarity with the clinic and
the staff can improve motivation to attend.
l Opportunity incorporates social influences and some people are afraid that people will find out about
their HIV status when they attend the clinic. Health-care professionals and partners can have positive or
negative influences; peer support is very powerful.
l Barriers such as financial difficulties, work and child care responsibilities, homelessness and immigration
issues can limit opportunity.
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Chapter 7 Findings: improving engagement in
HIV care
This chapter begins with a brief summary of the findings from the previous chapters on the factorsassociated with engagement in HIV care, with a focus on where potential interventions should
be targeted.
We will then summarise the data collected from PLWH and key informants on how to improve
engagement in HIV care. We were primarily interested in asking patients about their lived experiences,
whereas service improvements and interventions formed the main focus of the key informant interviews.
The short summary of patient suggestions is followed by the more detailed data provided by the
key informants.
Last, we will present our suggestions for interventions to improve engagement in HIV care based on this
accumulation of evidence, including a shortlist with preliminary costing. This chapter addresses the final
objective of our study, to:
l develop intervention models to improve EIC, to be tested in future studies.
Summary of evidence from REACH on where to target interventions
The data from the three phases of REACH provide consistent evidence on where to target interventions to
improve engagement in HIV care.
Background
The evidence from our survey complemented the evidence from secondary analysis of UK CHIC data on the
background factors associated with regular clinic attendance. In both cases, the analysis suggested that
the association with gender could be explained by other factors, whereas there was a clear indication
that younger patients were more likely to disengage from care. On the other hand, survey respondents
were also more likely to disengage the longer they had been diagnosed whereas higher engagement
among UK CHIC participants was found only in the first year after being initially seen at a clinic. Both
analyses found an association between acquisition of HIV through sex between men and being on ART
with better EIC. The survey found better engagement among white participants and UK CHIC found that
those of ‘other ethnicity’ had poorer engagement. In addition, the survey indicated that lower education
and not being registered with a GP were associated with a period of disengagement. The data suggest that
interventions might be usefully targeted at these patient groups.
Physical capability
The findings from the survey were supported and enhanced by the findings from the qualitative
component of the study. The data indicated that, when patients felt unwell, they are more likely to miss
appointments, but ill health could also be the trigger for people to re-engage with care. Poorer health was
reported among IAs and feeling unwell was given as a reason for not attending appointments by survey
participants and those taking part in qualitative research. The data from clinic notes also showed that
irregular attendance was more likely among patients who had had stayed in hospital because of their HIV.
The study suggests that patients may need extra help – both psychological and practical – to attend the
HIV service when they are not well.
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Psychological capability
The quantitative and qualitative data indicated that forgetting to attend was a key reason for missed
appointments. The survey data furthermore suggested that this may be associated with neurocognitive
impairment. The evidence indicates that appointment reminders could be usefully employed to reduce
missed appointments.
Data from the questionnaire and clinic notes indicated that alcohol and recreational drugs use were
associated with disengagement from care. Although only one interviewee discussed recreational drug use,
he gave this as a key reason for missed appointments, and interventions targeting drug and alcohol use
should be considered.
Patients who took part in interviews and FGs showed the importance of information in tackling self-stigma
and becoming empowered to take care of one’s health. Education can provide patients with the
knowledge to engage with care.
Motivation
Depression emerged as a key reason for irregular attendance from both the quantitative and qualitative
data sets. Although depression is more common among PLWH,70 the data from REACH suggested that
people who disengage from care may be less well equipped to manage this and take charge of their
health care. Mental health services have a key role to play in maintaining EIC.
Interview and FG participants expressed a clear association between not adhering to ART and not
attending HIV services. Interventions tackling poor adherence to ART might help some people engage
with HIV care more generally, as well as interventions targeting the language used by clinicians when
addressing non-adherence with their patients.
Narratives of stigma were widespread among those participating in the qualitative research and self-stigma
could contribute to disengagement from care. Items from the quantitative measure of internalised stigma
indicated high prevalence of low self-esteem (34.1%), self-blame (28.8%) and shame (28.7%), but the
summative score did not distinguish between groups. NAs were, however, more likely to give issues
relating to stigma, such as not wanting to think about HIV or not wanting to be seen at the clinic, as
reasons for not attending. This suggests that interventions that deal with stigma could help people to
engage in HIV care.
Opportunity: social influences
Although many patients felt that the dedicated HIV clinic created a safe space, as described above, fear of
involuntary disclosure of HIV status could stop people attending the clinic. Holding clinics in premises not
associated with HIV might encourage some people to attend. Although there was little in the survey about
peer support, its potential to address stigma in addition to other important benefits was consistently
highlighted in the qualitative component of the study.
The quantitative and qualitative data generally suggested that HIV staff created a positive environment for
patients. However, the relationship with health-care professionals could break down and interventions
targeting staff interactions with patients might help some patients attend more regularly.
Opportunity: barriers
The quantitative and qualitative research emphasised the negative impact of poverty on EIC. Patients
dealing with social issues like homelessness or immigration problems did not always prioritise their health
care. Although we cannot tackle the overall problem of economic inequality, free transport to the clinic
might reduce missed appointments. In addition, multidisciplinary, holistic support including social workers,
psychologists and peer workers might provide advocacy and support to help patients engage in care.
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Other barriers, including lack of child care and work responsibilities, were raised in both the survey and
interviews. More flexible services, which offer services outside usual hours or in different locations, might
help to address these obstacles.
Patients’ suggestions to improve engagement in HIV care
Suggestions that address capability
Appointments
Text reminders were seen as helpful, as were online appointment systems. Text reminders might include
the options: press 1 – attend, press 2 – not attend, press 3 – telephone consultation. Clinics should always
call patients when they missed their appointments.
Information
A booklet for new patients that helped to signpost facilities and an information pack about HIV for
patients who were admitted to hospital at the point of diagnosis and had no access to information.
Adherence
Dosette boxes should be issued as standard.
Suggestions that address motivation
Education of others
A strong public message was needed to destigmatise HIV because people were still thinking about the
‘coffin adverts’. Health-care professionals from outside the field of sexual health and HIV need more
education about HIV.
Clinics
Clinics aimed at particular groups (women, gay men and so on) might make coming to clinic more
comfortable for some people.
Suggestions that address opportunity: social influences
Interaction with staff
Receptionists should not make patients feel like they are being told off and consultants should ask patients
directly what they should do if they do not attend their appointments.
Peer support
Patients wanted peer support based in the HIV service. They wanted an opportunity to get together
informally to talk about issues. Peer support at the point of starting medication was particularly useful.
Suggestions that address opportunity: barriers
Advice and support
Patients wanted advisers who could give practical social support in the HIV service.
Opening hours
Flexible opening hours including evening and weekends would be helpful.
Transport
Transport should be paid in advance and hospital transport made more available for people
with disabilities.
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Consultations
Home visits and Skype consultations would be useful.
Facilities
Patients wanted a crèche for children, somewhere to leave them during an appointment that was away
from HIV information.
Key informant suggestions to improve engagement in HIV care
There was no one-size-fits-all solution to improving engagement in HIV care and a range of tools should
be developed based on patient need, with case conferences helping to devise tailored support. It might
also help to look at other conditions for interventions or service improvements that had been successfully
implemented.
Key informants raised the importance of systematically identifying NAs as well as redirecting resources to
them, and we begin this section with a summary of these two issues. This is followed by a description of
interventions based on the key informant interviews according to the three elements of the COM-B model.
Identifying non-attenders
Key informants raised the issue of pre-empting non-attendance by identifying those at risk of disengaging
and keeping an eye on them, as well as considering that risk may change over time. They highlighted
the importance of taking a systematic approach to tracing people who had disengaged from care by
drawing up an explicit, consistent follow-up policy involving a service with accountable staff who had time
dedicated to this work. A service manager with clinical support or a lead clinician with multidisciplinary
support could lead this.
The key informants talked about the sort of systems that might work and who should be involved. For
example, there could be an electronic solution whereby a member of staff was responsible for an active
process of flagging and tracking NAs. This might require integrating multiple data systems and improving
data sharing between clinics. Technology might also be used to help keep patients contact details up to
date, asking them to text their new address or telephone number.
Regular clinics or meetings could be held to identify NAs who should then be contacted by telephone,
e-mail and/or letter. All attempts to contact patients should be documented. There were different
suggestions about who should make the contact with patients. There was some benefit in the consultant
who knew the patient making the approach, whereas in other services a nurse took responsibility for
tracking people down. Patient representatives could also take on the role or health advisors had the skills
to make an initial approach and then make an appointment to see the patient when they came into clinic.
GPs could also be involved in tracing patients.
Redistribution of resources
Another central topic of discussion was the redistribution of resources. Reconfiguring services to reduce
the cost of stable patients might free resources to be available for the most vulnerable patients who had
engagement issues.
Interventions that address capability
One of the factors associated with disengagement is forgetting. This is one of the possible outcomes of
substance abuse that could be tackled at the clinic by, for example, introducing a drug and alcohol worker
into the clinic.
Although text messages can remind patients of their appointments, a personal reminder might be more
powerful. An intervention was described whereby patients received a personal reminder call from someone
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that they knew in advance of their appointment and a personal call from the same person within
24–48 hours of missing an appointment. Others reported that an informal personal reminder has been
found to be effective:
So some people tell me personally, oh, can you remind when it’s getting to, so maybe, a next day or a
week to the appointment. I just give them a call and said, oh, you have appointment, so you need to
come. And they will come.
Receptionist
The qualitative data described earlier indicated that knowledge could empower patients to take control of
their health and engage with care. Peer support was one of the key means of imparting knowledge and
we will come on to look at that under social influences. Areas of learning which might help patients to
engage with the HIV service included education about the implications of disengagement, about going to
clinic even if you are well, about the confidentiality of the clinic and around self-stigma.
Reinforcing an expectation of attendance might also encourage engagement. Professor of Medicine (MM)
described creating a clinic culture that reinforced this expectation through the use of posters and staff
messages and public health expert 1 talked about a proactive telephone call on one missed appointment
to suggest that attending is the norm, with staff reinforcing this message.
Interventions that address motivation
Various ways of addressing stigma were suggested. These included raising public awareness through
national campaigns or role models with the aim of normalising HIV and showing how it is now a treatable
condition. The Time to Change campaign against mental health discrimination was given as an example.
Media campaigns could also be used to engage different groups. Changes might also be made at the local
level to destigmatise the clinic and to reassure patients that they are safe when they come to clinic.
Awareness should be raised among other health-care providers who needed updating on HIV. They could
sit in at HIV clinics or attend specially designed workshops. Teaching to medical students could be
reconfigured to include HIV stigma.
One key informant talked about providing HIV services in a way that was more similar to other long-term
conditions might also have the effect of ‘normalising’ HIV by demything the condition and making care
more accessible, although it may still need special provision:
There’s always this battle in one’s own head about shall we normalise HIV and, you know, do we
need all this kind of special treatment? And then, every week you come across appalling instances of
how people with HIV are treated, it makes you realise it sadly isn’t normal yet.
Patient representative 1
Appropriate and improved mental health provision was widely recognised as being needed for PLWH,
reflecting the impact on mental health from moment of diagnosis and an elevated need for psychology in
the population as a whole. Although mental health professionals were the key providers, additional
support from a member of staff who was trained in psychological well-being could provide back-up to
this service.
Self-efficacy was also seen as an important element of motivation, incorporating the idea of patients as
their own caseworker. Clinic staff could be trained to raise health literacy and promote self-management.
Specific interventions aimed at empowering patients included educational programmes and techniques
such as the Expert Patient Programme, the Living Well Programme and Cornerstone Conversations.
Technological solutions, such as hand-held health records, could engender patient activation by helping
them to monitor and self-manage their health. Non-technical solutions included a written record of lab
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tests and a written dedicated action plan. Small changes might also help empower people. Examples
included asking the patient to write down the date of their next appointment or providing the facility for
them to book their own appointment.
Interventions that address opportunity: social influences
Key informants emphasised the importance of continuity of care, of health-care professionals building a
relationship with patients and making them feel welcome and valued. There should be an ongoing
dialogue between consultants and their patients. However, developing and maintaining this relationship
could take time.
In-house training could make staff more welcoming and engender a clinic culture of valuing the patient
being there. When patients came back to the clinic, it was particularly important that staff should be
trained to respond to them in an appropriate and sensitive way.
The importance of peer support in building confidence and understanding was highlighted and different ways
of providing peer support were discussed. Peer support could involve patient representatives who were part
of the service or peer mentors who were either employed by or affiliated to community organisations. There
were different ideas on whether peer mentors should be volunteers or paid members of staff. Being a paid
member of staff could raise the issue of confidentiality and discussing sensitive issues about the clinic and the
staff with another member of the staff. On the other hand, paid staff could work with other professionals
and provide an effective way of facilitating valuable discussion. Payment also implied a professional identity
and certain expectations of performance. Professor of Medicine (MM) talked about the high turnover in peer
support and how stressful the work could be. He raised the importance of training, roles and responsibilities,
and supervision.
When peer support was integrated into the HIV service, it could be used to change the dynamics and start
conversations. Peer mentors had time to talk to patients and gave patients a sense of hope:
It’s very powerful, I can say to a patient, shake their hand, say, I’m Chris, I’ve been living with HIV for
over thirty years, so any idea of you dying – forget. And they can see that . . . it’s a visual form
of education.
Patient representative 3 (CS)
In addition to one-to-one discussions, peer support groups held in the clinic or elsewhere could also enable
people to learn from each other. It was suggested that peer mentors could also visit community clinics
once a month to provide information.
It was crucial to try and engage with people as soon as possible after diagnosis both through one-to-one
peer support and courses for the newly diagnosed. Newly diagnosed people should be routinely directed
towards this support and, when peer mentors were available in the clinic, they could be introduced to
them right away.
Interventions that address opportunity: barriers
Key informants indicated that multidisciplinary, holistic support helping patients to prioritise their health
care should be funded and consistently available across the country. HIV clinics should work towards
providing an overarching supportive environment and not just a clinical service, with social support
incorporated through the clinic or in collaboration with external agencies, such as community organisations
and Citizens Advice Bureaux.
Making changes to patient pathways could mean that patients would not always need to come into the
HIV clinic for bloods or to see the doctor; services could be taken to them. The community nurse specialist
role needed definition but might deliver such a service, providing continuity of care by seeing patients
in the clinic, on the ward and at home. Such changes to service delivery might also include greater
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involvement of GP practices. Key informants suggested different configurations, including HIV clinicians
or nurse specialists doing clinics at the GP practice, bloods being done at the GP practice or at home
and skilling up GPs for shared care. Some patients, however, found it easier to have all their care in
one service:
You go to your GP and say to your GP, my HIV clinician said I must come to see you about this, and
the GP says, I’m sorry, I can’t treat you for that, you need to go back to your clinic . . . we’ve got to
get rid of this ping-pong.
Patient representative 1
In addition, key informants suggested that some consultations for some patients could be conducted using
various technological and innovative solutions including a virtual HIV clinic; consultations or results by
telephone, e-mail, WhatsApp (WhatsApp Inc., Mountain View, CA, USA) or Skype; and electronic access
to results.
Patient-friendly facilities and services that were flexible and accessible might facilitate attendance.
Key informants talked about organising facilities so that the waiting area was out of earshot of reception,
seats were not facing the door, and there was a place for prams and child care provision. A comfortable
environment could make a difference and calm the patients. Other suggestions included evening and
weekend clinics; a more flexible walk-in system; fewer appointments if patients were stable on treatment;
co-ordinated appointments so that patients could see all health-care professionals on the same day; and
one telephone number to call. Volunteers from community organisations could also help with logistical
issues including babysitting or driving someone to clinic.
Interventions for addressing financial issues might enable patients to stay engaged. Suggestions included
giving supermarket vouchers to patients who were badly in need. The problem of getting to the clinic could
be addressed by pre-paid Oyster cards, an emergency travel fund or guaranteed travel reimbursement.
It was important, however, to explain what was available to patients and facilitate travel reimbursement
because it would be embarrassing and complicated to claim. People who were very difficult to engage in
care might be provided with a cheap mobile phone to call or text clinic and which the clinic could also use
to contact them.
Selected interventions
The key informant interviews did not provide sufficient detail to be able to put together complex
interventions so the interventions that we have developed are based on the factors identified as important
from across all the components of the study. The above evidence indicates that there is no one-size-fits-all
approach to improving engagement in HIV care. Clinics should consider incorporating suggestions made by
patients and key informants into their care provision, such as text reminders and standardised systems for
identifying and following up NAs. The prevalence and impact of poverty suggests that financial incentives
such as supermarket voucher schemes and travel reimbursement might also help people to attend the HIV
clinic. Our findings suggest that child-friendly clinics could be beneficial, but such broad-brush changes to
service provision are difficult to cost.
We have identified four interventions based on our findings and put together a preliminary analysis of their
costs. The interventions are listed in Table 27, together with the setting and target population for each.
Each intervention addresses one or more of the key barriers to attendance described above, in line with
the COM-B model, which proposes that behaviour occurs as an interaction between the three elements
and suggests that more complex interventions will necessarily draw on each of the elements to a greater
or lesser extent.
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Our research indicated that peer support has an important role to play in EIC. It helps PLWH cope with
self-stigma and provides role models, emotional support and an opportunity to talk about HIV care and
living with HIV. Our first intervention describes a structure within which to implement one-to-one peer
support. This individualised support is aimed at patients who are at risk of disengaging from care. It
enables identification of needs so that they can be directed to the level of care that they require, including
signposting to other services such as psychology and social care that our research has identified as
important, as well as provision of information and support to deal with the stigma that is a key barrier to
attendance. Patients are offered up to eight sessions with a peer worker but some may only need two or
three sessions, so costs will be variable. The intervention offers advice and support within the clinic, as
recommended by patients and key informants.
Our second intervention brings together a multidisciplinary team (MDT), including a consultant, specialist nurse,
psychologist, social worker and peer caseworker, into one clinic for patients who have difficulty engaging with
care. It provides holistic care and the opportunity to address the range of health, psychological, social and
economic needs identified above at the same time. There is no need for patients to incur the costs of returning
to the clinic on several occasions.
The above interventions address stigma through peer support but some PLWH do not attend the HIV clinic
because they are afraid to be seen there. In our third intervention, the clinic is held in an alternative
setting, providing the opportunity to reach these patients and a possible bridge into regular care at the HIV
clinic. Key informants, in particular, recommended the idea of taking services to patients.
Our fourth intervention has been proven to be effective in the USA through the use of co-ordinated messaging
to encourage attendance.71 Staff are trained to create a welcoming environment and deliver messages that
clarify the importance of keeping appointments and practical steps to achieving this. The intervention showed
a relative overall improvement in keeping two consecutive outpatient HIV appointments in the USA from
pre-intervention to intervention of 7.0%. However, the effects were much greater among groups who are
at particular risk for disengaging from care. For example, the relative improvement was 28.2% for new or
re-engaging patients compared with 5.3% for active patients; and 19.9% for patients aged 16–29 years
compared with 6.1% for patients aged 50–85 years. This intervention aims to reinforce an expectation of
attendance, as identified by our key informants, and to address issues of communication between patients and
staff that have been implicated in disengagement from care.
Intervention costs
A description of each of the four identified interventions, and a preliminary analysis of their costs,
is provided below.
TABLE 27 Summary of selected interventions
Intervention Setting Target patient population
Structured peer involvement HIV clinic Disengaged
‘One-stop-shop’ MDT clinic HIV clinic Disengaged
Clinic in alternative setting Not HIV clinic Disengaged
Low-cost clinic-wide intervention HIV clinic All
MDT, multidisciplinary team.
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Intervention 1: structured peer involvement
Description of intervention
This intervention comprises a collaborative model of care between the NHS and a third sector agency,
with the latter providing support for patients using peer support workers. The peer support workers have
individual sessions in a variety of formats with patients over a 6-month period, providing the support for
the following:
l signposting and supportive conversations about living with HIV and seeking treatment for it
l providing practical support about living with HIV and seeking treatment for it
l helping patients to build relationships with clinical staff.
The peer support worker may provide support for the patient via face-to-face meetings in non-threatening
locations and at flexible times, and also via telephone, online and social media.
The intervention is likely to comprise the following activities:
l identifying patients who are eligible for peer support
l booking patients into the peer support programme and making appointments to see the peer
support worker
l devising an individual peer support care plan designed to support engagement with care
l up to eight sessions between the patient and peer support worker, with the latter providing support of
various kinds as described above
l a monthly supervision session with a psychologist for each peer support worker
l allowances for both patients and peer support workers to facilitate interaction.
Cost analysis
The costs of this intervention are summarised in Table 28. They comprise each of the activities described
above. Patient identification is assumed to be undertaken by a senior clinic worker [Agenda for Change (AfC)
band 7] and takes 15 minutes per patient. The patient is assumed to be booked into the programme by a
receptionist (AfC band 2), taking 15 minutes in total. For each patient in the programme an individualised care
plan is devised, which is assumed to take 1 hour of time by an AfC band 5 worker. The main element of the
programme consists of up to eight individual sessions each of 1 hour’s duration with a peer support worker.
The peer support worker might range from being an unpaid helper to a paid peer caseworker at AfC band 5,
with a range of costs. We calculated the costs for up to eight sessions with each type of peer support worker
and then used the average. Patients are expected to receive a transport allowance and a food allowance for
meetings with the peer support worker, valued at £10 per session and £5 per session, respectively. Peer
support workers are also expected to receive the same allowances, and in addition receive a telephone
allowance of £50 a month, a proportion of which is used to contact each patient. We assume that on average
each patient may receive peer support from a range of peer support worker types, and taking the average cost
across all types, the expected cost of this intervention per patient over a 6-month period is £538 (see Table 28).
The actual provision of this and the other interventions considered in this section may vary from one location
to another. If only, for example, three peer support sessions were needed instead of eight then the total
costs would be £433. If all of the peer support sessions were provided by an unpaid peer helper the total costs
would be £370; if half were provided by an unpaid peer helper and half by a paid peer helper at AfC band 2
the cost would be £416; and if they were all provided by a paid peer caseworker at AfC band 5 the total costs
would be £658. If there was only one supervision session with a psychologist during the 6-month period the
cost would be £501; and if there were three sessions the cost would be £516.
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Intervention 2: ‘one-stop-shop’ multidisciplinary team clinic
Description of intervention
This intervention comprises a weekly MDT clinic, a 4-hour session involving a range of health and social
care workers providing care for patients. The clinic is designed to provide a ‘one-stop-shop’ for patients,
reducing the number of appointments needed to meet with each member of the team. The MDT is like to
comprise the following workers:
l consultant
l specialist nurse
l administrator
l clinical psychologist
l social worker
l peer caseworker.
TABLE 28 Estimated costs of structured peer involvement
Cost component Cost (£)
Patient identified as eligible by clinical team member
15 minutes of one AfC band 7 worker at £54 per hour 14
Patient booked into peer assessment appointment with clinician/third sector
15 minutes of one AfC band 2 worker at £23 per hour 6
Individualised peer care plan devised to support engagement with care
1 hour of one AfC band 5 worker at £36 per hour 36
Eight sessions (1 hour each) with a designated level of peer worker
Eight sessions with an unpaid peer helper 0
Eight sessions with a paid peer helper (AfC band 2) at £23 per hour 184
Eight sessions with a paid peer mentor (AfC band 3) at £25 per hour 200
Eight sessions with a paid peer caseworker (AfC band 5) at £36 per hour 288
Average 168
Monthly peer worker supervision with psychologist (1 hour)
Six sessions with a psychologist at £54 per hour 324
Six sessions with support workers at an average of £21 hour 126
Subtotal 450
Mean cost per patient (estimated 10 patients seen each month) 45
Allowances for patients
Transport allowance (eight sessions at £10 per session) 80
Food allowance (eight sessions at £5 per session) 40
Allowances for peer workers
Transport allowance (eight sessions at £10 per session) 80
Food allowance (eight sessions at £5 per session) 40
Telephone allowance (£50 per month for 6 months per peer worker, assume 10% per patient) 30
Total (mean cost per patient over a 6-month period) 538
AfC, Agenda for Change.
All costs are in 2015/16 GBP. Unit costs for staff costs were taken from Curtis and Burns.69
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Cost analysis
The costs of this intervention are summarised in Table 29. The MDT meeting is assumed to be a weekly
4-hour meeting involving all the team members described above. In addition to the 4 hours of clinical
time, additional administrative time is allocated to each meeting. As well as these staff costs, patients are
expected to receive a transport allowance and a food allowance for the MDT meetings, valued at £10 per
session and £5 per session, respectively. Peer case support workers are also expected to receive the same
allowances for participating in the meetings. The cost of the weekly MDT meeting is estimated to be
£1472. To calculate the cost per patient, we assume that, on average, each MDT will see eight patients
each week, and that eligible patients will be seen once every 3 months. On this basis, the expected cost of
this intervention per patient over a 6-month period is £398 (see Table 29). If each eligible patient was seen
more or less frequently, for example every month, 2 months or 6 months, the estimated costs would be
£1194, £597 or £199 per patient, respectively.
Intervention 3: running a clinic in a non-NHS/alternative NHS setting
Description of intervention
This intervention comprises a weekly specialist clinic, which, rather than being held on the usual NHS site,
is instead held off-site in an easy-to-access non-intimidating setting providing anonymity for patients (e.g. a
library, general practice or pharmacy). The intention is that this may improve engagement by making it less
obvious that patients are visiting the clinic (i.e. preserving anonymity), and also making the clinic easier
to get to. If the clinic takes place in a general practice setting it may also facilitate management of
comorbidities requiring GP involvement.
TABLE 29 Estimated costs of ‘one-stop-shop’ MDT clinic
Cost component Cost (£)
Weekly 4-hour MDT (including clinical and administration time)
5 hours (4 hours clinical, 1 hour administration) of one consultant at £105 per hour 525
5 hours (4 hours clinical, 1 hour administration) of one specialist nurse (AfC band 7) at £54 per hour 270
1 hour of one administrator (AfC band 4) at £28 per hour 28
5 hours (4 hours clinical, 1 hour administration) of one clinical psychologist (AfC band 7) at £54 per hour 270
4 hours (clinical) of one social worker at £55 per hour 220
4 hours of one peer caseworker (AfC band 5) at £36 per hour 144
Allowances for peer caseworkers
Transport allowance at £10 per session 10
Food allowance at £5 per session 5
Subtotal 1472
Number of patients per weekly MDT 8
Allowances for patients
Transport allowance at £10 per session 10
Food allowance at £5 per session 5
Mean cost per patient per weekly MDT 199
Number of times patient seen over a 6-month period 2
Total (mean cost per patient over a 6-month period) 398
All costs are in 2015/2016 GBP. Unit costs for staff costs were taken from Curtis and Burns.69
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Cost analysis
The costs of this intervention are summarised in Table 30. The clinic is assumed to be a weekly 4-hour
session involving a consultant and specialist HIV nurse and administrator. The calculation allows for clinical
and administration time.
As well as these staff costs, costs will be incurred for staff transport to the venue, and patients are expected
to receive a transport allowance of £10 per session. The main potential non-staff cost is room hire, which
we assume in a non-NHS setting will cost £800 per month. The cost of the weekly clinic is estimated to be
£1129. To calculate the cost per patient we assume that, on average, each clinic will see eight patients each
week, and a patient will attend the clinic once every 3 months. On this basis, the expected cost of this
intervention per patient over a 6-month period is £302 (see Table 30). If the clinic was held at a zero-costed
venue the estimated costs would be £247 per patient. If only 1 hour of dedicated administrator time is
needed (e.g. if the venue is a GP surgery with reception staff), then the cost would be £281 per patient.
If each eligible patient was seen more or less frequently, for example every month, 2 months or 6 months,
the estimated costs would be £906, £453 or £151 per patient, respectively.
Intervention 4: low-cost clinic-wide intervention
Description of intervention
This intervention comprises brief verbal messages to be used by clinic staff, encouraging patients to adhere
to treatment and engage with care. It also includes a set of printed materials including a leaflet, posters
and staff pocket guides.
Cost analysis
The costs of this intervention are summarised in Table 31. The leaflets, posters and staff pocket guides
have been costed based on design and printing costs of £300, which would produce sufficient volume of
materials for a total of 2800 patients in a single clinic. Staff training is required to instruct staff in the use of
brief verbal messages to encourage engagement with care. This includes the costs of a professional trainer
and the cost of clinic staff attending the training sessions provided by the trainer. It is assumed that each
TABLE 30 Estimated costs of running a clinic in a non-NHS/alternative NHS setting
Cost component Cost (£)
4-hour clinical session per week in a non-intimidating space (including clinical and administration time)
5 hours (4 hours clinical, 1 hour administration) of one consultant at £105 per hour 525
5 hours (4 hours clinical, 1 hour administration) of one specialist nurse (AfC band 7) at £54 per hour 270
4 hours of one administrator (AfC band 4) at £28 per hour 112
Room hire (at £800/month + VAT) 222
Staff transport (at £10 per staff member for three staff) 30
Subtotal 1129
Number of patients per clinic 8
Allowances for patients
Transport allowance at £10 per session 10
Mean cost per patient per weekly clinic 151
Number of times patient seen over a 6-month period 2
Mean cost per patient over a 6-month period 302
VAT, value added tax.
All costs are in 2015/16 GBP. Unit costs for staff costs were taken from Curtis and Burns.69
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staff member will attend one 2-hour group training session and that to train 27 staff in one clinic will require
one 2-hour session of professional trainer time plus preparatory work. The total cost of the printed materials
and training is £4787 in a clinic with 2800 patients. Therefore, the cost per patient is £2 (see Table 31). This
estimate assumes the intervention affects only current patients. For example, if twice as many patients were
affected if the intervention effects persist into the future then the cost per patient would be £1.
Summary of findings from Chapter 7
l Interventions are proposed that support a holistic approach to care including peer support; address
stigma by holding clinics in alternative locations; and encourage patients to attend through training
staff to deliver co-ordinated messages.
l The costs of the interventions range from £2 to £538 (Table 32).
TABLE 31 Estimated costs of running a low-cost clinic-wide intervention
Cost component Cost (£)
Posters/leaflets/staff pocket guides (design and printing costs per clinic) 300
Professional trainer (per clinic)
Preparatory work 75
One 2-hour session at £900+ VAT 1080
Subtotal 1155
Staff attendance at training (per clinic, each staff member to attend one 2-hour session)
Three AfC band 2 workers at £23 per hour 138
Three AfC band 3 workers at £25 per hour 150
Four AfC band 6 workers at £45 per hour 360
One AfC band 7 worker at £54 per hour 108
Seven specialist registrars at £49 per hour 686
Nine consultants at £105 per hour 1890
Subtotal 3332
Total 4787
Number of patients 2800
Mean one-off cost per patient 2
VAT, value added tax.
All costs are in 2015/16 GBP. Unit costs for staff costs were taken from Curtis and Burns.69
TABLE 32 Summary of costs for the four interventions
Intervention Cost (£)
Structured peer involvement 538
‘One-stop-shop’ MDT clinic 398
Running a clinic in a non-NHS/alternative NHS setting 302
Low-cost clinic-wide intervention 2
All costs are in 2015/16 GBP.
The cost of the low-cost clinic-wide intervention is a one-off cost per patient.
The other costs are mean costs per patient over a 6-month period.
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Chapter 8 Discussion and conclusions
This chapter summarises the findings of the study and how they address the objectives that we set outto achieve. We will discuss the limitations of our findings in relation to each of the objectives.
Objective 1: outpatient attendance patterns among people living
with HIV
In addition to our original objectives we have developed the EIC algorithm, which provides a flexible new
approach to measuring engagement in outpatient HIV care. It adapts to the changing treatment and
health status of the patient, which reflects the reality described to us by clinicians. It provides a binary
measure of whether patients are in care or out of care for each month of follow-up which can be used to
analyse patterns of engagement over time42 and to examine associations between predictive variables and
the proportion of months that patients are in care following diagnosis.
The EIC algorithm was developed from interviews with clinicians, who indicated that the timing between
appointments is dependent on a range of factors. We used 6 months as the maximum time between
routine visits in the algorithm, as described by physicians and in accordance with the UK guidelines for
routine monitoring at the time.27 However, the EIC algorithm can be adapted to changing guidelines and
to local clinic policies on how often to see patients. For example, guidelines in the UK now recommend
starting ART irrespective of CD4 count,43 and this can be incorporated into the EIC algorithm when applied
to future cohort data.
Any algorithm is clearly only an approximation to a far more complex clinical process and it is difficult in an
observational cohort setting to incorporate other factors, such as social factors, that may lead to more regular
scheduled visits. Although such data are not currently collected for UK CHIC, they could be incorporated into
an algorithm if it were available. For example, the HARS 3 measure of patient complexity that we used in our
survey could be incorporated into future iterations of the EIC algorithm. As it stands, the algorithm may provide
an underestimation of engagement in HIV care as it does not account for patients whom clinicians may wish to
see earlier for treatment of comorbidities and psychosocial issues associated with HIV. In addition, it measures
EIC up to the point of last visit and does not therefore include time when patients are LTFU after this.
In common with other analyses of EIC using HIV cohort data, we have used laboratory data and ART
start dates as surrogate markers of clinic visits. We may therefore have missed some visits at which no
laboratory test was performed. On the other hand, visits were grouped into care episodes to negate the
effect of repeated laboratory measures within short time intervals.
As analysis of our survey data has shown, different factors are associated with irregular attendance and
with stopping clinic attendance altogether. Although this is a limitation of measuring a cumulative effect
of EIC, the EIC algorithm allows for the fact that patients may move between attendance patterns over
time, as described in our qualitative data. We have developed a new concept of how to measure EIC by
incorporating a time-updated measure of patients’ treatment and health status that adds to the options
available for measuring this key performance indicator.
We used the EIC algorithm in group-based trajectory analysis to explore patterns of engagement in HIV
care over time. This method of analysis is applied to cohort data to identify groups of individuals following
a similar progression in a behaviour or outcome of interest over age or time. Since its early use for
monitoring antisocial behaviour in boys as they grew older,39 its applications have included patterns of
sexual risk behaviour among participants in the National Longitudinal Survey of Youth,72 diaphragm use
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among South African and Zimbabwean women taking part in a clinical trial73 and adherence to ART
among patients in the Swiss HIV Cohort Study.42 The last, for example, identified four groups whose
adherence could be characterised as good (51.8%), worsening (17.4%), improving (17.6%) or poor
(13.2%). Our analysis identified four attendance patterns whereby the first consisted of the majority
of patients who were consistently engaged in care, then two groups who experienced a decline in
attendance at different points on the trajectories and a fourth group who appeared to drop out before
gradually returning to care. These groups were relatively consistent for patients who had been diagnosed
in each of the three diagnosis periods that we examined (2000–2, 2003–5 and 2006–8).
Whereas the Swiss HIV Cohort Study42 limited its analysis to the 4.5-year period when adherence data
were collected from questionnaires, there was no set time delineation for our analysis of UK CHIC data.
Assuming that patients were vulnerable to dropping out of care soon after diagnosis8 and more likely
to disengage from care the longer they had been diagnosed,22 we grouped patients into three 3-year
diagnosis periods. Grouping around 6000 patients into four trajectories is a necessarily broad-brush
attempt to characterise how HIV patients engage in care over time. However, the consistency between the
trajectories for the three different diagnosis groups lends credibility to the findings.
We selected a four-trajectory solution, based on the interpretability of the plots. The first and largest group
engages consistently in care, whereas the last group appears to drop out of care and then return after
about 4–6 years. It is more difficult to describe and understand what is happening to the remaining two
groups. Furthermore, it would be useful to know what factors are associated with the points at which
the trajectories change direction but difficult to conceptualise such an analysis. Given this degree of
uncertainty about the meaning of the findings from the group-based trajectory analysis, we considered
the proportion of time that patients were engaged in care to be a better and more flexible measure for
exploring predictive factors for disengagement.
Objective 2: predictive factors of disengagement
Using the EIC algorithm showed that patients were engaged in care for 83.9% of months over the
follow-up period of up to 13 years. Our findings are consistent with previous studies among UK populations
in showing that disengagement from HIV care is more likely among women and less likely among MSM.8,22
A study of gender disparities concluded that poorer engagement in HIV care by women was underpinned
by a complex array of factors,74 and findings from both our survey and analysis of UK CHIC data suggested
that the association between gender and disengagement could be explained by other factors.
There was strong evidence from both of our data sources that younger patients were more likely to
disengage from care and other studies have also found an association between younger age and
disengagement from care.8,21,28 Patients who were not currently on ART were more likely to disengage
according to both survey and cohort data and in keeping with other research.21 Although our survey
suggested that PLWH were increasingly likely to disengage from care the longer they had been diagnosed,
this pattern was not found in the analysis of UK CHIC data.
There are many advantages to using cohort data,25 such as the associated years of follow-up, statistical
power and representative patient populations. We have included a description of the limitations of using
cohort data above. In addition, our analysis of predictive factors was restricted to the limited number of
background factors available in the UK CHIC data set to predict disengagement from care. Our survey
provided a much richer source of data for this purpose and its advantages and limitations will be discussed
below under Objective 4: retention risk tool and Objective 5: factors influencing outpatient attendance.
Our study furthermore benefits from using multiple data sources and the triangulation of our findings.
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Objective 3: health and financial costs of disengaging from care
Health costs of disengagement
We examined the association between EIC and mortality, adjusting for CD4 count to see if differences
were being mediated by differences in CD4 count profiles. There were 2279 deaths in the cohort and the
analysis showed that each 10% increment in EIC was associated with a 9% reduction in the risk of
mortality. This remained fairly constant when we adjusted for fixed covariates but, importantly, when we
adjusted for the CD4 count at the time and over follow-up, the association was attenuated completely
to 1. The results were consistent when we included AIDS or death as the outcome measure, suggesting
that patients with poor EIC tended to experience poorer outcomes because their CD4 counts were
generally lower.
Next we restricted the analysis to patients who had started ART. The analysis showed that around 40%
were engaged in care for 90–100% of the time. As the proportion of EIC increased, more MSM and
people of white ethnicity were represented among these groups. As we would expect, patients with
higher engagement had a higher CD4 count on average and, as a reflection, were more likely to start a
non-nucleoside as opposed to a PI.
The association with mortality was equally strong for this group, even though they were on treatment, with
a very strong association between EIC before starting treatment and mortality after starting treatment. This
was affected only minimally by adjustment for fixed covariates, but when we controlled for the CD4 count
and viral load, the effect moved towards 1 and became non-significant. This confirmed that people with
poor EIC generally not only have lower CD4 counts at the time of starting treatment but have poorer CD4
count and viral load responses after starting treatment.
Our analysis indicated that higher EIC is associated with improved clinical outcomes, even when looking at
least 1 year into the future and when we consider a subgroup of patients who are already in care and who
start treatment, a group that we would think would be at relatively low risk of mortality. On the whole,
clinical outcomes were largely explained by poorer CD4 count profiles in those with suboptimal EIC.
Although this analysis is subject to the limitations of the EIC algorithm, as described earlier, it benefits from
the advantages of using the extensive UK CHIC data set to explore the health costs of disengaging from HIV
care. Although death and AIDS diagnoses occur infrequently in the population, we have found a strong
association with disengaging from care. The analysis is also complicated by the fact that these negative
outcomes are associated with high levels of engagement in the period leading up to the event when
patients attend services because they are unwell. We have accounted for this by looking at EIC before
starting ART and death after starting ART in order to avoid contamination of this ‘reverse causality’ effect.
Association between test costs and disengagement from care
Our analysis of financial costs was limited by available data in UK CHIC on NHS resource use, and hence
we focused on laboratory test costs. Given the limitations of the data, our analysis was descriptive. There
was some suggestion that people in the most engaged groups had more tests per patient in each quarter,
and therefore higher test costs and that those who are least engaged seem to have fewer tests and lower
test costs but the differences are small. There does not seem to be any appreciable crossover in test costs
between pre-ART EIC groups in later quarters as their health declines.
Further research focusing on a wider range of NHS resource use would be beneficial, including clinical
appointment costs, medication costs and costs of hospital stays. This requires a data set with detailed
information on NHS resource use associated with each of these items plus measures of EIC. A more
sophisticated analysis would take a wider costing perspective, such as a societal perspective, which would
also consider costs of disengaging from care on patients and families, business and costs to social services
and other parts of the public sector. When considering impacts on patients and families, this should
account for the possibility that, on the one hand, engaging in care might increase time and travel costs to
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patients and families (e.g. taking time off work to attend clinics, travelling to and from clinics), but, on the
other hand, may also reduce costs to patients and families by avoiding deteriorations in health.
As well as evaluating the costs of disengaging with care, further research would also be beneficial to
evaluate the cost-effectiveness of interventions to improve EIC, such as the interventions described in
Chapter 7. Economic evaluation of interventions such as this should account for:
l the cost of the interventions
l the impact of the interventions on EIC
l the impact of engaging in care on health outcomes (both in terms of mortality and health-related
quality of life)
l the impact of engaging in care on costs associated with illness, from both NHS and wider
societal perspectives.
As noted above, evaluation of the interventions on mortality, health-related quality of life and NHS and
other costs should appropriately account for biases caused by ‘reverse causality’.
Objective 4: retention risk tool
The retention risk tool was developed to help clinicians identify newly diagnosed patients who are at risk
of disengaging from care. From the outset of the study, it was agreed that this part of the study was not
funded to be a tested electronic tool but would take the form of an algorithm or equation, summarising
the key variables and their contribution to risk retention. We found that a combination of six variables
from the REACH survey and clinical data set provided the best set of predictive variables. These were age
at diagnosis, having children, recreational drug use in the past 5 years, drug/alcohol dependency in the
past year, money for basic needs and use of public transport to get to the clinic. The AUROC curve for this
model was 0.707, which is fair. Other tools developed for use in sexual health have achieved similar levels
of performance in, for example, identifying patients at risk for chlamydia and/or gonorrhoea (AUROC
curve = 0.74)64 and identifying MSM at risk for HIV acquisition (AUROC curve = 0.67).75
It was suggested that having children may be more likely to affect attendance among women than men
and, indeed, the gender variable was excluded from the model when having children was introduced.
However, univariable analysis indicated that there was a significant effect for being a mother or a father
compared with having no children and this variable did not provide any additional explanatory value when
incorporated into the model instead of the binary variable.
The original plan had been to use UK CHIC data to develop this tool. The size of the data set would have
enabled the use of cross-validation methods to generate estimates of the AUROC curve and pseudo-R2 and
to provide a measure of internal validity. Although the UK CHIC data set is rich in longitudinal clinical data
from the point of diagnosis, other variables for potential use in the tool are limited to age, gender, ethnic
group, route of acquisition, country of birth and laboratory data at the point of diagnosis. The survey
provides an extensive data set of additional explanatory variables for identifying patients at risk of
disengaging from care. It was not, however, powered to be divided for comparison of subgroups in order
to validate the tool internally. Although it is also possible that different sets of predictive variables may
apply to different groups of individuals, such as men and women, the survey was similarly not powered for
such analysis.
Our survey was neither longitudinal nor prospective and this is a limitation to using these data for developing
a retention risk tool for newly diagnosed patients. In order to develop our tool, it was necessary to exclude
variables from the analysis that would have occurred after or as a result of HIV diagnosis. As the survey
respondents had already disengaged from care when they took part in the study, it remains possible that the
tool may not be predictive of disengagement at the point of diagnosis. Although we have been able to test a
DISCUSSION AND CONCLUSIONS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
100
broad set of factors associated with disengagement from HIV care for use in our tool, it will be important to
test its external validity among newly diagnosed patients in order to examine its predictive value.
It should also be noted that our retention tool was developed using data from patients attending HIV
clinics in London. It is possible that barriers to engagement in HIV care may differ across the UK. Although
the qualitative study on non-attendance of HIV clinics in Scotland highlighted similar key factors to those
that we found among patients attending HIV clinics in London,37 use of public transport and issues of
getting to the clinic may be different outside the capital and require testing outside London.
Clinicians have expressed great interest in the tool. If successful, it would be a very valuable way of
identifying people who may be at risk of disengaging from care, thereby triggering further action within
the clinic.
Objective 5: factors influencing outpatient attendance
Before looking at the factors associated with outpatient attendance, it is important to consider the
experiences and circumstances across the population of HIV patients who took part in our survey. The data
indicate that, in addition to managing their physical health, many HIV patients are faced with social and
psychological issues that may, at some point, overwhelm them and/or take priority over their health care.
Over a half of our sample did not always have enough money for basic needs (57%), one-fifth reported
moderate or severe hunger (19.3%) and one-fifth were currently unemployed (22%). Two-fifths reported
feelings of self-stigma (44%) and one-third had been diagnosed with depression (32%). One-fifth had
been recently abused by or afraid of a partner (21%) and nearly one-fifth reported low social support
(17%). This indicates high support needs across the population and the importance of constant vigilance
to ensure that patients do not fall out of care with changing needs and circumstances.
The data from the phases 2 and 3 of the study, which incorporated the quantitative and qualitative
examination of patient experience and the key informant study, were highly consistent in their identification
of the factors that influence outpatient attendance. This triangulation of the findings from our survey of
almost 1000 HIV patients, interviews with 33 patients, two FGs and 19 key informant interviews provides a
strong measure of validation. Questions included in our investigation of patient experience and key informant
interviews were based on the COM-B model, which proposes that behaviour is the outcome of an interaction
between an individual’s capability, opportunity and motivation.45 Our primary data collection aimed to
understand the factors associated with capability, opportunity and motivation to engage in HIV care in order
to develop interventions to address these issues and improve outpatient HIV attendance.
Capability to attend was more often associated with irregular attendance and missed appointments rather
than dropping out of care altogether. Feeling or being unwell could stop patients from attending their
appointments. On the other hand, when patients were very unwell, this could bring them back into care
after a period of disengagement. Patients often forgot their appointments and this may be associated with
neurocognitive impairment. It may also be associated with stigma and wanting to put HIV to the back of
their minds, illustrating how the components of the COM-B model work together to influence outpatient
attendance. Engagement in HIV care and adherence to ART have been associated with alcohol and drug
use,21,31,76,77 and our findings also indicated that use of alcohol and recreational drugs were associated with
disengagement from care. We also found that knowledge about HIV was very powerful in giving patients
the capability to tackle self-stigma and prioritise their health.
Patients needed to have the motivation to attend clinic and depression consistently came up as a factor
that stopped people from feeling able to come to the clinic. This is supported by our findings that poorer
engagement was associated with low self-efficacy and feelings of not being in control of life. Previous
research has found that real and perceived stigma can seriously undermine access to HIV care and other
support services.32,34,35 We found that stigma had a strong impact on attendance and the findings suggest
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that the necessary conditions for dropping out of care were underpinned by self-stigma. Symptoms of
psychological distress are highly prevalent among PLWH and have also been associated with poorer
adherence to ART.78 Although the scores from the MARS may not be directly comparable to those from
studies using the complete validated scale with framing statements, our data indicated a clear association
between not adhering to ART and not coming to the clinic. Some patients did not want their clinician to
know that they had been having difficulties with adherence that could delay their clinic attendance and
drift into long periods of disengagement. Similarly, a paternalistic approach to patients was found to be a
barrier to care.79
Opportunity to enact behaviour is shaped by the social environment, and the actual or expected interaction
with clinic staff had an impact on attendance, as described above in relation to adherence to ART. Patients
want to feel that staff are listening to them80 and our findings reflect previous research indicating that HIV
patients were less likely to miss appointments when care was patient centred and they were known as
individuals.81 Many of the patients who took part in the REACH study reported excellent relationships with
their clinicians and a sense of belonging at their clinic, which could provide strong motivation to attend.
However, the fear of being seen at the clinic and people finding out that you have HIV remained a
powerful disincentive for attending among some patients.
Peer support could have a very positive effect on EIC, helping people to address stigma and providing role
models, emotional support and the opportunity to exchange ideas with other PLWH. Many people praised
the courses for newly diagnosed patients that they had attended. Although partners could also provide a
strong source of social support, we found that partners could also have a negative effect on attendance by
undermining patients’ confidence. Previous research has found that intimate partner violence is associated
with missed HIV appointments.82
Financial difficulties were highlighted as one of the key barriers to attendance. Other barriers, including
lack of child care and work responsibilities, were often raised and, although the effects of homelessness or
immigration issues were less prevalent, they had a clear and direct impact on EIC for some people. In
common with other work, service providers in our study were concerned that immigration issues could
adversely impact attendance.83 Our findings support the proposition that PLWH who are burdened with a
range of socioeconomic problems are less likely to prioritise their HIV care.84
Our qualitative research suggested an overlap between missing appointments and dropping out of care that
bears some similarity to a cyclical process of attendance and non-attendance found in other qualitative
research.85 However, our survey found some differences between people who had missed appointments in
the past year and those who had recently dropped out of care altogether. The survey indicated that younger
patients, those who had been diagnosed for longer, those with children and with drug and/or alcohol issues
were likely to both miss appointments and disengage from HIV care altogether. IAs were also more likely
to report symptoms of neurocognitive impairment and ill health which may be associated with missing
appointments, whereas NAs were less likely to be registered with a GP, to be a homeowner or to feel that
the nurse listened to them at their last clinic visit. Furthermore, NAs were more likely to cite reasons
associated with motivation for missing appointments. It is possible that some of the reasons provided are
capturing the same underlying causes and a multivariate analysis might identify underlying dimensions. In
terms of improving EIC, our qualitative data indicate that these differences should be interpreted cautiously,
and the support needs of patients at risk of disengagement should be assessed individually.
The same factors were consistently highlighted as associated with EIC across our different data sources.
These factors were similar to the emerging findings from the Antiretrovirals, Sexual Transmission Risk and
Attitudes (ASTRA) study (presented at the Conference on Retroviruses and Opportunistic Infections 2015),
which showed that virological rebound was associated with increasing financial hardship, non-employment,
non-homeownership, non-university education and low social support. This suggests that our difficulties
with recruiting NAs did not adversely affect our results. It should be noted, however, that our final survey
sample of NAs (n = 164) was two-thirds of the size originally planned, which may have limited our ability to
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detect statistical differences between RAs and NAs. In addition, our sample of NAs had all returned to care,
which may impact on their responses to our survey and colour their perceptions and reflections when
talking about their experiences of disengaging from care. Our finding that 45% of NAs had an undetectable
viral load suggests that they do not form a cohesive group, but one that is made up of a variety of patients
including stable patients and elite controllers (who may only be expected to attend clinic once a year);
patients who have been back in care after a period of LTFU but are now on ART and undetectable; as well
as those who have very recently returned to care and are not virologically suppressed. It was always
understood, however, that recruiting this group of patients would be challenging and, despite this, we
managed to achieve a sample that was large enough to be used in analysis.
In addition, the FG for non-African men and women had to be cancelled because no one volunteered
to take part. However, experiences of heterosexual non-African men and women were collected from
10 individuals who took part in in-depth interviews. We also found that the FGs did not lend themselves to
discussion between the participants because participants were keen to take turns to relate their individual
stories and experiences rather than discuss issues among themselves. The data were therefore more similar
to interview data and integrated well into the qualitative data set. Framework was a useful analytical
approach for organising and reducing our extensive data set, while retaining a close link to the original
data and the capacity to consider the relationship between both themes and participants.66 We changed
our sampling strategy to ensure that patients’ attendance patterns were categorised according to current
or recent behaviour. As described earlier, the fact that our data were not collected prospectively may bias
our survey results to the extent that patients respond differently in the light of their previous experiences of
irregular or non-attendance. The findings from our qualitative research may also reflect the fact that most
of the participants were not currently working and may represent a certain subselection of the patient
population. Faith is furthermore an important part of life for many black Africans,86 which did not come up
a great deal in our interviews but might bear further examination.
It is also important to note that our quantitative and qualitative data were wholly collected in London.
Although it is possible that the factors that we have identified as driving disengagement from HIV care
may be different outside London, it is reassuring that the findings from the analysis of our primary data are
similar to those from our analysis of UK CHIC data, and are also congruent with the findings from the
ASTRA study, which included study sites across the UK.
Our findings have shaped the development of the intervention models that follow. They can also help
clinicians to define roles within the service and identify where they need to target their attention in order
to improve engagement in outpatient HIV services and meet the quality performance targets set by the
British HIV Association standards.
Objective 6: intervention models to improve engagement in care
Supported by data from REACH, we put together four interventions that aim to address the needs of
people who have disengaged from care or who are at risk of doing so. It will be important to formally test
the interventions in clinics based both in London and outside London to determine their acceptability and
feasibility, and assess their ability to improve engagement in HIV care in different contexts.
The evidence from our qualitative research highlighted the importance of peer support. Our first intervention
comprises structured peer involvement that is targeted at PLWH who are at high risk of disengaging from
care. This is the most expensive intervention although costs will vary depending on need. In addition to
the peer element of the intervention that is vital, the individual nature of the intervention reflects the no
one-size-fits-all finding of our study while providing a clear structure to enable the effects of the intervention
to be evaluated. A number of studies in other HIV settings have found that patients benefit from peer
support,87–89 and the evidence in the UK so far has been promising but limited in scale.90
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Our second intervention addresses the diverse needs of patients by providing a ‘one-stop-shop’ where they
can see different members of the MDT at the same visit. The evidence from REACH indicates that patients
have high needs for social and psychological support. Poverty and poor mental health were prevalent
among those that took part in our study, and even more so among those who disengaged from care.
Putting the various elements of support together in one clinic enables patients who may not prioritise their
health care to benefit from a holistic approach to their overall well-being and facilitates access to social,
psychological and peer support.
One-fifth of NAs in our survey said that they sometimes or often missed appointments because they were
afraid to be seen at the clinic and the qualitative research found a connection between wanting to block
out HIV to disengaging from care. As our survey was conducted among people who are currently
attending the clinic, this suggests that the problem could be even more severe among the population of
PLWH as a whole. Our third intervention was aimed at this group of people who may prefer to attend a
clinic at an alternative venue, including those who would prefer not to take their children into a sexual
health or HIV clinic. Although such clinics are aimed at circumventing the self-stigma that patients currently
experience, they also provide a link back to the HIV clinic. They do, however, raise the issue of whether
their implementation will lead to more or less stigma in the long run.
The fourth intervention that we have costed is based on successful intervention that was implemented in
the USA.71 It is the only intervention that is not targeted at people who have disengaged from care or are
at risk of doing so. Although the US study found that the benefits across HIV patient population were
modest, there was a much greater effect among new or re-engaging patients than among active patients,
and among younger compared with older patients. The cost of the intervention makes it an attractive
option should it be similarly successful in the UK. Our findings have indicated that there is room for
improvement in communication between health-care staff and patients that this intervention would aim
to address.
The costs of the four interventions range from £2 to £538 per patient included in the intervention. There
are several caveats that should be borne in mind when considering these estimated figures. First, there is
considerable uncertainty with these estimates as they have not yet been subject to empirical testing;
further work is needed to evaluate the actual costs under both research and real-world conditions. Second,
caution should be taken when comparing between the interventions based on their costs alone, as such a
comparison does not take into account potential differential effects between the interventions. For example,
it may be the case that more expensive interventions are also more effective at improving engagement.
Third, our analysis considers the potential intervention costs for a range of possible interventions for
improving EIC. A full cost analysis would include not just the costs of the interventions but also their
impact on subsequent health and social care costs; for example, impact on treatment costs due to better
engagement with care. These costs should be included in a full economic evaluation of the interventions.
In addition to the above selection, our data suggest other interventions that would benefit from detailed
economic evaluation. For example, the use of various technological and innovative solutions may not only
reduce missed appointments but, if adopted among more stable patients, could make resources available
to redistribute for the support of patients who require more intensive care.
Practice implications
Findings from this research indicate that the HIV specialist outpatient clinic provides valued patient-centred
care for the majority of service users. Despite this, however, significant barriers to optimal engagement and
outcomes exist for a high proportion of clinic attendees. Clinics linked with mental health services, drug
and alcohol support, social and outreach services and peer support will be best placed to address these
diverse challenges.
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In keeping with other studies, health outcomes were poorer in IAs, as well as those experiencing a period
of disengagement. Clinical practice would benefit from information technology systems to monitor
engagement in real time, enabling timely intervention where needed.
Patient and public involvement
The REACH project has fundamentally been about listening to PLWH with the aim of adapting services to
better meet their needs. At the same time, we have found the additional perspectives of community
representation to be invaluable in the design and implementation of our research. The project has also
benefited from the inclusion of participants who were recruited via community contacts: Memory
Sachikonye, a collaborator on this study, is co-ordinator at the UK-CAB, a network for community HIV
treatment advocates across the UK. She was responsible for recruiting FG participants and the discussion
that occurred in our FGs suggested that recruiting people in this way may have enabled PLWH to talk
more openly about their experiences with clinic staff.
Our findings will be fed back to service user groups and patients at participating clinics over the coming
months and a summary of the findings has been published on www.aidsmap.com an online information
resource which creates and disseminates information rooted in the experience of those most affected by
HIV and AIDS.
Summary of limitations
Our analyses using UK CHIC were limited by the data available within the data set. The EIC algorithm is,
thereby, an approximation of a complex clinical decision that does not account for time LTFU after a
patient’s last visit. Our examination of the financial costs of disengagement necessarily focused on the
costs of laboratory tests.
Developing the retention risk tool for newly diagnosed patients using the rich REACH survey data set
instead of UK CHIC data meant that we needed to make certain assumptions about which variables to
include in the analysis and were unable to test its external validity.
Primary quantitative and qualitative data were collected from patients using HIV clinics in London and from
London-based providers. Although the findings are consistent with those from UK-wide studies, the factors
and interventions that we have identified may not equally apply to clinic populations outside London.
The costs that we have calculated for our proposed interventions have not been tested and all models
require a full economic evaluation to incorporate their potential impacts into the costs.
Conclusions
The REACH study has shown the adverse health impacts of disengaging from HIV care. Our findings have
indicated that particular factors are associated with disengaging from care and we have developed a
retention risk tool that could help clinicians to identify those most at risk of suboptimal EIC and to intervene
accordingly. We recommend that the predictive power of this tool is tested across different clinic
populations and settings. We believe this to be of particular importance given that there is presently no
proven method for clinicians to identify which newly diagnosed PLWH are most at risk of disengaging from
care and thereby take preventative measures. Our findings have demonstrated the importance of the wider
health and social context in being able to manage HIV effectively and suggest that interventions need to
address broader issues that impact on health-care utilisation. We have developed two complex interventions
that seek to do this under the current financial constraints by providing holistic approaches that benefit
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from the strengths of peer support and aim to manage the multiple psychological, social and economic
issues which deter optimal engagement in HIV care. We have developed a third intervention which
provides an alternative clinic setting for people who are particularly concerned about disclosure of their HIV
status and our fourth intervention uses co-ordinated messaging to encourage attendance and improve
communication with patients. We recommend conducting robust clinical trials of these interventions that
incorporate full health and economic evaluation.
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Dr Leena Sathia Ian Charleson Day Centre, Royal Free Hospital.
Dr Ann Sullivan, Dr Tristan Barber: Kobler Day Care Unit, Chelsea and Westminster Hospital.
Ms Sophie Strachan: Positively UK.
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Mr Paul Clift: King’s College Hospital NHS Foundation Trust/UK-CAB.
Professor Paul Flowers: Glasgow Caledonian University.
Professor Jonathan Sterne: University of Bristol.
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Appendix 2 REACH questionnaire
 
  REACH 
 
 
 
 
Thank you for agreeing to complete this confidential survey.  Please answer all 
the questions as fully as you can.  You are free to leave out any question 
you do not want to answer. 
 
Please do NOT write your name or clinic number on this survey.  Your 
answers will NOT be seen by doctors and nurses in the clinic, and your 
answers will NEVER be recorded in your clinic notes. 
 
If you have any questions or need any help, please ask the person who gave 
you this survey.
 
Please place your completed survey in the envelope, seal the envelope and 
give it back to the staff member who gave it to you. 
 
Thank you for your help! 
 
 
Date: ____ / ____ / ____ 
 
Unique study number: _________________________ 
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 SECTION A: GENERAL INFORMATION 
 
 
 
A1. Are you: 
 
 
 Male  Female 
 Transgender male  Transgender female 
 
 
 
A2. What is your date of birth? 
 
 
Month: _____________________ Year: _______________________ 
 
 
 
A3. What is your ethnic group?  Choose one section from A to E,  
         then tick one box to best describe your ethnic group or background 
 
 
A White 
 English / Welsh / Scottish / 
    Northern Irish / British 
 Irish 
 Gypsy or Irish Traveller 
 Any other White background 
 
B Mixed / multiple ethnic groups 
 White and Black Caribbean 
 White and Black African 
 White and Asian 
 Any other mixed / multiple 
    ethnic background 
 
C Asian / Asian British 
 Indian 
 Pakistani 
 Bangladeshi 
 Chinese 
 Any other Asian background 
 
D Black / African / Caribbean /  
    Black British 
 African 
 Caribbean 
 Any other Black / African /  
    Caribbean background 
 
E Other ethnic group 
 Arab 
 Hispanic / Latino 
 Any other ethnic group 
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A4. Were you born in the UK? 
 
 
 Yes       IF YES, PLEASE GO TO QUESTION A5 
 No 
 
    If NO, which country were you born in? ________________________ 
 
 
    In which year did you first arrive in the UK? ____________________ 
 
 
    What is your immigration status in the UK? 
 
 British citizen  Student visa 
 Citizen of another European Union 
    country 
 Refugee / seeking asylum 
 Right to stay for an indefinite amount of 
     time (Indefinite Leave to Remain - ILR) 
 No papers to be in the UK 
 Right to stay for a fixed amount of time 
     (Exceptional Leave to Remain – ELR) 
 Work permit 
 Other 
 
 
 
A5. What is your main language? 
 
 
 English 
 Other (please write in):  __________________________ 
 
 
 
A6. Are you currently in an ongoing relationship with a partner 
         (wife / husband or civil partner or girlfriend / boyfriend)? 
 
 
 No, I am not currently in an ongoing relationship with a partner 
                  IF NO, PLEASE GO TO QUESTION A7 
 Yes, I am in a relationship and living with my partner 
 Yes, I am in a relationship but not living with my partner 
 
    If YES, how long have you been in this relationship? (please write in) 
 
    Years: __________________ Months:________________ 
 
    If YES, does your partner have HIV? 
 
 Yes  No  Don’t know / unsure 
 
DOI: 10.3310/hsdr05130 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Howarth et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
121
 A7. Do you have any children from current or previous  
         relationships? 
 
 
 Yes  No 
 
    If YES, how many children do you have? 
 
 
 
A8. FOR WOMEN ONLY: are you currently pregnant? 
 
 
 Yes  No  Don’t know / unsure 
 
 
 
A9. FOR WOMEN ONLY: have you had a baby in the last 12  
         months? 
 
 
 Yes  No 
 
 
 
A10. What is your current work situation? 
 
 
 Employed or self-employed FULL-TIME (at least 30 hours per week) 
 Employed or self-employed PART-TIME (less than 30 hours per week) 
 Full-time student / education / training 
 Unemployed and registered for benefits 
 Unemployed, NOT registered for benefits 
 Permanently sick / disabled (for 3 months or more) 
 Temporarily sick / disabled (for less than 3 months) 
 Looking after home / family / dependents full-time 
 Retired 
 Other (please specify): _____________________________________ 
 
 
 
A11. How many years in full-time education have you had since 
         you were 16? 
 
 
 None 
 Up to 2 years 
 3 years or more 
 1  2  3 or more 
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 A12. What is your religion? 
 
 
 No religion       PLEASE GO TO QUESTION A13   
 Christian  Buddhist 
 Hindu   Jewish 
 Muslim  Sikh 
  Any other religion 
 
    How important is religion in your life?   Very 
  Somewhat 
  Not very 
  Not at all 
 
 
 
A13. Which of the following options best describes how you think 
         of yourself? 
 
 
 Heterosexual or straight      PLEASE GO TO QUESTION A14 
 Gay or lesbian 
 Bisexual 
 Other 
 Prefer not to say 
 
    How open are you about your sexuality?  Completely open 
  Open to most people 
  Open to some people 
  Not open 
 
 
 
A14. Do you currently have enough money to cover your basic 
         needs (eg food, clothes, heating, accommodation)? 
 
 
 All of the time 
 Most of the time 
 Some of the time 
 No 
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 A15. Which of the following describes your current  
         accommodation? (please tick all that apply) 
 
 
 Own my own home (including mortgage / loan / shared ownership) 
 
Renting  
 Renting from the council / a housing association 
 Renting from a private landlord 
 Rent paid by housing benefit 
 
 Temporary accommodation (eg hostel, shelter, bed & breakfast) 
 Staying with partner / friend(s) / family 
 Homeless       PLEASE GO TO QUESTION A16 
 Other 
 
    How long have you lived or stayed in your current accommodation? 
 
 Less than 6 months 
 6 months to 1 year 
 1 to 5 years 
 5 years or more 
 
    What is your postcode? (please write in):    _________________  
 
 
 
A16. Thinking back over the past FOUR weeks  
 
 
   was there ever no food to eat of any kind in your house because  
       of lack of resources (eg money, vouchers etc)? 
 
 Never  Sometimes  Often  Rather not say 
 
   did you go to sleep at night hungry because there was not   
       enough food? 
 
 Never  Sometimes  Often  Rather not say 
 
   did you go a whole night and day without eating anything at all  
       because there was not enough food? 
 
 Never  Sometimes  Often  Rather not say 
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 SECTION B: LIFE WITH HIV 
 
 
 
B1. When did you first find out you were HIV positive? 
 
 
If you are unsure of the month, please give the year only: 
 
Month: __________________  Year: ________________ 
 
 
 
B2. FOR WOMEN ONLY: did you find out you were HIV positive  
         during pregnancy? 
 
 
 Yes  No 
 
 
 
B3. Where were you first diagnosed with HIV? 
 
 
 GP / family doctor  While donating blood 
 Doctor in private practice  Community venue 
 Sexual health clinic  Used a home testing / sampling kit 
 Antenatal clinic  HIV testing service 
 Hospital as an in-patient  Prison 
  Elsewhere 
 
 
 
B4. At your last test, what was your CD4 count? 
 
 
 Less than 200 
 200 - 350 
 351 - 500 
 More than 500 
 Don’t know / can’t remember 
 
 
 
B5. At your last test, was your viral load undetectable? 
 
 
 Yes  No  Don’t know / can’t remember 
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 B6. Does your HIV affect your day-to-day activities? 
 
 
 No  Yes, a little  Yes, a lot 
 
 
 
B7. Apart from health care staff, have you told anyone that you 
         have HIV? 
 
 
 Yes  No      IF NO, PLEASE GO TO QUESTION B8 
 
   If YES, who have you told that you have HIV? 
 
I have told my partner / wife / husband  Yes 
  No 
  Not applicable 
 
I have told other family members  Most or all 
(eg children, parents, brothers or sisters)  Some 
  None 
  Not applicable 
 
I have told my friends  Most or all 
  Some 
  None 
  Not applicable 
 
I have told my employer  Yes 
  No 
  Not applicable 
 
 
 
B8. In the last 12 months, have you experienced any of the following 
feelings because of your HIV status: 
       (please tick all that apply) 
 
 
 I feel ashamed  I feel guilty 
 I blame myself  I blame others 
 I have low self-esteem  I feel I should be punished 
 I feel suicidal  None of these 
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 B9. Please indicate your agreement with the following sentences: 
 
 
 Strongly disagree Disagree Uncertain Agree 
Strongly 
agree 
The demands of 
everyday life often get 
me down 
     
I am quite good at 
managing the many 
responsibilities of my 
daily life 
     
In general, I feel I am in 
charge of the situation in 
which I live 
     
 
 
 
B10. Do you look after or care for any children, family members, 
         neighbours or others? (do not count anything you do as part of  
         your paid employment) 
 
 
 Yes  No       IF NO, PLEASE GO TO QUESTION B11 
 
    If YES, how often have you missed your HIV clinic appointments 
    because you had to look after children, a family member, 
    neighbour or others? 
 
 Never  Rarely   Sometimes  Often 
 
 
 
B11. Within the last year, have you been humiliated or emotionally 
         abused in other ways by your partner or your ex-partner? 
 
 
 No  Yes   Prefer not to say  Not applicable 
 
 
 
B12. Within the last year, have you been afraid of your partner or  
         ex-partner? 
 
 
 No  Yes   Prefer not to say  Not applicable 
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 B13. Here is a list of some things that other people do or use that 
         may be helpful or supportive.  Please tick the column that is 
         closest to your situation: 
 
 
 
As much 
as I 
would 
like 
Almost 
as much 
as I 
would 
like 
Some, 
but 
would 
like more 
Less 
than I 
would 
like 
Much 
less than 
I would 
like 
I have people who 
care what happens to 
me 
     
I get love and 
affection      
I get chances to talk to 
someone I trust about 
my personal problems 
     
I get invitations to go 
out and do things with 
other people 
     
I get help when I am 
sick in bed      
 
 
 
B14. Has anyone at an HIV clinic ever given you information about 
         support groups for people who have HIV? 
 
 
 Yes  No  Don’t know / can’t remember 
 
 
 
B15. Have you been to a support group for people who have HIV in  
         your local area? 
 
 
 Yes, more than once 
 Yes, but only once 
 No, but I would like to                                 PLEASE GO TO QUESTION B16 
 No, and I do not want to                             PLEASE GO TO QUESTION B16 
 I am not aware of a local support group     PLEASE GO TO QUESTION B16 
 
    If YES, have you found it helpful? 
 
 Yes, definitely  Yes, to some extent  No 
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 B16. Have you ever injected yourself with non-prescribed drugs or  
         other substances? 
 
 
 Yes  No       IF NO, PLEASE GO TO QUESTION B17 
 
    If YES, when was the last time you injected yourself with  
    non-prescribed drugs or other substances? 
 
 In the last 7 days 
 Between 7 days and 4 weeks ago 
 Between 4 weeks and 1 year ago 
 Between 1 year and 5 years ago 
 Longer than 5 years ago 
 
 
B17. In the last five years, have you taken any recreational drugs?  
         (this includes drugs such as heroin, cocaine, crystal meth, 
         amphetamines, marijuana or steroids, but does not include any drug  
         taken under a doctor’s instructions) 
 
 
 Yes  No       IF NO, PLEASE GO TO QUESTION C1 
 
    If YES, in the last 12 months, have you used  
    (please tick all that apply) 
 
 Crystal meth  Crack cocaine 
 Heroin  Ketamine 
 GBL   Mephedrone 
 Other 
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 SECTION C: YOUR HEALTH AND HEALTH CARE 
 
 
 
C1. Overall, how would you rate your health during the past 4  
         weeks? 
 
 
 Excellent  Very good  Good  Fair  Poor 
 
 
 
C2. Over the past 2 weeks, have you been bothered by these  
         problems? 
 
 
 Not at all Several days 
More days 
than not 
Nearly 
every day 
Feeling nervous, 
anxious or on edge     
Not being able to stop or 
control worrying     
Feeling down, 
depressed or hopeless     
Little interest or pleasure 
in doing things     
 
 
 
C3. In the last 12 months, have you received support from any of the 
following, to help you cope with your HIV? 
        (please tick all that apply) 
 
 
 Specialist HIV doctor  GP / family doctor 
 Specialist HIV nurse  Counsellor or psychologist 
 Psychiatrist   Health adviser 
 Community nurse  Patient representative  
 Social worker   Peer mentor  
 Telephone helpline  Other 
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 C4. Has the doctor ever told you that you have any of the following?  
(please tick all that apply) 
 
 
 Asthma (as an adult)   High blood pressure (hypertension)  
 Depression  Kidney failure 
 Diabetes (any type)   Stroke (any form) 
 Heart condition  Sickle cell anaemia 
 Hepatitis B  Tuberculosis (TB) 
 Hepatitis C  Neuropathy 
 Arthritis  None of these 
 
 
 
C5. Do you have a long-standing condition that causes you difficulty 
with accessing buildings, streets or vehicles? 
 
 
 Yes  No 
 
 
 
C6. Do you experience frequent memory loss (eg do you forget the 
occurrence of special events even the more recent ones, 
appointments etc)? 
 
 
 Never  Hardly ever  Yes, definitely 
 
 
 
C7. Do you feel that you are slower when reasoning, planning activities 
or solving problems? 
 
 
 Never  Hardly ever  Yes, definitely 
 
 
 
C8. Do you have difficulties paying attention (eg to a conversation, a 
book or a movie)? 
 
 
 Never  Hardly ever  Yes, definitely 
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 C9. Are you currently registered with a GP / family doctor in the 
       UK? 
 
 
 Yes  No        IF NO, PLEASE GO TO QUESTION C10 
 
    If YES, have you told your GP that you have HIV? 
 
 Yes  No 
 
 
 
C10. When was the last time you attended a GP’s surgery in the UK 
        (for your own health needs)? 
 
 
 In the last year 
 1 to 5 years ago 
 More than 5 years ago 
 I have never attended a GP’s surgery in the UK 
 Don’t know / can’t remember 
 
 
 
C11. Have you ever stayed in a hospital in the UK as an in-patient? 
 
 
 Yes  No        IF NO, PLEASE GO TO QUESTION C12 
 
    If YES, when was the last time you stayed in a hospital in the UK? 
 
 In the last 
     year 
 1 to 5 years 
     ago  
 More than 5 
     years ago 
 Don’t know /  
     can’t remember 
 
 
 
C12. Thinking about your health care, please indicate your degree 
         of agreement with the following sentences: 
 
 
 Strongly disagree Disagree Uncertain Agree 
Strongly 
agree 
I can figure out how and 
where to get the 
information I need 
     
I feel that I am in control 
over how and what I 
learn about my health 
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 SECTION D: YOUR HIV CARE 
 
 
 
D1. Since your HIV diagnosis, have there been any periods of a year or 
more when you have not seen a doctor about your HIV? 
 
 
 No 
 Yes 
 Don’t know / can’t remember 
 I have been diagnosed for less than a year 
 
 
 
D2. Since your HIV diagnosis, how often have you missed your 
appointments at the HIV clinic because you: 
 
 
 Never Rarely Sometimes Often 
Simply forgot     
Felt too sick or ill     
Felt too tired     
Felt depressed / overwhelmed     
Felt well     
Didn’t want to think about 
being HIV positive     
Didn’t have enough money     
Didn’t have transport     
Were afraid of being seen at 
the clinic     
Didn’t think a doctor could help     
Had not followed the doctor’s 
advice     
Had enough medication     
Couldn’t get time off work     
 
 
 
D3. Have you ever missed an appointment at the HIV clinic because of 
drinking alcohol? 
 
 Yes  No  Don’t know / can’t remember 
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 D4. Have you ever missed an appointment at the HIV clinic because of 
taking recreational drugs? 
 
 
 Yes  No  Don’t know / can’t remember 
 
 
 
D5. Since your HIV diagnosis, have you attended more than one HIV 
clinic in the UK? 
 
 
 Yes  No      IF NO, PLEASE GO TO QUESTION D6 
 
  If YES, how many HIV clinics have you attended in the UK? 
  (please write in):  
                    _______________________ 
 
 
 
 
 
 Thinking about the HIV clinic that you currently  
 attend  
 
 
 
D6. When did you last see a doctor or nurse at this clinic? 
 
 
 Today 
 In the last month 
 Between 1 and 6 months ago 
 Between 6 months and 1 year ago 
 Longer than 1 year ago 
 
 
 
D7. How long was the gap between the last time you saw a doctor or 
nurse at this clinic and the time before that? 
 
 
 1 month or less 
 Between 1 and 6 months 
 Between 6 months and 1 year 
 Longer than 1 year 
 I have not previously seen a doctor or nurse at this clinic 
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 D8. How long have you been receiving medical care at this HIV clinic? 
(please write in) 
 
 
Years: __________________ Months:________________ 
 
 
 
D9. In the last 12 months, how many appointments have you missed at 
this HIV clinic? 
 
 
Please write in:  ___________________ 
 
 
 
D10. How do you usually travel to the clinic?  Tick the box for the 
         longest part, by distance, of your usual journey to the HIV clinic: 
 
 
 Public transport   Hospital transport  
 Car   Bicycle 
 Motorcycle, scooter, moped   On foot 
 Taxi, minicab  Other 
 
 
 
D11. If you usually travel by car, have you ever had difficulty with   
         finding a parking space near the clinic? 
 
 
 Never 
 Rarely  
 Sometimes 
 Often 
 Not applicable 
 
 
 
D12. How long does it usually take you to get to the clinic? 
 
 
 Up to 30 minutes 
 30 – 60 minutes 
 1 – 2 hours 
 More than 2 hours 
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 D13. How convenient for you are the opening hours at the clinic? 
 
 
 Very convenient 
 Fairly convenient 
 Not very convenient 
 Not at all convenient 
 
 
 
D14. What additional opening hours would be convenient for you?   
         (please tick all that apply) 
 
 
 Early morning opening (Monday to Friday)  
 Evening opening (Monday to Friday) 
 Saturday opening  
 Sunday opening  
 Other (please specify): ___________________________________ 
 
 
 
D15. In the past, have you had consultations with a doctor or nurse 
         at this clinic using  (please tick all that apply) 
 
 
 Face-to-face communication  
 Telephone  
 SMS / text messaging 
 Email 
 Skype or other web-based communication 
 
 
 
D16. In the future, would you like to have consultations with a  
         doctor or nurse at this clinic using   (please tick all that apply) 
 
 
 Face-to-face communication  
 Telephone  
 SMS / text messaging 
 Email 
 Skype or other web-based communication 
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 D17. How often do you expect to have a routine consultation with a  
         doctor or nurse at this clinic? 
 
 
 Every month 
 Every 3 months 
 Every 4 months 
 Every 6 months 
 Every year 
 Other (please specify): ___________________________________ 
 
 
 
D18. How likely are you to recommend this HIV clinic to friends and  
         family if they needed similar care or treatment? 
 
 
 Extremely likely 
 Likely 
 Neither likely nor unlikely 
 Unlikely 
 Extremely unlikely 
 Don’t know 
 
 
 
D19. The last time you made an appointment at this HIV clinic, how 
         did you book your appointment? 
 
 
 In person  
 By telephone  
 By SMS / text message 
 By email 
 Online booking system 
 Don’t know / can’t remember      PLEASE GO TO QUESTION D20 
 
    How easy was it for you to book your last appointment at this clinic? 
 
 Very easy  Fairly easy  Not very easy  Not at all easy 
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  Thinking about the last time you came to see a doctor 
  or nurse at this clinic  
 
 
 
D20. Were the reception staff friendly and approachable? 
 
 
 Yes, 
     definitely 
 Yes, to some 
     extent 
 No  Don’t know /  
     can’t remember 
 
 
 
D21. Last time you came to see a doctor or nurse at this clinic  
 
 
 did you book an appointment before you came?  Yes   No 
 was it a routine consultation?     Yes   No 
 did you feel sick or ill?       Yes  No 
 
 
 
D22. Please indicate how important each of the following reasons 
  were for you the last time you came to see a doctor or nurse 
  at this clinic: 
 
 
 Very 
important 
Somewhat 
important 
Not at all 
important 
I wanted advice / information on 
my HIV    
I wanted advice / information on 
something other than my HIV    
I needed practical support (eg 
letter for housing, benefits etc)    
I needed more HIV medication     
 
 
D23. Did the doctor or nurse explain the reasons for any treatment 
         or action in a way that you could understand? 
 
 
 Yes, completely 
 Yes, to some extent 
 No 
 Did not need an explanation 
 No treatment or action was needed  
 Don’t know / can’t remember 
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  Thinking about the last time you saw a doctor at  
  this clinic  
 
 
 
D24. Was the doctor you saw friendly and approachable? 
 
 
 Yes, 
     definitely 
 Yes, to some 
     extent 
 No  Don’t know /  
     can’t remember 
 
 
 
D25. Did the doctor listen to what you had to say? 
 
 
 Yes, 
     definitely 
 Yes, to some 
     extent 
 No  Don’t know /  
     can’t remember 
 
 
 
D26. Did you have confidence and trust in the doctor? 
 
  
 Yes, 
     definitely 
 Yes, to some 
     extent 
 No  Don’t know /  
     can’t remember 
 
 
 
 Thinking about the last time you saw a nurse at  
  this clinic  
 
 
 
D27. Was the nurse you saw friendly and approachable? 
 
 
 Yes, 
     definitely 
 Yes, to some 
     extent 
 No  Don’t know /  
     can’t remember 
 
 
 
D28. Did the nurse listen to what you had to say? 
 
 
 Yes, 
     definitely 
 Yes, to some 
     extent 
 No  Don’t know /  
     can’t remember 
 
 
 
D29. Did you have confidence and trust in the nurse? 
 
  
 Yes, 
     definitely 
 Yes, to some 
     extent 
 No  Don’t know /  
     can’t remember 
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 SECTION E: MEDICINES 
 
 
 
E1. Please indicate your degree of agreement with the following 
sentences: 
 
 
 Strongly disagree Disagree Uncertain Agree 
Strongly 
agree 
Medicines help many 
people to live better 
lives 
     
Medicines help many 
people to live longer      
Doctors use too many 
medicines      
Natural remedies are 
safer than medicines      
Doctors place too much 
trust in medicines      
If doctors had more time 
with patients they would 
prescribe fewer 
medicines 
     
 
 
 
E2. Are you currently taking HIV medicine (HIV treatment /  
         antiretroviral therapy / HAART)? 
 
 
 Yes           IF YES, PLEASE GO TO SECTION F 
 No – but I have taken HIV medicine previously       IF NO, PLEASE GO 
      TO SECTION G  No – I have never taken HIV medicine 
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 SECTION F: FOR PEOPLE WHO ARE 
                      CURRENTLY TAKING HIV MEDICINE 
 
 
 
F1. Does your HIV clinic have an HIV medicine delivery service? 
         Some HIV clinics provide a service which delivers HIV medicine (HIV 
treatment / antiretroviral therapy / HAART) to a patient’s home, work 
place or a local business for collection      
 
 
 Yes - I am currently using it 
 Yes - I have used it but I am not currently using it 
 Yes - but I haven’t used it 
 No 
 Don’t know / can’t remember 
 
 
 
F2. Many people find a way of using their medicines which suits them.  
For each of the following statements, please tick the box which best 
applies to you: 
 
 
 Always Often Sometimes Rarely Never 
I forget to take them      
I alter the dose      
I stop taking them for a 
while      
I decide to miss out a 
dose      
I take less than 
instructed      
 
 
 
F3. During the past 7 days, on how many days have you missed taking 
any of your pills? 
 
 
 None  4 days 
 1 day  5 days 
 2 days  6 days 
 3 days  7 days 
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 F4. Thinking about taking HIV medicine, please indicate your degree of 
agreement with the following sentences: 
 
 
 Strongly disagree Disagree Uncertain Agree 
Strongly 
agree 
My health, at present, 
depends on these 
medicines 
     
My health in the future 
will depend on these 
medicines 
     
These medicines are my 
best hope for the future      
These medicines keep 
me alive      
Having to take these 
medicines worries me      
I sometimes worry about 
becoming too 
dependent on these 
medicines 
     
These medicines give 
me unpleasant side 
effects 
     
The taste of this 
medicine makes me feel 
unwell 
     
You have finished all the questions for you, please go 
to Section H 
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 SECTION G: FOR PEOPLE WHO ARE NOT  
                       CURRENTLY TAKING HIV MEDICINE 
 
 
 
G1. Has your doctor advised you to take HIV medicine? 
 
  
 Yes IF YES, PLEASE GO TO QUESTION G2 
 No IF NO, PLEASE GO TO SECTION H 
 
 
 
G2. If your doctor has advised you to take HIV medicine, how important 
were the following factors in deciding not to take HIV medicine at 
this time? 
 
 
 Very 
important 
Somewhat 
important 
Not at all 
important 
Side effects of medication    
Feeling depressed or overwhelmed    
Don’t want to think about being HIV 
positive    
Using alcohol or recreational drugs    
Don’t want anyone to see the 
medication    
Homelessness    
Taking alternative or complementary 
medicines    
Medication is too complicated to 
take    
Medication is harmful    
Information from friends or support 
groups    
Information from media (eg TV, 
newspapers, internet)    
DOI: 10.3310/hsdr05130 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Howarth et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
143
 
 SECTION H: Please use the space below for any  
 further comments or information that you feel may be 
 relevant to the survey 
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  REACH  
 
Thank you very much for completing this survey
 
Please seal the survey in the envelope provided and give it back to the staff 
member who gave it to you. 
 
Thank you 
 
Support, advice and information about living with HIV is available from: 
THT Direct  
10am to 8pm - Monday to Friday 
Information can also be found on the Terrence Higgins Trust website at: 
www.tht.org.uk 
 
This project is run by 
Research Department of Infection and Population Health 
University College London
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Appendix 3 Framework for REACH primary
research
COM-B system:
sources of behaviour
Theoretical domains
framework Constructs
Factors related to engagement in
HIV services requiring change
Opportunity: social Social influences:
interpersonal processes that
can change thoughts,
feelings, behaviours
Social norms, social
support, alienation,
modelling, power, group
identity, social pressure,
group conformity, social
comparisons, group norms,
intergroup conflict
l Living without support/in
isolation
l Rejection by faith-based
communities
l Communication with/trust in
medical practitioners
Opportunity: physical Environmental context and
resources: circumstances
that discourage or
encourage development of
skills and abilities,
independence, social
competence, adaptive
behaviour
Barriers and facilitators,
environmental stressors,
resources, organisational
culture/climate, salient
events/critical incidents,
person/environment
interaction
l Mental health services that
do not proactively support
individuals
l Services not connected to
other services
l Mobility of circumstances
l Long distances for short
appointments
l Transport costs/loss of earnings
l Support of employer
l Caring responsibility/child care
l Other conditions/ill health
Capability: physical Physical skills: ability
acquired through practice
Skills, skills development,
competence, ability,
practice, skill assessment
Capability:
psychological
Knowledge: awareness of
existence of something
Knowledge, procedural
knowledge, knowledge of
task environment
l Accuracy of information
about ART
l Not understanding system
l Understanding of information
l Negotiating booking systems
(language barriers/telephone
access)
Cognitive and interpersonal
skills: ability acquired
through practice
Skills, competence,
interpersonal skills, skills
development, ability,
practice, skill assessment
Memory, attention, decision
processes: ability to retain
info, focus selectively and
choose between alternatives
Decision-making, cognitive
overload/tiredness, memory,
attention, attention control
Behavioural regulation:
management or change of
objectively observed or
measured actions
Self-monitoring, breaking
habit, action planning
l Alcohol and drug use
Motivation: automatic Reinforcement: increasing
probability of response
through a given stimulus
Incentives, consequences,
reinforcement, rewards,
punishment, contingencies,
sanctions
Emotion: complex reaction
pattern to deal with
personally significant matter
or event
Fear, anxiety, affect, stress,
depression, positive/
negative affect, burn-out
l Shame/stigma
l Anxiety about loss of anonymity
l Impact of diagnosis during
pregnancy
l Anxiety about side effects
of ART
l Medication as reminder of
HIV status
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COM-B system:
sources of behaviour
Theoretical domains
framework Constructs
Factors related to engagement in
HIV services requiring change
Motivation: reflective Social/professional role and
identity: coherent set of
behaviours and displayed
personal qualities in social or
work setting
Social identity, group
identity, leadership,
professional identity,
professional role, identity,
professional boundaries,
professional confidence,
organisational commitment
Beliefs about capabilities:
acceptance of truth, reality
or validity about ability,
talent or facility
Self-confidence, perceived
competence, self-efficacy,
perceived behavioural
control, beliefs,
self-esteem, empowerment,
professional confidence
Optimism: confidence things
will happen for the best
or desired goals will be
attained
Optimism, pessimism,
unrealistic optimism,
identity
Intentions: conscious
decision to perform a
behaviour/resolve act in a
certain way
Stability of intentions,
stages of change model,
transtheoretical model/
stages of change
Goals: mental
representations of desired
outcomes/end states
Goal priority, goals (distal/
proximal), goal priority,
goal/target setting, goals
(autonomous/controlled),
action planning,
implementation intention
Beliefs about consequences:
acceptance of truth, reality,
validity of behaviour
outcomes in given situation
Consequences, beliefs,
outcome expectancies,
characteristics of outcome
expectancies, anticipated
regret, consequences
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Appendix 4 Patient interview screening questions
1. What is your gender? Are you male, female, transgender?
2. What is your date of birth?
3. Were you born with HIV?
4. When did you first find out you were HIV positive?
5. Are you currently taking HIV medicine (HIV treatment/ART/highly active ART)?
6. What is your ethnic group?
7. If black, are you black African, black Caribbean or any other black background?
8. Which country were you born in?
9. (Men only) I’m going to read out a list of terms people sometimes use to describe how they think
of themselves:
i. heterosexual or straight
ii. gay or lesbian
iii. bisexual
iv. other.
10. As I read the list again please say ‘yes’ when you hear the option that best describes how you think
of yourself.
11. Have you ever injected yourself with non-prescribed drugs or other substances?
12. Since your HIV diagnosis, have there been any periods of a year or more when you have not seen a
doctor about your HIV?
If yes, when was the last time that this happened?
13. In the last 12 months, how many appointments with a doctor or nurse specialist have you missed and
not rescheduled at your HIV clinic?
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Appendix 5 Topic guide: in-depth interviews
 
Topic guide – in-depth interviews 
 
 Title of project: REACH 
Retention and Engagement Across Care services for HIV positive patients 
 
Researcher: Dr Fiona Burns 
 
1. INTRODUCTION 
 
2. HIV DIAGNOSIS AND LINK TO SERVICES 
i. Can you tell me how you found out you were positive? 
ii. When they told you you were HIV positive, did they give you any information 
or support? 
iii. After you were told, did you feel motivated to start attending the HIV clinic?  
Why (not)? 
iv. Can you briefly describe the HIV clinics you have used since your diagnosis? 
v. How do you feel about attending the HIV clinic at the moment?  Has that 
changed since you were first diagnosed? 
vi. How do you feel before you come to the HIV clinic / after you have been to 
the clinic?   
vii. Would you like to attend more or less often than you do at the moment?  Why 
is that? 
 
3. CURRENT HIV CLINIC ATTENDANCE 
- expectations of HIV clinic 
- appointment booking and cancellation 
- journey to the clinic  
- arriving at the clinic - impressions at arrival, reception area and reception 
staff 
- time spent waiting; impression of waiting room, facilities 
- seeing the nurse and / or doctor 
- what makes a good nurse / doctor 
- moving through the service from one part of the clinic to the next 
- seeing a peer worker for impromptu support 
- how could the clinic be improved? 
- summarise positive aspects of the clinic 
 
4. PATIENTS REGULARLY ATTENDING AN HIV CLINIC 
i. What helps you to attend regularly?  Why do you attend regularly? 
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ii. Have you ever had difficulty keeping up regular attendance – what makes it 
difficult? 
iii. Why do you not always attend regularly? 
iv. Tell me about the last time you didn’t attend an appointment. 
v. Is there anything the HIV clinic could do to help you? 
 
5. PATIENTS NOT CURRENTLY REGULARLY ATTENDING AN HIV CLINIC 
i. In the past have you attended regularly and (if so) what helped you with this?  
What helped you to attend regularly?  Why did you attend regularly? 
ii. Would you like to attend more regularly? 
iii. What makes it difficult to keep up regular attendance? 
iv. Why do you not always attend regularly?  What would make it easier?  What 
would help you to attend more regularly? What would you need to change to 
make it easier? 
v. Tell me about the last time you didn’t attend an appointment. 
vi. Is there anything an HIV clinic could do to help you? 
 
6. LIVING WITH HIV 
i. Can you tell me about the impact of HIV on your life? 
ii. Who have you told about your HIV?  Are these people able to support you?  
If so, in what ways? 
iii. Have you ever experienced stigma or discrimination because of your HIV?  
Do you worry about this?  Does it impact on your clinic attendance or taking 
ART? 
iv. Is there anything else about being HIV positive that makes it difficult to attend 
the HIV clinic regularly or take your treatments?  
 
7. TAKING ANTIRETROVIRAL THERAPY (ART) 
i. Are you taking any ART at the moment? 
- How do you feel about taking ART? 
- What makes it difficult / helps you to keep up taking ART? 
- Is there anything your HIV clinic could do to help you? 
- Does taking antiretroviral therapy affect attending the HIV clinic? 
ii. Some HIV clinics provide a delivery service – how does / would that work for 
you? 
 
8. ATTENDING OTHER NHS SERVICES 
i. How do you feel about attending the GP?  Is easier or more difficult than 
attending the HIV clinic? 
ii. Is there anything HIV clinics can learn from other NHS services? 
 
9. OTHER BARRIERS AND FACILITATORS 
i. Have you had any particular experiences that have put you off attending the 
HIV clinic?  Can you tell me more?  How did it make you feel? 
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ii. What other agencies – charities, other services – have helped you along the 
way? 
iii. Has an agency, service or individual ever done something particular that has 
helped you engage with the HIV clinic?  Can you tell me more about that? 
 
10. TO CONCLUDE 
i. Is there anything that you would like to tell us about attending the HIV clinic 
and taking ART that we haven’t covered in the interview? 
ii. Do you have any questions? 
 
 
      Version 1: 
21.11.2013 
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Appendix 6 Topic guide: key informant interviews
 
 
 
Topic guide – key informant interviews 
 
 Title of project: REACH 
Retention and Engagement Across Care services for HIV positive patients 
 
Principal investigator: Dr Fiona Burns 
 
 
 
1. In your experience, why do patients miss appointments or stop going to the HIV 
clinic? (probe motivation, opportunity, capability) 
 
2. What do you think are the most important issues to address in order to improve 
engagement in HIV care? 
 
3. If money were no object, what interventions or service improvements would you 
implement to improve engagement in HIV care? 
 
4. What interventions or service improvements do you think would be feasible to 
implement in HIV clinics to improve engagement in care? 
 
5. What kind of resources do you think you would need? 
 
6. Are there any quick wins? 
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Appendix 7 Tests per person per quarter by
starter since started antiretroviral therapy
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FIGURE 13 Liver function tests per person per quarter by starter since started ART.
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FIGURE 14 Lipid tests per person per quarter by starter since started ART.
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FIGURE 15 Full blood count tests per person per quarter by starter since started ART.
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FIGURE 16 Urea tests per person per quarter by starter since started ART.
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FIGURE 17 Creatinine tests per person per quarter by starter since started ART.
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FIGURE 18 Glucose tests per person per quarter by starter since started ART.
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